GLP-1 Market
LLY $1415.55 ▼ -1.1% NVO $40.70 ▼ -2.2% PFE $28.47 ▼ -1.4% VKTX $26.88 ▲ +0.3% KLRA $12.20 ▼ -2.9% GPCR $18.17 ▼ -2.2% RHHBY $60.28 ▼ -1.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Immunosuppressive Agents

Company
City of Hope Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
150 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

150 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026

Find a Clinical Trial Near Me

See recruiting studies for Immunosuppressive Agents and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00001352

    Fungal Infection Susceptibility

    National Institute of Allergy and Infectious Diseases (NIAID) 800 participants 1 site
    Other conditions: Cryptococcal Infection, Cryptococcal Pneumonia, Pulmonary Cryptococcosis, Cryptococcal Meningitis, Cryptococcosis
    View official trial listing →
  • Recruiting NCT NCT01283295

    Immune Monitoring and Assay Development in Organ Transplant Recipients

    Emory University 5000 participants Est. completion 2028-12 2 sites
    Other conditions: Organ Transplantation, Transplantation Immunology
    View official trial listing →
  • Recruiting NCT NCT01555892

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

    Not yet reported Baylor College of Medicine 136 participants Est. completion 2027-07-01 3 sites
    Other conditions: Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease, Lymphoma
    View official trial listing →
  • Recruiting NCT NCT02310867

    Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy

    Not yet reported Linda Cendales 50 participants Est. completion 2028-06 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT02446431

    Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

    Not yet reported Miller Children's & Women's Hospital Long Beach 20 participants Est. completion 2029-07 2 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT03092180

    Optimizing Treatment on Idiopathic Inflammatory Myopathies

    University of Sao Paulo 60 participants Est. completion 2024-12-04 1 site
    Other conditions: Idiopathic Inflammatory Myopathies
    View official trial listing →
  • Recruiting NCT NCT03173937

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 37 participants Est. completion 2032-03-01 1 site
    Other conditions: Severe Aplastic Anemia, Hypo-Plastic MDS, Myelodysplastic Syndrome (MDS)
    View official trial listing →
  • Recruiting NCT NCT03399175

    Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

    Not yet reported University of Sao Paulo 40 participants Est. completion 2028-12 1 site
    Other conditions: Vogt Koyanagi Harada Disease
    View official trial listing →
  • Recruiting NCT NCT03520647

    Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 56 participants Est. completion 2028-06-01 1 site
    Other conditions: Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
    View official trial listing →
  • Recruiting NCT NCT03591302

    Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.

    Not yet reported Stephan Busque 25 participants Est. completion 2028-10-01 1 site
    Other conditions: Immune Tolerance
    View official trial listing →
  • Recruiting NCT NCT03835312

    Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM

    Not yet reported Children's Hospital of Fudan University 50 participants Est. completion 2030-12-31 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1, Immunologic Deficiency Syndromes
    View official trial listing →
  • Recruiting NCT NCT03852407

    Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

    Not yet reported University of Liege 114 participants Est. completion 2038-11-01 10 sites
    Other conditions: Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome, Myeloproliferative Disorder, Acute Lymphoid Leukemia in Remission, Multiple Myeloma, Chronic Lymphoid Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04098133

    Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital

    University Hospital, Basel, Switzerland 100 participants Est. completion 2029-06-30 1 site
    Other conditions: Infections With CPB
    View official trial listing →
  • Recruiting NCT NCT04106830

    Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

    Beijing Tiantan Hospital 1000 participants Est. completion 2028-12-31 1 site
    Other conditions: NMO Spectrum Disorder, MRI, Multiple Sclerosis, MOGAD
    View official trial listing →
  • Recruiting NCT NCT04150744

    RFA Plus Carrizumab vs Carrizumab Alone for HCC

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 120 participants Est. completion 2026-12-30 1 site
    Other conditions: Tumor Immunity, Immunosuppression, Radiofrequency Ablation
    View official trial listing →
  • Recruiting NCT NCT04180085

    Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)

    Not yet reported Nantes University Hospital 25 participants Est. completion 2028-01-01 4 sites
    Other conditions: Heart Transplant Failure
    View official trial listing →
  • Recruiting NCT NCT04182984

    TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

    Tang-Du Hospital 200 participants Est. completion 2026-06-30 1 site
    Other conditions: Ocular Myasthenia Gravis
    View official trial listing →
  • Recruiting NCT NCT04207580

    A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.

    University Hospital, Limoges 1180 participants Est. completion 2048-01 48 sites
    Other conditions: Idiopathic Nephrotic Syndrome
    View official trial listing →
  • Recruiting NCT NCT04474847

    Abatacept for the Treatment of Giant Cell Arteritis

    Not yet reported University of Pennsylvania 78 participants Est. completion 2029-12 10 sites
    Other conditions: Giant Cell Arteritis
    View official trial listing →
  • Recruiting NCT NCT04521790

    Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

    Scientific Institute San Raffaele 1000 participants Est. completion 2035-12-31 1 site
    Other conditions: Myocarditis, Ventricular Arrythmia, Inflammatory Cardiomyopathy, Genetic Predisposition, Autoimmunity, Arrhythmia, Cardiomyopathies, Immunosuppression, Catheter Ablation
    View official trial listing →
  • Recruiting NCT NCT04545762

    Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

    Not yet reported C. Babis Andreadis 36 participants Est. completion 2026-10-31 1 site
    Other conditions: Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Diffuse Large B Cell Lymphoma, Small Lymphocytic Lymphoma, Transformed Lymphoma, Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04625907

    FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

    Not yet reported, Not yet reported University of Birmingham 1672 participants Est. completion 2030-06 128 sites
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT04702022

    Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients

    Not yet reported University of Liege 50 participants Est. completion 2027-01-01 1 site
    Other conditions: Kidney Transplant Rejection, Kidney Transplant; Complications
    View official trial listing →
  • Recruiting NCT NCT04742621

    Liver Transplantation for Unresectable Liver Limited Colorectal Metastases

    Weill Medical College of Cornell University 20 participants Est. completion 2035-07-27 1 site
    Other conditions: Unresectable Liver-limited Colorectal Metastases
    View official trial listing →
  • Recruiting NCT NCT04745728

    Different Immunosuppressive Treatment in iMN

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2029-12 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04877288

    A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

    Not yet reported Bristol-Myers Squibb 102 participants Est. completion 2034-06-30 38 sites
    Other conditions: Renal Allograft Recipients
    View official trial listing →
  • Recruiting NCT NCT04888741

    Methods of T Cell Depletion Trial (MoTD)

    Not yet reported University of Birmingham 400 participants Est. completion 2027-08-23 17 sites
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Chronic Myelogenous Leukemia, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT04924491

    Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children

    Not yet reported, Not yet reported Rafael Correa-Rocha 11 participants Est. completion 2026-12-31 1 site
    Other conditions: Heart Transplantation
    View official trial listing →
  • Recruiting NCT NCT04936854

    Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

    Not yet reported Haukeland University Hospital 60 participants Est. completion 2028-12 1 site
    Other conditions: Thyroid-Associated Ophthalmopathy
    View official trial listing →
  • Recruiting NCT NCT04972760

    Baricitinib in Patients With Relapsing or naïve Dermatomyositis

    Not yet reported Assistance Publique - Hôpitaux de Paris 62 participants Est. completion 2028-02-28 1 site
    Other conditions: Dermatomyositis
    View official trial listing →
  • Recruiting NCT NCT05043870

    Combined Immunosuppression for Pediatric Crohn's Disease

    Not yet reported Children's Hospital of Fudan University 128 participants Est. completion 2026-12-31 1 site
    Other conditions: Crohn Disease, Infliximab, Immunosuppression, Children, Only
    View official trial listing →
  • Recruiting NCT NCT05284877

    The Organ Transplant Recipient HPV and Skin Cancer Study

    Merete Haedersdal 1500 participants Est. completion 2043-03 3 sites
    Other conditions: Solid Organ Transplant Recipient, Skin Cancer, Skin Dysplasia, HPV Infection, Cervical Intraepithelial Neoplasia, Cervical Cancer, HPV-Related Malignancy
    View official trial listing →
  • Recruiting NCT NCT05305066

    Stand UP to Rheumatoid Arthritis (SUPRA)

    Not yet reported Marie Hudson, MD 75 participants Est. completion 2030-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT05321758

    Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease

    Not yet reported Tongji Hospital 50 participants Est. completion 2027-06-30 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT05385432

    Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies

    Not yet reported University Hospital, Tours 244 participants Est. completion 2030-12-30 1 site
    Other conditions: Renal Transplant Rejection, Induction Therapy
    View official trial listing →
  • Recruiting NCT NCT05415267

    Immunosuppression and COVID-19 Boosters

    Not yet reported Kirby Institute 320 participants Est. completion 2026-12-31 5 sites
    Other conditions: COVID-19
    View official trial listing →
  • Recruiting NCT NCT05436418

    The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

    Not yet reported, Not yet reported National Cancer Institute (NCI) 260 participants Est. completion 2028-06-25 2 sites
    Other conditions: Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05463133

    Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2032-12-31 1 site
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Recruiting NCT NCT05510323

    Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

    Not yet reported Air Force Military Medical University, China 208 participants Est. completion 2028-08 1 site
    Other conditions: Glomerulonephritis, IGA
    View official trial listing →
  • Recruiting NCT NCT05525507

    Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

    Not yet reported University of California, Los Angeles 10 participants Est. completion 2026-12 1 site
    Chronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT05698745

    Immunological Characteristics of Preclinical IBD

    Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 450 participants Est. completion 2038-07-01 25 sites
    Other conditions: Crohn Disease, Ulcerative Colitis, IBD
    View official trial listing →
  • Recruiting NCT NCT05826535

    Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

    Not yet reported, Not yet reported Lyell Immunopharma, Inc. 270 participants Est. completion 2031-06-30 35 sites
    Other conditions: Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Large B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05832515

    AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis

    Not yet reported St. Petersburg State Pavlov Medical University 200 participants Est. completion 2026-12-01 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT05860400

    Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

    Peking Union Medical College Hospital 39 participants Est. completion 2026-09 1 site
    Cardiovascular disease Other conditions: Coronary Artery Stenosis, Coronary Artery Restenosis, Inflammation, Inflammatory Disease, Inflammation Vascular
    View official trial listing →
  • Recruiting NCT NCT05888870

    ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 50 participants Est. completion 2026-12-01 1 site
    Other conditions: Hemophilia A With Inhibitor
    View official trial listing →
  • Recruiting NCT NCT05908331

    MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    Not yet reported Concept Medical Inc. 492 participants Est. completion 2028-07 28 sites
    Cardiovascular disease Other conditions: In-Stent Restenosis
    View official trial listing →
  • Recruiting NCT NCT05946564

    A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

    Not yet reported Assistance Publique - Hôpitaux de Paris 126 participants Est. completion 2028-11 25 sites
    Other conditions: ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis
    View official trial listing →
  • Recruiting NCT NCT05947669

    Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis

    Not yet reported Odense University Hospital 195 participants Est. completion 2028-09 3 sites
    Other conditions: Colitis
    View official trial listing →
  • Recruiting NCT NCT05998759

    Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

    Not yet reported Beijing Hospital 296 participants Est. completion 2025-12 23 sites
    Other conditions: Connective Tissue Diseases, Thrombocytopenia
    View official trial listing →
  • Recruiting NCT NCT06005493

    Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

    Not yet reported, Not yet reported AstraZeneca 392 participants Est. completion 2029-03-16 25 sites
    Other conditions: Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma, Esophageal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06047171

    Rescue of Nephrons With ALE.F02 (RENAL-F02)

    Not yet reported Alentis Therapeutics AG 80 participants Est. completion 2028-02-28 53 sites Stand-alone
    Other conditions: Glomerulonephritis Rapidly Progressive
    View official trial listing →
  • Recruiting NCT NCT06048484

    Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

    Not yet reported Gulam Manji 60 participants Est. completion 2027-04 5 sites
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06058078

    RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

    Not yet reported Jiangsu Renocell Biotech Company 60 participants Est. completion 2028-12-31 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Recruiting NCT NCT06059989

    InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 158 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Inflammatory Disease, Disease Crohn, Bowel Disease
    View official trial listing →
  • Recruiting NCT NCT06072482

    A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

    Not yet reported Amgen 300 participants Est. completion 2036-12-31 82 sites
    Other conditions: Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    View official trial listing →
  • Recruiting NCT NCT06193889

    KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

    Not yet reported, Not yet reported Kyverna Therapeutics 66 participants Est. completion 2028-09 22 sites
    Other conditions: Myasthenia Gravis, Generalized Myasthenia Gravis
    View official trial listing →
  • Recruiting NCT NCT06213857

    Beneficial Effect of Silymarin in Ulcerative Colitis

    Not yet reported Tanta University 44 participants Est. completion 2025-06 2 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT06249750

    Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

    Not yet reported Pengyuan Liu 60 participants Est. completion 2026-12-31 1 site
    Other conditions: Metastatic Castration-resistant Prostate Cancer (CRPC)
    View official trial listing →
  • Recruiting NCT NCT06254248

    Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

    Not yet reported Assistance Publique - Hôpitaux de Paris 50 participants Est. completion 2030-01-01 10 sites
    Other conditions: Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic Treatment
    View official trial listing →
  • Recruiting NCT NCT06262776

    Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

    Not yet reported Central Adelaide Local Health Network Incorporated 160 participants Est. completion 2027-12 1 site
    Other conditions: Immunosuppression, Vaccine Response Impaired
    View official trial listing →
  • Recruiting NCT NCT06271590

    MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

    Not yet reported Concept Medical Inc. 1605 participants Est. completion 2031-11 24 sites
    Cardiovascular disease Other conditions: Native Coronary Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT06327568

    Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens

    European Institute of Oncology 200 participants Est. completion 2029-06-17 1 site
    Other conditions: Anal Intraepithelial Neoplasia 2, Anal Intraepithelial Neoplasia 1, Anal Cancer, High-Risk Cancer
    View official trial listing →
  • Recruiting NCT NCT06347718

    CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

    Not yet reported, Not yet reported Miltenyi Biomedicine GmbH 24 participants Est. completion 2026-05-31 1 site
    Other conditions: Systemic Lupus Erythematosus, Systemic Sclerosis, Dermatomyositis, Polymyositis
    View official trial listing →
  • Recruiting NCT NCT06354179

    Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

    Not yet reported University Hospital, Limoges 162 participants Est. completion 2028-04-15 18 sites
    Other conditions: Liver Transplantation, Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT06358638

    Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

    Not yet reported Children's National Research Institute 12 participants Est. completion 2054-09 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT06363006

    Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

    Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2027-01-01 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06371274

    A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

    Not yet reported First Affiliated Hospital of Zhejiang University 29 participants Est. completion 2026-04-30 1 site
    Other conditions: Triple-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06472219

    PREDICATE Trial For Respiratory Tract Infections

    Not yet reported The University of Hong Kong 1300 participants Est. completion 2028-12-08 1 site
    Other conditions: Respiratory Tract Infections
    View official trial listing →
  • Recruiting NCT NCT06552169

    REgulatory T Cell Therapy to Achieve Immunosuppression REduction

    Not yet reported Singulera Therapeutics Inc. 34 participants Est. completion 2031-12 7 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06591260

    Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)

    Scientific Institute San Raffaele 20 participants Est. completion 2030-12-31 1 site
    Other conditions: Myocarditis, Ventricular Arrhythmia, Inflammatory Cardiomyopathy, Genetic Predisposition, Autoimmunity, Arrhythmia, Cardiomyopathies, Immunosuppresion, Catheter Ablation
    View official trial listing →
  • Recruiting NCT NCT06594068

    Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

    Not yet reported AstraZeneca 16 participants Est. completion 2027-08-31 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT06609668

    Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

    Centre Hospitalier Universitaire Dijon 78 participants Est. completion 2027-10 1 site
    Other conditions: Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)
    View official trial listing →
  • Recruiting NCT NCT06646497

    Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

    Not yet reported Assistance Publique - Hôpitaux de Paris 52 participants Est. completion 2030-01-24 26 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT06652126

    Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria

    University Hospital, Lille 1000 participants Est. completion 2029-12-01 1 site
    Other conditions: Critically-ill Patients
    View official trial listing →
  • Recruiting NCT NCT06659029

    Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

    AstraZeneca 442 participants Est. completion 2031-04-15 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT06682169

    Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 182 participants Est. completion 2030-12 41 sites
    Other conditions: Graft-versus-host Disease
    View official trial listing →
  • Recruiting NCT NCT06692426

    Trial of Cell Based Therapy for DMD

    Not yet reported Masonic Cancer Center, University of Minnesota 8 participants Est. completion 2027-03-03 1 site
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Recruiting NCT NCT06750172

    Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method

    Peking Union Medical College Hospital 33 participants Est. completion 2024-12-25 1 site
    Other conditions: Primary Aldosteronism
    View official trial listing →
  • Recruiting NCT NCT06751992

    Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

    Not yet reported Massachusetts General Hospital 92 participants Est. completion 2027-10-01 1 site
    Other conditions: Kidney Transplant Recipients, Old Age
    View official trial listing →
  • Recruiting NCT NCT06753565

    L-carnitine Supplementation in Rheumatoid Arthritis Patients

    Not yet reported German University in Cairo 60 participants Est. completion 2025-06 1 site
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Recruiting NCT NCT06763848

    Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 144 participants Est. completion 2026-12-31 1 site
    Other conditions: Neuromyelitis Optica Spectrum Disorders
    View official trial listing →
  • Recruiting NCT NCT06789172

    A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

    Not yet reported Epkin 146 participants Est. completion 2028-09 10 sites
    Obstructive sleep apnea Other conditions: Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer, NSCLC, Colorectal Cancer (CRC), Solitary Fibrous Tumors, Undifferentiated Pleomorphic Sarcoma (UPS), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic, Gastric / Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06795893

    The Anifrolumab PRIM Program

    AstraZeneca 240 participants Est. completion 2031-04-15 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT06801067

    A Study of SER-155 to Treat Diarrhea in People on Immunotherapy

    Not yet reported Memorial Sloan Kettering Cancer Center 15 participants Est. completion 2027-01-24 7 sites
    Other conditions: Diarrhea, Enterocolitis
    View official trial listing →
  • Recruiting NCT NCT06817525

    Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

    Not yet reported Henan Cancer Hospital 64 participants Est. completion 2026-05-31 1 site
    Other conditions: Triple-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06821919

    Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)

    Western Galilee Hospital-Nahariya 70 participants Est. completion 2031-12-30 1 site
    Other conditions: Diabetes Mellitus, Kidney Disease
    View official trial listing →
  • Recruiting NCT NCT06824714

    Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System

    Nanjing Medical University 150 participants Est. completion 2028-07-01 1 site
    Other conditions: Large Vessel Vasculitis
    View official trial listing →
  • Recruiting NCT NCT06829719

    TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

    Not yet reported Hospices Civils de Lyon 600 participants Est. completion 2031-02-02 4 sites
    Other conditions: Infection, Cancer, Rejection, Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06829771

    Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma

    Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90 participants Est. completion 2026-12 25 sites
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06834191

    Relationship Between Immunosuppressive Treatment Status and Clinical Course of Parkinson's Disease

    Medical University of Warsaw 80 participants Est. completion 2028-09 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06845410

    Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study

    Peking Union Medical College Hospital 120 participants Est. completion 2026-12 1 site
    Cardiovascular disease Other conditions: Coronary Artery Stenosis, Coronary Artery Restenosis, Inflammation, Inflammatory Disease, Inflammation Vascular
    View official trial listing →
  • Recruiting NCT NCT06859424

    A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Center for International Blood and Marrow Transplant Research 358 participants Est. completion 2028-06 13 sites Stand-alone
    Other conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06859437

    Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department

    Not yet reported Medical University of Silesia 300 participants Est. completion 2027-10-31 1 site
    Other conditions: Clostridioides Difficile Infection
    View official trial listing →
  • Recruiting NCT NCT06864975

    Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

    Not yet reported Runhui WU 110 participants Est. completion 2028-06-21 1 site
    Other conditions: Hemophilia a with Inhibitor
    View official trial listing →
  • Recruiting NCT NCT06866119

    Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency

    Massachusetts General Hospital 45 participants Est. completion 2029-06-30 1 site
    Other conditions: Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications, Endothelial Function (FMD), Estrogen Replacement Therapy
    View official trial listing →
  • Recruiting NCT NCT06873100

    Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

    Not yet reported, Not yet reported Peking University People's Hospital 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Relapsing Polychondritis
    View official trial listing →
  • Recruiting NCT NCT06874257

    Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 20 participants Est. completion 2026-10-31 1 site
    Other conditions: AML (Acute Myelogenous Leukemia)
    View official trial listing →
  • Recruiting NCT NCT06881927

    Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

    Not yet reported University Hospital, Strasbourg, France 212 participants Est. completion 2029-08-01 1 site
    Other conditions: Sepsis and Septic Shock, Acute Respiratory Failure, Kidney Transplant Recipients, Immunosuppressive Agents
    View official trial listing →
  • Recruiting NCT NCT06885957

    Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

    Tongji Hospital 200 participants Est. completion 2027-12-31 1 site
    Other conditions: NMO Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT06900777

    Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT

    Not yet reported Xijing Hospital 90 participants Est. completion 2026-04-01 1 site
    Other conditions: Vitiligo, Child, Progressive Disease
    View official trial listing →
  • Recruiting NCT NCT06902896

    Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy

    Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 43 participants Est. completion 2028-12-31 1 site
    Heart failure Other conditions: Dilated Cardiomyopathy (DCM)
    View official trial listing →
  • Recruiting NCT NCT06962800

    A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

    Not yet reported Biogen 180 participants Est. completion 2031-01-17 117 sites
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT06981767

    Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus

    Not yet reported Cairo University 42 participants Est. completion 2026-08-15 1 site
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Recruiting NCT NCT07003997

    JAK Signaling in Depression

    Not yet reported Emory University 100 participants Est. completion 2030-02 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Recruiting NCT NCT07015684

    131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

    Not yet reported Columbia University 24 participants Est. completion 2032-03-12 1 site
    Other conditions: Sickling Disorder Due to Hemoglobin S
    View official trial listing →
  • Recruiting NCT NCT07021495

    SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

    Leiden University Medical Center 840 participants Est. completion 2029-12-31 8 sites
    Other conditions: Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO), Atopic Dermatitis (AD), CTCL/ Mycosis Fungoides
    View official trial listing →
  • Recruiting NCT NCT07042035

    Study of Tacrolimus Melt-Dose® for Lung Transplant Patients

    Chiesi España, S.A.U. 240 participants Est. completion 2026-12-31 2 sites
    Other conditions: Lung Trasplant, Lung Transplantation
    View official trial listing →
  • Recruiting NCT NCT07045467

    Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study

    Not yet reported Qianfoshan Hospital 30 participants Est. completion 2027-06-01 1 site
    Chronic kidney disease Other conditions: Renal Transplantation
    View official trial listing →
  • Recruiting NCT NCT07053462

    CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

    Not yet reported, Not yet reported AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90 participants Est. completion 2028-12-28 1 site
    Other conditions: End-Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Disease With Renal Transplant, Kidney Transplant Rejection, Kidney Tumor, Kidney Failure, Kidney Ischemia
    View official trial listing →
  • Recruiting NCT NCT07053488

    CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

    Not yet reported, Not yet reported AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90 participants Est. completion 2028-12-28 1 site
    Other conditions: Liver Diseases, Liver Cancer, Liver Cirrhosis, Liver Failure, Liver Metastases, Liver Transplant Rejection, Liver Steatoses
    View official trial listing →
  • Recruiting NCT NCT07074951

    Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

    Not yet reported St. Petersburg State Pavlov Medical University 240 participants Est. completion 2027-12-10 2 sites
    Other conditions: Primary IgA-nephropathy, High-risk, Caucasians
    View official trial listing →
  • Recruiting NCT NCT07077486

    Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

    Not yet reported Tongji Hospital 100 participants Est. completion 2027-03-25 1 site
    Other conditions: Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT07084480

    Giant Cell Arteritis - Ways to Precision Medicine

    Wuerzburg University Hospital 400 participants Est. completion 2033-07-31 1 site
    Other conditions: Giant Cell Arteritis, Polymyalgia Rheumatic (PMR)
    View official trial listing →
  • Recruiting NCT NCT07104058

    A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

    Not yet reported Luo Yaping 46 participants Est. completion 2027-12-01 1 site
    Other conditions: IgG4-Related Diseases
    View official trial listing →
  • Recruiting NCT NCT07120464

    Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

    Liaoning Chengda Biotechnology CO., LTD 180 participants Est. completion 2026-12-31 1 site
    Other conditions: Rabies Exposure, Immunocompromised, Chronic Disease
    View official trial listing →
  • Recruiting NCT NCT07138898

    Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

    Not yet reported NYU Langone Health 80 participants Est. completion 2028-01 1 site
    Other conditions: Rheumatic Disease
    View official trial listing →
  • Recruiting NCT NCT07143773

    SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients

    Not yet reported Odense University Hospital 88 participants Est. completion 2027-08-01 1 site
    Other conditions: Kidney Transplantation Recipients, Sodium-Glucose Transporter 2 Inhibitors, Non-Diabetic Patients, Randomized Controlled Trial, Placebo Control Design
    View official trial listing →
  • Recruiting NCT NCT07173114

    New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)

    University Hospital, Montpellier 300 participants Est. completion 2026-09-22 2 sites
    Other conditions: Hospitalization, All Conditions
    View official trial listing →
  • Recruiting NCT NCT07175285

    A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

    Bristol-Myers Squibb 223 participants Est. completion 2032-10-05 70 sites
    Other conditions: Systemic Lupus Erythematosus (SLE)
    View official trial listing →
  • Recruiting NCT NCT07214818

    SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

    Not yet reported, Not yet reported Mansoura University 75 participants Est. completion 2026-09-06 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Recruiting NCT NCT07242092

    Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs

    Not yet reported University of Sao Paulo General Hospital 192 participants Est. completion 2028-12-30 1 site
    Other conditions: Autoimmune Rheumatic Diseases
    View official trial listing →
  • Recruiting NCT NCT07258524

    PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis

    University of Edinburgh 120 participants Est. completion 2029-01 1 site
    Other conditions: ANCA Associated Vasculitis (AAV)
    View official trial listing →
  • Recruiting NCT NCT07275632

    The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients

    Not yet reported, Not yet reported First Affiliated Hospital of Chongqing Medical University 47 participants Est. completion 2026-12-31 2 sites
    Other conditions: Delayed Graft Function, Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT07276425

    Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis

    UMC Utrecht 40 participants Est. completion 2028-06-01 1 site
    Other conditions: Prurigo Nodularis (PN)
    View official trial listing →
  • Recruiting NCT NCT07288918

    The Effect of Education on Quality of Life, Adherence to Immunosuppressive Therapy and Symptom Control in Organ Transplant Patients

    Not yet reported Ondokuz Mayıs University 108 participants Est. completion 2027-05-30 1 site
    Other conditions: Organ Transplantation, Mobile Applications, Nursing
    View official trial listing →
  • Recruiting NCT NCT07295535

    Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised and Healthy Cohorts

    Fondazione IRCCS Policlinico San Matteo di Pavia 40 participants Est. completion 2027-09-30 1 site
    Other conditions: Immuno-modulation, Immuno-suppression, Immunocompromised Patients, Healthy Subjects, Oncological Patients
    View official trial listing →
  • Recruiting NCT NCT07319598

    A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease

    Not yet reported Peking University Third Hospital 100 participants Est. completion 2027-01-01 1 site
    Other conditions: Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung Disease
    View official trial listing →
  • Recruiting NCT NCT07340463

    The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

    Not yet reported Nanjing University School of Medicine 50 participants Est. completion 2029-06 1 site
    Other conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
    View official trial listing →
  • Recruiting NCT NCT07383649

    Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

    Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2030-05 1 site
    Other conditions: Brain Cancer Metastatic, CMV Viremia
    View official trial listing →
  • Recruiting NCT NCT07410039

    Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

    Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2029-06-30 1 site
    Other conditions: Neuromyelitis Optica Spectrum Disorder Attack
    View official trial listing →
  • Recruiting NCT NCT07426484

    Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

    Not yet reported Dana-Farber Cancer Institute 80 participants Est. completion 2032-12-15 2 sites
    Other conditions: Cutaneous Squamous Cell Carcinoma, Skin Cancer
    View official trial listing →
  • Recruiting NCT NCT07430306

    A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    Not yet reported AstraZeneca 245 participants Est. completion 2029-01-26 108 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT07493395

    Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

    Not yet reported University Hospital, Montpellier 6 participants Est. completion 2028-06-11 4 sites
    Other conditions: Scleroderma, Systemic
    View official trial listing →
  • Recruiting NCT NCT07503652

    Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

    Not yet reported First Hospital of China Medical University 10 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Palmoplantar Pustulosis (PPP)
    View official trial listing →
  • Recruiting NCT NCT07505199

    Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2029-04-01 1 site
    Other conditions: Ischemic Cardiomyopathy, Cell Therapy
    View official trial listing →
  • Recruiting NCT NCT07516288

    Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 5 participants Est. completion 2027-12-31 1 site
    Heart failure Other conditions: Dilated Cardiomyopathy (DCM)
    View official trial listing →
  • Recruiting NCT NCT07529171

    HBV Reactivation in Immunocompromised Patients (REANT STUDY)

    Yaşar Bayındır, MD 490 participants Est. completion 2029-12-31 16 sites
    Other conditions: HBV
    View official trial listing →
  • Recruiting NCT NCT07548177

    Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33 participants Est. completion 2029-06 15 sites
    Other conditions: Alveolar Soft Part Sarcoma
    View official trial listing →
  • Recruiting NCT NCT07572071

    Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease

    Not yet reported Royan Institute 6 participants Est. completion 2030-08-01 3 sites
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07581704

    Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

    Not yet reported Christopher Strouse 10 participants Est. completion 2029-10-01 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT07607873

    TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases

    Not yet reported Niguarda Hospital 70 participants Est. completion 2031-06-15 1 site
    Other conditions: Colorectal Liver Metastases
    View official trial listing →
  • Recruiting NCT NCT07679412

    Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.

    Not yet reported LucasBio 5 participants Est. completion 2027-08-14 1 site
    Other conditions: CMV Retinitis
    View official trial listing →
  • Recruiting NCT NCT07717281

    PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 40 participants Est. completion 2028-03-31 1 site
    Other conditions: Myasthenia Gravis Generalized
    View official trial listing →
  • Recruiting NCT NCT07718204

    The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients

    Not yet reported Nationwide Children's Hospital 25 participants Est. completion 2028-12-31 1 site
    Other conditions: Hematopoietic Cell Transplant
    View official trial listing →
  • Recruiting NCT NCT07775235

    Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

    Singapore General Hospital 80 participants Est. completion 2029-07-01 1 site
    Other conditions: Interstitial Lung Disease, Myositis
    View official trial listing →
  • Recruiting NCT NCT07815834

    FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)

    Not yet reported Fudan University 198 participants Est. completion 2031-03-01 1 site
    Other conditions: Colon Rectal Cancer Adenocarcinoma, Peritoneal (Metastatic) Cancer, Second-line Treatment, Radiation Therapy, Immunotherapy
    View official trial listing →
  • Recruiting NCT NCT07843381

    Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease

    Peking University People's Hospital 60 participants Est. completion 2027-11-20 1 site
    Other conditions: Sjögren's Disease, Interstitial Lung Disease
    View official trial listing →
  • Recruiting NCT NCT07875595

    Immune Biomarkers for Predicting Complications After Liver Transplantation

    Hospital Italiano de Buenos Aires 60 participants Est. completion 2028-03 3 sites
    Other conditions: Liver Transplantation (LT), Immuno-suppression, Biomarkers / Blood, Rejection, Infections
    View official trial listing →
  • Recruiting NCT NCT07895394

    Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients

    Not yet reported Seoul National University Hospital 80 participants Est. completion 2028-10 1 site
    Other conditions: Vaccination, Respiratory Syncytial Virus (RSV), Lung Transplant Recipient
    View official trial listing →
  • Recruiting NCT NCT07904546

    ADBest TREAT Registry

    Universitätsklinikum Hamburg-Eppendorf 5000 participants Est. completion 2032-12-31 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT00000880

    A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 30 participants Est. completion 2000-05 12 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00001212

    Drug Therapy in Lupus Nephropathy

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45 participants Est. completion 2004-09 1 site
    Other conditions: Nephrotic Syndrome, Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00001637

    Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 28 participants Est. completion 2016-12-28 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Graft vs Host Disease, Leukemia, Myelodysplastic Syndrome, Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00001764

    Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2004-06 1 site
    Other conditions: Vasculitis, Wegener's Granulomatosis
    View official trial listing →
  • Completed NCT NCT00001839

    A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

    Not yet reported National Institutes of Health Clinical Center (CC) 182 participants Est. completion 2000-05 1 site
    Other conditions: Hematologic Diseases, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00001962

    A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 100 participants Est. completion 2010-09 1 site
    Other conditions: Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia
    View official trial listing →
  • Completed NCT NCT00002657

    SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

    Not yet reported SWOG Cancer Research Network 20 participants Est. completion 2011-07 86 sites
    Other conditions: Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003657

    High-dose ICE With Amifostine

    Not yet reported Dana-Farber Cancer Institute 24 participants Est. completion 2002-06 3 sites
    Other conditions: Bladder Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00004567

    Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2004-06 1 site
    Other conditions: Vasculitis, Wegener's Granulomatosis
    View official trial listing →
  • Completed NCT NCT00006178

    Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12 participants Est. completion 2007-12 1 site
    Other conditions: Kidney Failure
    View official trial listing →
  • Completed NCT NCT00009009

    Kidney Transplant for HIV-Infected Patients in Renal Failure

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10 participants Est. completion 2002-12 1 site
    Other conditions: Chronic Kidney Failure, HIV Infection
    View official trial listing →
  • Completed NCT NCT00010283

    Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2002-07 1 site
    Other conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00016419

    S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

    Not yet reported SWOG Cancer Research Network 130 participants Est. completion 2007-01 94 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00021645

    Vitamin E to Treat Uveitis-Associated Macular Edema

    Not yet reported National Eye Institute (NEI) 80 participants Est. completion 2004-06 1 site
    Other conditions: Cystoid Macular Edema, Uveitis
    View official trial listing →
  • Terminated NCT NCT00023244

    Steroid Withdrawal in Pediatric Kidney Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 274 participants Est. completion 2005-06 19 sites
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT00023790

    Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

    Not yet reported Case Comprehensive Cancer Center 3 participants Est. completion 2006-02 1 site
    Other conditions: Breast Cancer, Head and Neck Cancer, Lymphoma, Metastatic Cancer, Non-melanomatous Skin Cancer, Sarcoma
    View official trial listing →
  • Completed NCT NCT00027560

    Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 51 participants Est. completion 2009-04 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00033475

    Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation

    Not yet reported University of Edinburgh 50 participants 12 sites
    Other conditions: Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT00045305

    Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

    Not yet reported Eastern Cooperative Oncology Group 17 participants Est. completion 2014-09 6 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00049296

    Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

    Not yet reported Case Comprehensive Cancer Center 26 participants Est. completion 2006-01 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00056355

    Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2005-11 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT00061360

    Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 77 participants Est. completion 2015-09-08 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00064714

    Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes

    Not yet reported AstraZeneca 47 participants Est. completion 2008-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00075075

    Infliximab to Treat Non-Infectious Scleritis

    Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2007-09-06 1 site
    Other conditions: Scleritis
    View official trial listing →
  • Completed NCT NCT00078559

    Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

    Not yet reported, Not yet reported University of Wisconsin, Madison 10 participants Est. completion 2010-02 1 site
    Other conditions: Kidney Transplantation, Kidney Disease
    View official trial listing →
  • Completed NCT NCT00080431

    Daclizumab to Treat HIV-Infected Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2007-12-28 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Terminated NCT NCT00089141

    Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

    Not yet reported Martin, Paul 151 participants Est. completion 2008-09 16 sites
    Other conditions: Cancer
    View official trial listing →
  • Withdrawn NCT NCT00093678

    Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

    Not yet reported Eastern Cooperative Oncology Group
    Other conditions: Cachexia, Lymphoma, Melanoma (Skin), Ovarian Cancer, Pain, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00100178

    New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 126 participants Est. completion 2008-04 11 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00104338

    Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

    Not yet reported Astellas Pharma Inc 45 participants Est. completion 2006-08 21 sites
    Other conditions: BK Polyomavirus, Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00104858

    Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet reported Fred Hutchinson Cancer Center 66 participants Est. completion 2018-03-30 5 sites
    Other conditions: Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma, T-Cell Large Granular Lymphocyte Leukemia
    View official trial listing →
  • Completed NCT NCT00105235

    Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 27 participants Est. completion 2011-03 9 sites
    Other conditions: Liver Disease, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00106392

    A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

    Not yet reported Astellas Pharma Inc 131 participants Est. completion 2008-11 6 sites
    Other conditions: Erectile Dysfunction, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00106639

    A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients

    Not yet reported Pfizer 61 participants Est. completion 2006-07 20 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00114530

    Scleroderma: Cyclophosphamide or Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2016-04 17 sites
    Other conditions: Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    View official trial listing →
  • Completed NCT NCT00116090

    Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

    National Eye Institute (NEI) 6300 participants Est. completion 2008-04-21 4 sites
    Other conditions: Uveitis, Cancer, Infection, Mortality, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00125307

    Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

    Not yet reported Chinese University of Hong Kong 20 participants Est. completion 2008-02 1 site
    Other conditions: Lupus Nephritis, Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00128193

    Leprosy Skin Test Antigens Trial

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 260 participants Est. completion 2009-09 6 sites
    Other conditions: Leprosy
    View official trial listing →
  • Completed NCT NCT00132691

    Multicenter Uveitis Steroid Treatment (MUST) Trial

    Not yet reported JHSPH Center for Clinical Trials 255 participants Est. completion 2010-12 23 sites
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT00135954

    Treatment of Patients With Idiopathic Membranous Nephropathy

    Not yet reported Radboud University Medical Center 29 participants Est. completion 2008-07 1 site
    Other conditions: Glomerulonephritis, Membranous
    View official trial listing →
  • Completed NCT NCT00143845

    Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

    Not yet reported University of Michigan Rogel Cancer Center 54 participants Est. completion 2013-02 1 site
    Other conditions: Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade
    View official trial listing →
  • Terminated NCT NCT00148252

    Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

    Not yet reported University of Oslo School of Pharmacy 298 participants Est. completion 2007-02 9 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00149864

    Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302

    Not yet reported Novartis 264 participants Est. completion 2003-12
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00149916

    Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

    Not yet reported Novartis Pharmaceuticals 139 participants
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00149929

    Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

    Not yet reported Novartis 246 participants Est. completion 2003-04
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00150891

    Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection

    University of Giessen 84 participants Est. completion 2006-01 1 site
    Other conditions: Renal Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00154232

    Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

    Not yet reported Novartis Pharmaceuticals 46 participants
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00154284

    Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

    Not yet reported Novartis 114 participants Est. completion 2008-07
    Other conditions: Organ Transplantation, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00154297

    Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

    Not yet reported Novartis Pharmaceuticals 139 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00154310

    Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

    Not yet reported Novartis 300 participants Est. completion 2008-09 3 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT00159159

    LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant

    Not yet reported Hospices Civils de Lyon 106 participants 1 site
    Other conditions: Cardiac Transplantion
    View official trial listing →
  • Active, not recruiting NCT NCT00160732

    Allogenic Islet Cell Transplantation

    Not yet reported, Not yet reported University of Chicago 50 participants Est. completion 2030-10 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00160966

    Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

    Not yet reported University of Giessen 108 participants Est. completion 2010-03 1 site
    Other conditions: Polyomavirus Infections
    View official trial listing →
  • Completed NCT NCT00163657

    Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

    Not yet reported Baylor Research Institute 312 participants Est. completion 2007-01 1 site
    Other conditions: End Stage Liver Disease, Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT00166816

    The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

    Not yet reported National Taiwan University Hospital 40 participants Est. completion 2003-06 1 site
    Other conditions: Transplantation, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT00166829

    The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus

    Not yet reported National Taiwan University Hospital 40 participants 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00166842

    Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets

    Not yet reported National Taiwan University Hospital 40 participants 1 site
    Other conditions: Transplantation, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00169910

    VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients

    Not yet reported Leiden University Medical Center 119 participants Est. completion 2010-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00171496

    Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

    Not yet reported Novartis 693 participants Est. completion 2006-03
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00171509

    Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients

    Not yet reported Novartis 61 participants Est. completion 2005-10
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT00171743

    Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients

    Not yet reported Novartis 47 participants Est. completion 2006-01
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT00183248

    Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

    Not yet reported, Not yet reported University of Miami 9 participants Est. completion 2009-11 1 site
    Other conditions: Kidney Transplantation, Kidney Disease, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00189722

    Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

    Not yet reported Astellas Pharma Inc 160 participants Est. completion 2005-07 28 sites
    Other conditions: Asthma, Bronchial, Bronchial Asthma
    View official trial listing →
  • Completed NCT NCT00189787

    Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

    Not yet reported Astellas Pharma Inc 370 participants Est. completion 2005-08 49 sites
    Other conditions: Asthma, Bronchial, Bronchial Asthma
    View official trial listing →
  • Completed NCT NCT00193648

    Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

    Not yet reported Northwell Health 21 participants Est. completion 2007-10 2 sites
    Other conditions: Focal Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00195429

    A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 47 participants Est. completion 2007-10 1 site
    Other conditions: Kidney Failure, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT00195988

    Comparison of Immunosuppression Protocols After LTx in Children

    Not yet reported Children's Memorial Health Institute, Poland 40 participants Est. completion 2006-07 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00198224

    Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients

    Not yet reported Indiana University 50 participants Est. completion 2005-05 2 sites
    Other conditions: Renal Failure
    View official trial listing →
  • Status unknown NCT NCT00204191

    Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

    Not yet reported Uniwersytet Mikolaja Kopernika w Toruniu 300 participants Est. completion 2007-12 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00213590

    Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients

    Not yet reported University Hospital, Rouen 208 participants Est. completion 2006-11 1 site
    Other conditions: Kidney Transplantation, Primary Prevention, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00221026

    Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease

    Not yet reported Mallinckrodt 25 participants Est. completion 2006-06 15 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00223054

    Polymorphism of the Cytochrome P450-system in Renal Transplants

    University Hospital Schleswig-Holstein 200 participants Est. completion 2006-10 1 site
    Other conditions: Function of Renal Transplant
    View official trial listing →
  • Completed NCT NCT00229619

    Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 11 participants Est. completion 2010-06 1 site
    Other conditions: Anemia, Aplastic, Red-Cell Aplasia, Pure, Anemia, Diamond-Blackfan
    View official trial listing →
  • Withdrawn NCT NCT00230035

    Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT00235781

    Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

    Not yet reported Washington University School of Medicine 90 participants Est. completion 2006-02 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00240955

    Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

    Not yet reported Novartis 79 participants Est. completion 2006-05
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00240994

    Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 35 participants Est. completion 2009-11 4 sites
    Other conditions: Kidney Failure, Chronic, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00245037

    Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported, Not yet reported OHSU Knight Cancer Institute 147 participants Est. completion 2015-08 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition
    View official trial listing →
  • Status unknown NCT NCT00252655

    Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

    Not yet reported Wayne State University 40 participants Est. completion 2009-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00254709

    Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 66 participants Est. completion 2005-09
    Other conditions: Kidney Failure, Graft Rejection, Aged
    View official trial listing →
  • Terminated NCT NCT00260208

    Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

    Not yet reported Novartis Pharmaceuticals 361 participants 2 sites
    Other conditions: Liver Transplant, Hepatitis C
    View official trial listing →
  • Completed NCT NCT00260689

    Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 136 participants Est. completion 2016-05-04 1 site
    Other conditions: Immunosuppresion, Thrombocytopenia, Pancytopenia, Neutropenia
    View official trial listing →
  • Completed NCT NCT00261820

    Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 160 participants Est. completion 2005-01
    Other conditions: Graft Rejection, Kidney Failure, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00275522

    The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

    Not yet reported Mayo Clinic 16 participants Est. completion 2007-12 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00276250

    Islet Transplantation Using Abatacept

    Not yet reported Emory University 5 participants Est. completion 2014-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00284921

    MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

    Not yet reported Novartis Pharmaceuticals 60 participants
    Other conditions: De Novo Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00288626

    High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 25 participants Est. completion 2015-11 4 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00294112

    Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease

    Not yet reported Mesoblast, Inc. 10 participants Est. completion 2006-07-21 4 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00296296

    Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

    Not yet reported Stanford University 29 participants Est. completion 2014-10 1 site
    Type 2 diabetesChronic kidney disease Other conditions: Kidney Transplant
    View official trial listing →
  • Terminated NCT NCT00303719

    Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    Not yet reported Masonic Cancer Center, University of Minnesota 342 participants Est. completion 2019-05-08 1 site
    Other conditions: Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00306397

    Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

    Not yet reported University Hospital, Basel, Switzerland 100 participants Est. completion 2008-12 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00307593

    RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

    Not yet reported Assistance Publique - Hôpitaux de Paris 20 participants Est. completion 2007-06 1 site
    Other conditions: Wegener's Granulomatosis, Churg-Strauss Syndrome, Microscopic Polyangiitis
    View official trial listing →
  • Terminated NCT NCT00307658

    Intravenous Immunoglobulin After Relapse in Vasculitis

    Not yet reported Assistance Publique - Hôpitaux de Paris 40 participants Est. completion 2006-07 2 sites
    Other conditions: ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year, Post Treatment.
    View official trial listing →
  • Completed NCT NCT00307671

    Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

    Not yet reported Assistance Publique - Hôpitaux de Paris 108 participants Est. completion 2011-07 1 site
    Obstructive sleep apnea Other conditions: Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome
    View official trial listing →
  • Status unknown NCT NCT00319657

    Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

    Not yet reported, Not yet reported Stanford University 15 participants Est. completion 2026-07 1 site
    Other conditions: Immune Tolerance
    View official trial listing →
  • Completed NCT NCT00320606

    Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 20 participants Est. completion 2017-03-13 3 sites
    Other conditions: Liver Transplant, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00321113

    Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

    Not yet reported Astellas Pharma Inc 142 participants Est. completion 2008-03 14 sites
    Other conditions: KIDNEY TRANSPLANTATION
    View official trial listing →
  • Completed NCT NCT00321906

    Comparison of Sirolimus and Azathioprine in Lung Transplantation

    Not yet reported University of Chicago 181 participants Est. completion 2011-08 1 site
    Other conditions: Delayed Graft Function, Acute Graft Rejection
    View official trial listing →
  • Terminated NCT NCT00346151

    Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2010-02 2 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT00348153

    Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)

    Not yet reported, Not yet reported Heidelberg University 40 participants Est. completion 2013-03 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT00350181

    Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

    Not yet reported Stanford University 11 participants Est. completion 2010-04 1 site
    Other conditions: Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases, Acute GVHD
    View official trial listing →
  • Terminated NCT NCT00354198

    Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis

    Not yet reported National Taiwan University Hospital 7 participants Est. completion 2010-06 1 site
    Other conditions: Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT00355862

    Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

    Not yet reported University of Regensburg 525 participants Est. completion 2014-05 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT00359658

    Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation

    Not yet reported Hannover Medical School 40 participants Est. completion 2008-06 1 site
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT00359814

    Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation

    Not yet reported Hannover Medical School 23 participants Est. completion 2008-06 1 site
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT00364650

    Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation

    Not yet reported Swedish Medical Center 44 participants Est. completion 2009-12 1 site
    Other conditions: Immunosuppressant Associated Diarrhea
    View official trial listing →
  • Terminated NCT NCT00365274

    SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 6 participants Est. completion 2010-05 1 site
    Other conditions: Anaplastic Large Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00365521

    Prophylactic Photodynamic Therapy to Organ Transplant Patients

    Not yet reported Bispebjerg Hospital 50 participants 1 site
    Other conditions: Organ Transplants
    View official trial listing →
  • Completed NCT NCT00365846

    "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

    Not yet reported University of Wisconsin, Madison 29 participants Est. completion 2006-07 1 site
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00371826

    SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

    Not yet reported Novartis Pharmaceuticals 126 participants Est. completion 2012-06 7 sites
    Other conditions: Renal Transplanted Recipients
    View official trial listing →
  • Completed NCT NCT00377962

    Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

    Not yet reported Novartis Pharmaceuticals 282 participants Est. completion 2010-02 6 sites
    Other conditions: Disorder Related to Cardiac Transplantation
    View official trial listing →
  • Completed NCT NCT00378014

    Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

    Not yet reported Novartis Pharmaceuticals 276 participants Est. completion 2013-01 16 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00384137

    A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

    Not yet reported Astellas Pharma Inc 128 participants Est. completion 2007-07 13 sites
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT00384202

    A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients

    Not yet reported Astellas Pharma Inc 112 participants Est. completion 2007-11 13 sites
    Other conditions: Transplantation
    View official trial listing →
  • Status unknown NCT NCT00399971

    Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia

    Not yet reported, Not yet reported Shenzhen Zhongxing Yangfan Biotech Co. Ltd. 100 participants Est. completion 2009-12 1 site
    Other conditions: Anemia, Aplastic
    View official trial listing →
  • Completed NCT NCT00400400

    Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

    Not yet reported Novartis Pharmaceuticals 400 participants 53 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00402168

    A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids

    Not yet reported Bristol-Myers Squibb 173 participants Est. completion 2013-06 44 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00402532

    Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation

    Not yet reported Hannover Medical School 190 participants Est. completion 2011-12 1 site
    Other conditions: Lung Transplantation
    View official trial listing →
  • Completed NCT NCT00404794

    A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

    Not yet reported Hospital Authority, Hong Kong 20 participants Est. completion 2009-10 1 site
    Other conditions: Lupus Nephritis, Glomerulonephritis, Membranous
    View official trial listing →
  • Completed NCT NCT00404833

    Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental

    Not yet reported Hospital Authority, Hong Kong 16 participants Est. completion 2006-12 1 site
    Other conditions: Glomerulonephritis, Membranous, Glomerulosclerosis, Focal
    View official trial listing →
  • Completed NCT NCT00416546

    Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects

    Not yet reported Novartis 96 participants Est. completion 2007-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00426049

    Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

    Not yet reported German Heart Institute 484 participants 1 site
    Cardiovascular disease Other conditions: Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT00426517

    Donor Stem Cell Transplantation for Congenital Immunodeficiencies

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2019-11-01 1 site
    Other conditions: Inherited Immune Deficiencies
    View official trial listing →
  • Completed NCT NCT00431119

    Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid

    Not yet reported University Hospital Muenster 70 participants Est. completion 2000-10 11 sites
    Other conditions: Bullous Pemphigoid
    View official trial listing →
  • Completed NCT NCT00434811

    Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2014-05 8 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00434850

    Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00438984

    Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

    Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 11 participants Est. completion 2012-02 1 site
    Other conditions: Recurrent Melanoma, Stage IV Melanoma
    View official trial listing →
  • Completed NCT NCT00446264

    Islet Allotransplantation With Steroid Free Immunosuppression

    Not yet reported University Hospital, Lille 14 participants Est. completion 2009-02 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia, Metabolic Diseases
    View official trial listing →
  • Terminated NCT NCT00447265

    Etanercept for the Treatment of Lupus Nephritis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1 participants Est. completion 2009-03 6 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00464555

    Strategies to Improve Islet Survival

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-02 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00468117

    Efficacy of Islet After Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2017-07-05 10 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00468403

    LEA29Y (Belatacept) Emory Edmonton Protocol

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2013-04 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00468442

    B-Lymphocyte Immunotherapy in Islet Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2011-09 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00468871

    Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

    Not yet reported, Not yet reported Bausch & Lomb Incorporated 140 participants Est. completion 2006-06
    Other conditions: Non-infectious Uveitis
    View official trial listing →
  • Terminated NCT NCT00473824

    Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

    Not yet reported ADMA Biologics, Inc. 7 participants Est. completion 2009-02 3 sites Stand-alone
    Other conditions: Sequelae of Viral Hepatitis, Transplantation Infection, Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00474994

    Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

    Not yet reported Memorial Sloan Kettering Cancer Center 53 participants Est. completion 2010-11 2 sites
    Other conditions: Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor, Endometrial Cancer, Ovarian Cancer, Sarcoma, Small Intestine Cancer
    View official trial listing →
  • Completed NCT NCT00481481

    Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

    Not yet reported Astellas Pharma Inc 346 participants Est. completion 2009-04 56 sites
    Other conditions: Transplantation
    View official trial listing →
  • Terminated NCT NCT00481832

    Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

    Not yet reported Stanford University 50 participants Est. completion 2017-03-30 1 site
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Status unknown NCT NCT00484965

    Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis

    Not yet reported University of Rome Tor Vergata 100 participants Est. completion 2009-01 1 site
    Other conditions: Atherosclerosis, Acute-Phase Reaction
    View official trial listing →
  • Completed NCT NCT00489203

    Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 140 participants 2 sites
    Obstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Graft Versus Host Disease, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Disease, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00494741

    MMF vs. AZA for Kidney Transplantation

    Not yet reported Mario Negri Institute for Pharmacological Research 233 participants Est. completion 2017-11-29 6 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00501709

    Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus

    Not yet reported, Not yet reported University of California, San Francisco 10 participants Est. completion 2016-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT00514982

    Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2011-03-08 1 site
    Other conditions: Hermanski-Pudlak Syndrome, Colitis, Cytokines, Lymphocytes, Drug Evaluation
    View official trial listing →
  • Completed NCT NCT00531063

    This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

    Not yet reported Novartis Pharmaceuticals 237 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00531440

    This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

    Not yet reported Novartis Pharmaceuticals 256 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00533624

    Myfortic vs. Cellcept in Kidney Transplant Recipients

    Not yet reported, Not yet reported University of Miami 150 participants Est. completion 2006-02 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT00539838

    A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)

    Not yet reported Genentech, Inc. 33 participants Est. completion 2011-07-12
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00540423

    Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

    Not yet reported GlaxoSmithKline 23 participants Est. completion 2008-12 7 sites
    Other conditions: Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic
    View official trial listing →
  • Completed NCT NCT00542776

    Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

    Boston Children's Hospital 146 participants Est. completion 2008-02 1 site
    Other conditions: Inflammatory Bowel Disease (IBD), Immunosuppressed or Non-Immunosuppressed, Influenza Vaccine, Antibody Titers, Seroprotective Titers
    View official trial listing →
  • Completed NCT NCT00546546

    Early Immunosuppressants in Crohn's Disease

    Not yet reported Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 120 participants Est. completion 2013-06 26 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00554502

    Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy

    Not yet reported RWTH Aachen University 148 participants Est. completion 2015-02 34 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT00556933

    Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

    Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 site
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00565331

    Rituximab for Prevention of Rejection After Renal Transplantation

    Not yet reported, Not yet reported Radboud University Medical Center 280 participants Est. completion 2015-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00565773

    Belatacept Post Depletional Repopulation to Facilitate Tolerance

    Not yet reported Allan D Kirk, MD, PhD 40 participants Est. completion 2017-07-01 2 sites
    Other conditions: Organ Transplantation
    View official trial listing →
  • Completed NCT NCT00572585

    Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis

    Not yet reported Novartis Pharmaceuticals 60 participants Est. completion 2012-04 20 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00578448

    Belatacept Pharmacokinetic Trial in Renal Transplantation

    Not yet reported Bristol-Myers Squibb 14 participants Est. completion 2012-09 5 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT00582738

    Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

    Not yet reported Novartis Pharmaceuticals 43 participants Est. completion 2010-01 1 site
    Other conditions: Recurrent Hepatitis C
    View official trial listing →
  • Completed NCT NCT00587158

    Oral Paricalcitol in Kidney Transplant Recipients

    Not yet reported Mayo Clinic 100 participants Est. completion 2011-11 2 sites
    Other conditions: Transplant; Failure, Kidney, Renal Disease, End Stage, Hyperparathyroidism, Secondary
    View official trial listing →
  • Completed NCT NCT00604201

    Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 31 participants Est. completion 2021-09-14 1 site
    Other conditions: Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Completed NCT NCT00611351

    Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

    Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00619645

    Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

    Not yet reported University of California, Davis 8 participants Est. completion 2013-11 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00634920

    Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 204 participants Est. completion 2013-05 8 sites
    Other conditions: Renal Function
    View official trial listing →
  • Completed NCT NCT00636909

    Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

    Not yet reported Beth Israel Deaconess Medical Center 25 participants
    Other conditions: AML, ALL, CML Chronic Phase, Accelerated Phase, or Blast Crisis, CLL, MDS, RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA, APLASTIC ANEMIA, MULTIPLE MYELOMA, MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)
    View official trial listing →
  • Terminated NCT NCT00646425

    The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis

    Not yet reported Cerimon Pharmaceuticals 5 participants Est. completion 2008-11 6 sites
    Other conditions: Non-infectious Uveitis
    View official trial listing →
  • Status unknown NCT NCT00647283

    Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance

    Not yet reported Hospital Clinic of Barcelona 80 participants Est. completion 2012-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00658073

    Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts

    Not yet reported Fuzhou General Hospital 165 participants Est. completion 2010-10 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT00675441

    Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)

    Not yet reported M.D. Anderson Cancer Center 5 participants Est. completion 2011-08 1 site
    Other conditions: Graft-versus-Host Disease
    View official trial listing →
  • Completed NCT NCT00683046

    T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

    Not yet reported University of Chicago 204 participants Est. completion 2014-12 1 site
    Other conditions: Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia, Myeloproliferative Disorder, Anemia, Aplastic, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00686556

    Total Marrow Irradiation for Refractory Acute Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 12 participants Est. completion 2016-12 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT00694408

    A Pilot Trial of Pediatric Liver Transplantation Without Steroids

    Not yet reported Birmingham Women's and Children's NHS Foundation Trust 15 participants Est. completion 2011-08 1 site
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00694863

    Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy

    Not yet reported Radboud University Medical Center 20 participants Est. completion 2012-12 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT00705484

    European Safety Registry in Ulcerative Colitis (P04808)

    Merck Sharp & Dohme LLC 2239 participants Est. completion 2016-10-20
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT00706420

    Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

    Not yet reported City of Hope Medical Center 17 participants Est. completion 2027-09-13 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00706680

    Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol

    Not yet reported University Health Network, Toronto 30 participants Est. completion 2009-06 3 sites
    Other conditions: Diabetes, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00708604

    Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-06 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00709722

    Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

    Not yet reported, Not yet reported Nippon Kayaku Co., Ltd. 21 participants Est. completion 2007-04 6 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Active, not recruiting NCT NCT00716066

    Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

    Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2030-01-31 3 sites
    Other conditions: Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune, Multiple Sclerosis Transplant, MS Stem Cell Transplant, Multiple Sclerosis Stem Cell Transplant, Stiff Person Syndrome, HCT for Neurologic Autoimmune Disorders, CIDP Transplant, Myasthenia Gravis Transplant, Autoimmune Nervous System Disorder, Central Nervous System Vasculitis, Cerebellar Degeneration, Chronic Inflammatory Demyelinating Polyneuropathy, Lambert Eaton Myasthenic Syndrome, Myasthenia Gravis, Neuromyelitis Optica, Opsoclonus Myoclonus Syndrome, Rasmussen Subacute Encephalitis
    View official trial listing →
  • Completed NCT NCT00716573

    Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure

    Not yet reported Hospices Civils de Lyon 120 participants Est. completion 2014-04-17 1 site
    Other conditions: Cardiac Transplantation, Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00717379

    Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

    Not yet reported Astellas Pharma Inc 50 participants Est. completion 2008-10 6 sites
    Other conditions: Kidney Transplantation, Kidney Failure, Chronic, Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT00717470

    A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection

    Not yet reported Astellas Pharma Inc 1252 participants Est. completion 2010-03-02 110 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00717678

    A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 73 participants Est. completion 2010-04 5 sites
    Other conditions: Kidney Transplantation, Transplantation Immunology, Host vs Graft Reaction
    View official trial listing →
  • Completed NCT NCT00720408

    A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

    Not yet reported Astellas Pharma Inc 48 participants Est. completion 2009-09 4 sites
    Other conditions: Liver Transplantation, Transplantation Immunology, Host vs Graft Reaction
    View official trial listing →
  • Terminated NCT NCT00722280

    Human Upper Extremity (Hand and Forearm) Allotransplantation

    Not yet reported University of Pittsburgh 38 participants Est. completion 2017-10 1 site
    Other conditions: Amputation, Traumatic
    View official trial listing →
  • Completed NCT NCT00724529

    Post Marketing Surveillance of Remicade

    Janssen Korea, Ltd., Korea 938 participants Est. completion 2011-08
    Other conditions: Crohn's Disease, Ankylosing Spondylitis
    View official trial listing →
  • Terminated NCT NCT00727194

    Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

    Not yet reported Alexion Pharmaceuticals, Inc. 14 participants Est. completion 2011-07 25 sites
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Completed NCT NCT00727636

    Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy

    Not yet reported Boston Children's Hospital 53 participants Est. completion 2011-04 1 site
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT00729248

    The Differential Effects of 3 Different Immunosuppressive

    Northwestern University 12 participants Est. completion 2010-01 1 site
    Other conditions: Immunosuppression, Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00729768

    A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation

    Not yet reported, Not yet reported Genentech, Inc.
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00732316

    Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

    Not yet reported Asan Medical Center 54 participants Est. completion 2011-05 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00733733

    Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor

    Not yet reported Radboud University Medical Center 180 participants Est. completion 2010-06 1 site
    Other conditions: Renal Transplant Patients, Recipients of a Kidney From a Non-Heart-Beating Donor
    View official trial listing →
  • Completed NCT NCT00738257

    A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.

    Not yet reported Novartis Pharmaceuticals 126 participants 1 site
    Other conditions: Bone Loss
    View official trial listing →
  • Status unknown NCT NCT00750971

    Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)

    Not yet reported Charite University, Berlin, Germany 30 participants Est. completion 2020-08 8 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT00752479

    Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance

    Not yet reported, Not yet reported Mario Negri Institute for Pharmacological Research 4 participants Est. completion 2013-12 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00753103

    Anti-Cytokine Therapy for Vasculitis

    Not yet reported University Hospital Birmingham NHS Foundation Trust 37 participants Est. completion 2006-07 1 site
    Other conditions: Wegener's Granulomatosis, Renal Limited Vasculitis, Microscopic Polyangiitis
    View official trial listing →
  • Completed NCT NCT00755781

    Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

    Not yet reported APT Pharmaceuticals, Inc. 284 participants Est. completion 2011-11 19 sites
    Other conditions: Lung Transplant
    View official trial listing →
  • Completed NCT NCT00767650

    Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia

    National Heart, Lung, and Blood Institute (NHLBI) 7 participants Est. completion 2011-06-28 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00787722

    Hematopoietic Stem Cell Transplant in Devic's Disease

    Not yet reported, Not yet reported Northwestern University 13 participants Est. completion 2018-11 1 site
    Other conditions: Devic's Disease
    View official trial listing →
  • Completed NCT NCT00788021

    Protective Immunity Project 01

    Emory University 124 participants Est. completion 2011-10 1 site
    Other conditions: Kidney Transplantation, Immunity, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00788567

    CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants

    Not yet reported Hoffmann-La Roche 136 participants Est. completion 2008-05 9 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00790439

    Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2009-10
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00795132

    Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

    Not yet reported University of Utah 47 participants Est. completion 2009-07 1 site
    Other conditions: Acute Leukaemia, Chronic Disease, Leukemia, Myelodysplasia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00795886

    Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

    Not yet reported University of Utah 63 participants Est. completion 2010-03 1 site
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT00799799

    Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells

    Not yet reported University of Bologna 15 participants Est. completion 2009-12 1 site
    Other conditions: Myeloblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT00805428

    Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

    Clinical Hospital Center, Split 32 participants 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00805571

    Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

    Northwell Health 120 participants 1 site
    Other conditions: Kidney Transplant Dysfunction
    View official trial listing →
  • Terminated NCT NCT00811590

    Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

    Not yet reported University of Utah 3 participants Est. completion 2011-03 1 site
    Other conditions: Peutz-Jeghers Syndrome
    View official trial listing →
  • Completed NCT NCT00812123

    Calcineurin Free Immunosuppression in Renal Transplant Recipients

    Not yet reported University Hospital, Basel, Switzerland 127 participants Est. completion 2005-07 1 site
    Chronic kidney disease Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00812786

    Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients

    Not yet reported University Hospital, Limoges 42 participants Est. completion 2012-05 12 sites
    Other conditions: Heart Transplant
    View official trial listing →
  • Terminated NCT NCT00813501

    Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

    City of Hope Medical Center 60 participants Est. completion 2010-06 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases, Neuroblastoma, Therapy-related Toxicity
    View official trial listing →
  • Terminated NCT NCT00815633

    A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris

    Not yet reported Joshua Zeichner 1 participants Est. completion 2010-03 1 site
    Other conditions: Pityriasis Rubra Pilaris
    View official trial listing →
  • Terminated NCT NCT00816478

    Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor

    Not yet reported Northwell Health 15 participants Est. completion 2009-12
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Withdrawn NCT NCT00816504

    Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5

    Not yet reported Northwell Health Est. completion 2009-12 1 site
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Status unknown NCT NCT00828503

    Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients

    Not yet reported Marcus Saemann 40 participants Est. completion 2014-06 1 site
    Other conditions: Cytomegalovirus Disease
    View official trial listing →
  • Completed NCT NCT00829595

    Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

    Not yet reported Cedars-Sinai Medical Center 69 participants Est. completion 2007-12 1 site
    Other conditions: Inflammatory Bowel Disease, Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00833651

    Protective Immunity Project 02

    Emory University 97 participants Est. completion 2011-10 1 site
    Other conditions: Kidney Transplant, Immunology, Immunosuppression
    View official trial listing →
  • Terminated NCT NCT00838578

    Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 65 participants Est. completion 2012-10 12 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00856505

    Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation

    Not yet reported, Not yet reported University Hospital Freiburg 38 participants Est. completion 2011-03 1 site
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT00859586

    Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 8 participants Est. completion 2014-09 1 site
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic
    View official trial listing →
  • Terminated NCT NCT00866684

    Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

    Not yet reported Charite University, Berlin, Germany 44 participants Est. completion 2011-04-19 15 sites
    Other conditions: Skin Cancer
    View official trial listing →
  • Completed NCT NCT00866879

    Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

    Not yet reported Northwestern University 275 participants Est. completion 2019-03 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT00890552

    A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

    Not yet reported Stanford University 25 participants Est. completion 2012-10 1 site
    Other conditions: Leukemia, Amyloidosis
    View official trial listing →
  • Status unknown NCT NCT00895739

    Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

    Not yet reported Federico II University 50 participants 1 site
    Other conditions: Nonmalignant Neoplasm
    View official trial listing →
  • Completed NCT NCT00902980

    Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

    Astellas Pharma Inc 264 participants Est. completion 2006-12 13 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00905515

    Optima: Optimizing Prograf Therapy in Maintenance Allografts II

    Not yet reported East Carolina University 63 participants Est. completion 2008-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00909571

    Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus

    Not yet reported Astellas Pharma Inc 10 participants Est. completion 2010-03 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00922883

    A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 43 participants Est. completion 2018-04-24 1 site
    Other conditions: Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00929695

    Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

    Not yet reported Fred Hutchinson Cancer Center 164 participants Est. completion 2015-12-14 1 site
    Other conditions: Graft Versus Host Disease, Recurrent Adult Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00946790

    To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

    Not yet reported Sandoz 72 participants Est. completion 1993-12
    Other conditions: Immunosuppression, Rheumatism
    View official trial listing →
  • Status unknown NCT NCT00947492

    Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs

    Not yet reported Assistance Publique Hopitaux De Marseille 60 participants Est. completion 2014-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00948883

    Study of Cancers After Solid Organs Transplants

    Assistance Publique - Hôpitaux de Paris 330 participants Est. completion 2011-07 1 site
    Other conditions: Cancer, Organ Transplantation
    View official trial listing →
  • Completed NCT NCT00965094

    Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2013-06 3 sites
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Completed NCT NCT00968162

    Sickle Cell Disease Conditioning for Bone Marrow Transplant

    Not yet reported Emory University 8 participants Est. completion 2016-01-11 10 sites
    Other conditions: Bone Marrow Transplantation, Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT00972660

    Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease

    Not yet reported Guangdong Provincial People's Hospital 52 participants Est. completion 2017-12 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Terminated NCT NCT00975663

    Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

    Not yet reported University Hospital, Limoges 180 participants Est. completion 2011-02 9 sites
    Other conditions: Lung and Heart-lung Transplantation
    View official trial listing →
  • Completed NCT NCT00981838

    Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)

    Not yet reported Mario Negri Institute for Pharmacological Research 24 participants Est. completion 2011-04 7 sites
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT00987831

    Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

    Not yet reported, Not yet reported Oklahoma Medical Research Foundation 158 participants Est. completion 2012-12 2 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00995709

    Phase III Study in Refractory Behcet's Disease

    Not yet reported Novartis Pharmaceuticals 118 participants Est. completion 2010-07 49 sites
    Other conditions: Behcet Disease
    View official trial listing →
  • Completed NCT NCT00999362

    Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?

    University of Aarhus 40 participants Est. completion 2009-10 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01009957

    Everolimus on CKD Progression in ADPKD Patients

    Not yet reported, Not yet reported A. Manzoni Hospital 71 participants Est. completion 2015-06 7 sites
    Other conditions: Polycystic Kidney Diseases
    View official trial listing →
  • Completed NCT NCT01011205

    Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

    Not yet reported Astellas Pharma Inc 893 participants Est. completion 2013-01-04 72 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01014234

    Rapamycin and Regulatory T Cells in Kidney Transplantation

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 56 participants Est. completion 2013-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT01017757

    Interstitial Lung Abnormalities in Renal Transplant Recipients

    University of Parma 63 participants Est. completion 2009-11 1 site
    Other conditions: Renal Transplantation, Kidney-pancreas Transplantation
    View official trial listing →
  • Completed NCT NCT01022476

    Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

    Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 14 participants Est. completion 2013-05 1 site
    Other conditions: HIV Infection, Liver Failure, Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01022749

    Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 228 participants Est. completion 2013-07 1 site
    Other conditions: Inflammatory Bowel Disease (IBD)
    View official trial listing →
  • Completed NCT NCT01028092

    mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation

    Not yet reported University Hospital, Brest 327 participants Est. completion 2014-07 18 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Withdrawn NCT NCT01033500

    Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients

    Not yet reported University of Wisconsin, Madison Est. completion 2012-12 1 site
    Other conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT01034345

    Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients

    Not yet reported Hospital Clinic of Barcelona 52 participants Est. completion 2011-11 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Withdrawn NCT NCT01038505

    Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus

    Not yet reported University of Miami Est. completion 2013-01
    Other conditions: Living Donor Kidney Transplants Patients
    View official trial listing →
  • Terminated NCT NCT01044745

    Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported University of Nebraska 20 participants Est. completion 2017-10-10 1 site
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Graft Versus Host Disease, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Terminated NCT NCT01052259

    Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

    Not yet reported Nippon Kayaku Co., Ltd. 35 participants Est. completion 2012-12 8 sites
    Other conditions: Chronic Rejection
    View official trial listing →
  • Terminated NCT NCT01053221

    Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation

    Not yet reported University of Wisconsin, Madison 16 participants Est. completion 2012-08 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01065285

    Vaccination Against Influenza in Autoimmune Diseases

    Not yet reported Assistance Publique - Hôpitaux de Paris 234 participants Est. completion 2012-02 1 site
    Other conditions: Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT01079143

    Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2012-06 23 sites
    Other conditions: Renal Interstitial Fibrosis
    View official trial listing →
  • Terminated NCT NCT01093846

    38 Week Extension Study to CAIN457C2303

    Not yet reported Novartis Pharmaceuticals 59 participants Est. completion 2011-01 25 sites
    Other conditions: Uveitis
    View official trial listing →
  • Status unknown NCT NCT01109498

    Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]

    Not yet reported, Not yet reported Amsterdam Molecular Therapeutics 14 participants Est. completion 2013-06 1 site
    Other conditions: Familial Lipoprotein Lipase Deficiency
    View official trial listing →
  • Completed NCT NCT01109914

    Mucosal Response in Immunocompromised Host

    Not yet reported Leiden University Medical Center 51 participants Est. completion 2015-03 1 site
    Other conditions: Kidney Transplantation, Immunity
    View official trial listing →
  • Completed NCT NCT01131910

    TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs

    Not yet reported Sormland County Council, Sweden 68 participants Est. completion 2011-05 6 sites
    Other conditions: Rheumatoid Arthritis, Exposed to TBE-virus, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01134510

    Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

    Not yet reported, Not yet reported Stanley Jordan, MD 20 participants Est. completion 2013-11 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01135641

    Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)

    Not yet reported Nantes University Hospital 25 participants Est. completion 2014-03 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT01136395

    Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

    Not yet reported University of Giessen 85 participants Est. completion 2019-06-18 1 site
    Other conditions: Kidney Transplantation, Rituximab (RTx), Living Donors, Immunology, Virus
    View official trial listing →
  • Status unknown NCT NCT01154387

    Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

    Not yet reported, Not yet reported Tolera Therapeutics, Inc 85 participants Est. completion 2013-06 12 sites
    Other conditions: End Stage Renal Disease, Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT01165762

    Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.

    Not yet reported Everett Meyer 25 participants Est. completion 2025-06-14 2 sites
    Other conditions: ESRD
    View official trial listing →
  • Completed NCT NCT01183247

    An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

    Not yet reported University Hospital, Basel, Switzerland 63 participants Est. completion 2010-06 1 site
    Other conditions: Comparative Study, Immunosuppressive Agents
    View official trial listing →
  • Completed NCT NCT01183403

    CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease

    Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 80 participants Est. completion 2012-07 18 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01187017

    A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 1 participants Est. completion 2012-07 1 site
    Other conditions: Aplastic Anemia, Neutropenia, Pancytopenia, Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01195194

    Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.

    Not yet reported Josep M Grinyo 61 participants Est. completion 2013-06 2 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01196091

    A Study of LY2127399 in Participants With Systemic Lupus Erythematosus

    Not yet reported Eli Lilly and Company 1164 participants Est. completion 2015-06 192 sites
    Other conditions: Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune Disease
    View official trial listing →
  • Status unknown NCT NCT01198314

    Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients

    Not yet reported The Catholic University of Korea 20 participants Est. completion 2013-03 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01213329

    Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab

    Not yet reported Northwestern University 52 participants Est. completion 2009-04 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Terminated NCT NCT01213394

    Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients

    Not yet reported Ramesh Prasad 2 participants Est. completion 2011-12 1 site
    Cardiovascular disease Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01220297

    Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

    Not yet reported Stanford University 3 participants Est. completion 2011-08 1 site
    Other conditions: Hematologic Diseases, Acute-graft-versus-host Disease, Leukemia, Non-Hodgkin Lymphoma (NHL), Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01231841

    Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia

    Not yet reported The Cleveland Clinic 20 participants Est. completion 2010-12 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01232920

    First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial

    Not yet reported University of California, San Francisco 80 participants Est. completion 2012-06 2 sites
    Other conditions: Uveitis
    View official trial listing →
  • Withdrawn NCT NCT01244659

    A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment

    Not yet reported EMS Est. completion 2014-12 1 site
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01256294

    Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients

    Not yet reported Novartis 71 participants Est. completion 2011-05 2 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01264315

    Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant

    Not yet reported Fondazione EMN Italy Onlus 53 participants Est. completion 2023-02 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01265537

    A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

    Not yet reported University of British Columbia 30 participants Est. completion 2019-10-11 1 site
    Other conditions: Acute Graft Rejection, Diabetes
    View official trial listing →
  • Completed NCT NCT01266148

    SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2012-12 6 sites
    Other conditions: Renal Function and Chronic Allograft Vasculopathy
    View official trial listing →
  • Terminated NCT NCT01268995

    Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation

    Not yet reported Medical University of Vienna 32 participants Est. completion 2010-12 1 site
    Other conditions: New Onset Diabetes Mellitus After Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01276834

    Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation

    Not yet reported Dianet Dialysis Centers 13 participants Est. completion 2012-07 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01279616

    A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

    Not yet reported Nationwide Children's Hospital 8 participants Est. completion 2015-01 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Withdrawn NCT NCT01284257

    Observational Registry Study of Renal Transplant Patients

    Novartis Pharmaceuticals Est. completion 2010-05 8 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01284725

    Weaning of Immunosuppression in Nephritis of Lupus

    Not yet reported Assistance Publique Hopitaux De Marseille 100 participants Est. completion 2018-12-31 1 site
    Other conditions: Nephritis of Lupus
    View official trial listing →
  • Status unknown NCT NCT01289301

    Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant

    Not yet reported Hannover Medical School 124 participants Est. completion 2018-10 4 sites
    Other conditions: Disorder Related to Renal Transplantation, Immunosuppression Related Infectious Disease, Virus Diseases
    View official trial listing →
  • Completed NCT NCT01294020

    Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

    Not yet reported Astellas Pharma Europe Ltd. 81 participants Est. completion 2025-11-03 16 sites
    Other conditions: Intestine Transplantation, Kidney Transplantation, Lung Transplantation, Liver Transplantation, Heart Transplantation
    View official trial listing →
  • Terminated NCT NCT01296061

    Kidney Transplant Failure

    Ottawa Hospital Research Institute 270 participants Est. completion 2017-07 1 site
    Other conditions: Acute Graft Rejection, Renal Failure Chronic Requiring Dialysis
    View official trial listing →
  • Completed NCT NCT01297972

    Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia

    Not yet reported, Not yet reported University of Sao Paulo 9 participants Est. completion 2013-11 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01298492

    A Study To Monitor Long-Term Treatment With PF-00547659

    Not yet reported Shire 268 participants Est. completion 2016-07-27 112 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01300416

    Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

    Novartis Pharmaceuticals 101 participants Est. completion 2012-07 9 sites
    Other conditions: Kidney Transplantation, GI Symptoms Severity
    View official trial listing →
  • Completed NCT NCT01304836

    A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids

    Not yet reported Astellas Pharma Inc 1166 participants Est. completion 2013-05-22 100 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • No Longer Available NCT NCT01309022

    Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

    National Institute of Allergy and Infectious Diseases (NIAID) 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01312064

    De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction

    Not yet reported National Taiwan University Hospital 2 participants Est. completion 2012-04 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT01324934

    Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids

    Not yet reported Neovii Biotech 40 participants Est. completion 2011-01 10 sites
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT01325571

    A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

    Not yet reported Astellas Pharma Inc 83 participants Est. completion 2014-05 9 sites
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Completed NCT NCT01332201

    Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

    Not yet reported Astellas Pharma Inc 17 participants Est. completion 2013-11 8 sites
    Other conditions: Heart Transplantation, Lung Transplantation, Pancreas (Including SPK) Transplantation
    View official trial listing →
  • Status unknown NCT NCT01332526

    FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).

    Collegium Medicum w Bydgoszczy 70 participants
    Chronic kidney diseaseMetabolic syndrome Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01338779

    Study of Tolerant Kidney Transplant Recipients

    National Institute of Allergy and Infectious Diseases (NIAID) 197 participants Est. completion 2015-08 4 sites
    Other conditions: Transplant Rejection, Kidney Transplantation, Renal Transplantation, Renal Transplant, Transplant Tolerance
    View official trial listing →
  • Completed NCT NCT01339468

    A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation

    Not yet reported Astellas Pharma Inc 100 participants Est. completion 2014-05-27 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01342016

    A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

    Not yet reported Astellas Pharma Inc 84 participants Est. completion 2013-05 12 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01343953

    Cord Blood Transplantation in Severe Aplastic Anemia

    Not yet reported Assistance Publique - Hôpitaux de Paris 26 participants Est. completion 2017-06 1 site
    Other conditions: Hereditary Diseases, Acquired Aplastic Anemia, Relapse, Absence of an HLA Identical Donor
    View official trial listing →
  • Completed NCT NCT01346085

    Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation

    Not yet reported, Not yet reported Ospedale San Raffaele 10 participants Est. completion 2012-06 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT01353053

    Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection

    Federal University of São Paulo 82 participants 1 site
    Other conditions: Disorder of Transplanted Kidney, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01356277

    Intervention to Improve Adherence in Teen Kidney Transplant

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 170 participants Est. completion 2016-06 8 sites
    Other conditions: Kidney Transplantation, Medication Adherence
    View official trial listing →
  • Completed NCT NCT01363752

    A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

    Not yet reported Astellas Pharma Inc 853 participants Est. completion 2013-09-18 58 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01364896

    Anal Human Papillomavirus in Inflammatory Bowel Disease Study

    University of Pittsburgh 46 participants Est. completion 2015-12 1 site
    Other conditions: Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease (CD), Anal Human Papillomavirus
    View official trial listing →
  • Completed NCT NCT01369082

    Extended Follow-Up After Islet Transplantation in T1D

    National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2017-07 8 sites
    Other conditions: Type 1 Diabetes (T1D), Islet Transplantation
    View official trial listing →
  • Completed NCT NCT01370746

    Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation

    National Institute of Allergy and Infectious Diseases (NIAID) 502 participants Est. completion 2014-04 15 sites
    Other conditions: Organ Transplantation
    View official trial listing →
  • Completed NCT NCT01370824

    Clinical Diagnosis of Basal Cell Carcinoma Subtype

    Maastricht University Medical Center 150 participants Est. completion 2013-02 2 sites
    Other conditions: Basal Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT01371344

    A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

    Not yet reported Astellas Pharma Europe Ltd. 47 participants Est. completion 2017-04-02 12 sites
    Other conditions: Heart Transplantation, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01374750

    Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)

    Not yet reported Seoul National University Hospital 45 participants Est. completion 2016-05 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT01378091

    Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer

    Not yet reported Columbia University 64 participants Est. completion 2013-09 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01392872

    Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant

    Not yet reported University Hospital, Clermont-Ferrand 48 participants Est. completion 2016-01 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT01394640

    Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients

    Paolo Corradini 124 participants Est. completion 2011-01 1 site
    Other conditions: Lymphoma, Multiple Myeloma, Myeloproliferative Disease
    View official trial listing →
  • Completed NCT NCT01404325

    Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 130 participants Est. completion 2017-01-05 9 sites
    Other conditions: Lung Transplantation
    View official trial listing →
  • Status unknown NCT NCT01423552

    Pharmacology of Immunosuppressants Following Heart Transplantation

    Nigel E. Drury 100 participants 2 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Terminated NCT NCT01424345

    The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

    Not yet reported CAMC Health System 4 participants Est. completion 2012-07 1 site
    Other conditions: Kidney Transplant Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT01428973

    Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

    Not yet reported University of Liege 200 participants Est. completion 2024-12 13 sites
    Other conditions: Graft-Versus-Host Disease, Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT01429038

    Mesenchymal Stem Cells After Renal or Liver Transplantation

    Not yet reported, Not yet reported University of Liege 40 participants Est. completion 2019-03-11 1 site
    Other conditions: Liver Failure, Kidney Failure
    View official trial listing →
  • Terminated NCT NCT01436305

    Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2015-04 3 sites
    Other conditions: Kidney Transplantation, Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01445236

    Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance

    Not yet reported Hospital Clinic of Barcelona 25 participants Est. completion 2013-01 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01445821

    Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial

    Not yet reported Northwestern University 44 participants Est. completion 2019-10-10 1 site
    Other conditions: Scleroderma, Systemic
    View official trial listing →
  • Terminated NCT NCT01446211

    Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis

    Not yet reported Nordic Pharma SAS 4 participants Est. completion 2015-01 1 site
    Other conditions: Wegeners Granulomatosis
    View official trial listing →
  • Status unknown NCT NCT01446484

    Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

    Not yet reported, Not yet reported Pirogov Russian National Research Medical University 30 participants Est. completion 2014-11 2 sites
    Other conditions: End-Stage Renal Disease, Kidney Failure
    View official trial listing →
  • Completed NCT NCT01449955

    Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory

    Not yet reported University of Texas Southwestern Medical Center 54 participants Est. completion 2010-07 1 site
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT01450033

    Peers for Promoting Adolescent Transplant Health

    Not yet reported Children's Hospital of Philadelphia 74 participants Est. completion 2017-03-29 1 site
    Other conditions: Behavior and Behavior Mechanisms
    View official trial listing →
  • Terminated NCT NCT01467505

    An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

    Not yet reported Vertex Pharmaceuticals Incorporated 61 participants Est. completion 2014-04 22 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01467986

    Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

    Not yet reported University of Regensburg 130 participants Est. completion 2020-09-30 1 site Stand-alone
    Other conditions: Neuroblastoma Recurrent
    View official trial listing →
  • Completed NCT NCT01479881

    A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

    Not yet reported Tibotec Pharmaceuticals, Ireland 29 participants Est. completion 2011-12 1 site
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01481142

    Adacolumn in Refractory UC Patients Trial

    Not yet reported Otsuka Pharmaceutical Europe Ltd 100 participants Est. completion 2015-07 1 site
    Other conditions: Ulcerative Colitis, Active Moderate
    View official trial listing →
  • Completed NCT NCT01484496

    A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)

    Not yet reported Human Genome Sciences Inc., a GSK Company 839 participants Est. completion 2015-10-01 207 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01496417

    Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores

    Not yet reported University of Maryland 20 participants Est. completion 2018-03-01 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01505855

    Efficacy Study of Pneumococcal Vaccination in Crohn's Disease

    Not yet reported Kyunghee University Medical Center 197 participants Est. completion 2013-06 15 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01507103

    Tecemotide (L-BLP25) in Rectal Cancer

    Not yet reported Merck KGaA, Darmstadt, Germany 124 participants Est. completion 2014-06 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01508468

    Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

    Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2016-08-31 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Terminated NCT NCT01517984

    Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2015-05 11 sites
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01526889

    Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

    Not yet reported Novartis Pharmaceuticals 25 participants Est. completion 2017-08-24 8 sites
    Other conditions: Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Panuveitis
    View official trial listing →
  • Completed NCT NCT01529138

    Study of Axitinib and Temsirolimus in Solid Tumors

    Not yet reported Emory University 13 participants Est. completion 2014-03 1 site
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT01539902

    Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis

    Not yet reported CytoMed & Beike 25 participants Est. completion 2013-05 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01541280

    VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

    Not yet reported Nantes University Hospital 30 participants Est. completion 2015-07 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT01547143

    Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

    Not yet reported Asan Medical Center 12 participants Est. completion 2016-05 1 site
    Other conditions: Hemophagocytic Lymphohistiocytosis
    View official trial listing →
  • Completed NCT NCT01560572

    Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen

    Not yet reported University Medical Center Groningen 305 participants Est. completion 2016-04 3 sites
    Other conditions: Renal Insufficiency, Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01561404

    Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

    Not yet reported Josep M Cruzado 3 participants Est. completion 2013-12 1 site
    Other conditions: Disorder Related to Renal Transplantation, Exercise, Aerobic, Muscle Strength
    View official trial listing →
  • Terminated NCT NCT01562951

    Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

    Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 15 participants Est. completion 2014-03 30 sites
    Obstructive sleep apnea Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT01570348

    Crohn's Allogeneic Transplant Study

    Not yet reported Fred Hutchinson Cancer Center 2 participants Est. completion 2019-10-30 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT01598987

    Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.

    Not yet reported Novartis Pharmaceuticals 56 participants Est. completion 2016-06 32 sites
    Other conditions: Renal Function, Liver Transplant
    View official trial listing →
  • Terminated NCT NCT01609673

    Study of Everolimus in de Novo Renal Transplant Recipients

    Not yet reported Helady Pinheiro, MD, PhD 1 participants Est. completion 2013-05 4 sites
    Other conditions: End Stage Renal Failure With Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT01613963

    Causes of Visual Loss in Retinal Disease

    Royal Surrey County Hospital NHS Foundation Trust 2000 participants Est. completion 2012-12 2 sites
    Other conditions: Uveitis, Scleritis
    View official trial listing →
  • Completed NCT NCT01614665

    A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

    Not yet reported Astellas Pharma Europe Ltd. 44 participants Est. completion 2021-04-21 10 sites
    Other conditions: Heart Transplantation, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01621477

    T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    Not yet reported St. Jude Children's Research Hospital 34 participants Est. completion 2015-12 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hodgkin or Non-Hodgkin Lymphoma, Sarcoma, Myeloid
    View official trial listing →
  • Status unknown NCT NCT01627236

    Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis B

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2014-11 1 site
    Other conditions: Severe Acute Exacerbation of Chronic Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT01631058

    Renal Transplantation in the Elderly - nEverOld Study

    Not yet reported University of Sao Paulo General Hospital 90 participants Est. completion 2019-06 2 sites
    Other conditions: Chronic Renal Failure (CRF), Graft Failure, Transplant; Failure, Kidney, Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT01632241

    Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)

    Not yet reported Human Genome Sciences Inc., a GSK Company 503 participants Est. completion 2019-01-28 96 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT01636466

    The Everolimus-Transplant Exit Strategy Trial (E-TEST)

    Not yet reported Ashtar Chami 1 participants Est. completion 2014-05 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT01638559

    Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 161 participants Est. completion 2018-06-11 12 sites
    Other conditions: Liver Transplant Recipients, Liver Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01640743

    Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 58 participants Est. completion 2014-04 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT01649388

    A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

    Not yet reported Talaris Therapeutics Inc. Est. completion 2023-02-28 3 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01650662

    CYCLosporinE A in Reperfused Acute Myocardial Infarction

    Not yet reported Mario Negri Institute for Pharmacological Research 410 participants Est. completion 2014-10 31 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01653847

    Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

    Not yet reported Northwestern University 88 participants Est. completion 2020-05 1 site
    Other conditions: End Stage Renal Failure With Renal Transplant
    View official trial listing →
  • Completed NCT NCT01655563

    Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation

    Not yet reported The Hospital for Sick Children 75 participants Est. completion 2016-02 1 site
    Other conditions: Heart Transplantation, Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01660607

    Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

    Not yet reported, Not yet reported Stanford University 68 participants Est. completion 2023-12-20 1 site
    Other conditions: Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS), Lymphoma, Non-Hodgkin, Acute Lymphoblastic Leukemia (ALL), Myeloproliferative Syndrome, Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01672957

    An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil

    Hoffmann-La Roche 128 participants Est. completion 2015-07 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01675947

    Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy

    Not yet reported National Eye Institute (NEI) 52 participants Est. completion 2016-02 13 sites
    Other conditions: Geographic Atrophy
    View official trial listing →
  • Completed NCT NCT01678937

    Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

    Northwestern University 31 participants Est. completion 2008-09 1 site
    Other conditions: Liver Transplant Rejection, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01687192

    Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

    Not yet reported University Hospital, Bordeaux 37 participants Est. completion 2016-10-20 9 sites
    Other conditions: Transplantation, Systemic Lupus Erythematosus, Systemic Immune Disease
    View official trial listing →
  • Status unknown NCT NCT01690247

    Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance

    Not yet reported Beijing 302 Hospital 50 participants Est. completion 2015-02 1 site
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01692808

    Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease

    Not yet reported St. Justine's Hospital 20 participants Est. completion 2014-11 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01695668

    Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%

    Not yet reported University of Michigan 75 participants Est. completion 2015-02
    Other conditions: Dry Eyes
    View official trial listing →
  • Status unknown NCT NCT01699360

    The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

    Not yet reported Central South University 600 participants Est. completion 2013-12 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Suspended NCT NCT01705899

    Islet Allotransplantation in Type 1 Diabetes

    Not yet reported Ohio State University 20 participants Est. completion 2033-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01705977

    Belimumab Assessment of Safety in SLE

    Not yet reported GlaxoSmithKline 4019 participants Est. completion 2022-08-10 250 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01707550

    An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients

    Hoffmann-La Roche 414 participants Est. completion 2011-01 3 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01707849

    The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

    Not yet reported Hospital Vall d'Hebron 18 participants Est. completion 2016-08 1 site
    Other conditions: Hepatitis C Recurrence After Liver Transplant
    View official trial listing →
  • Completed NCT NCT01729455

    Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

    GlaxoSmithKline 3138 participants Est. completion 2025-02-28 179 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01733056

    Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression

    Not yet reported Emory University 43 participants Est. completion 2013-01 2 sites
    Other conditions: Immunosuppression
    View official trial listing →
  • Completed NCT NCT01739803

    Behavioral Contract Adherence Intervention

    Not yet reported University of Tennessee 150 participants Est. completion 2013-06 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01742624

    Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

    Not yet reported Astellas Pharma Korea, Inc. 60 participants Est. completion 2012-06 3 sites
    Other conditions: de Novo Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01743560

    An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

    Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2016-08-15 11 sites
    Other conditions: Oestrogen Receptor Positive Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01744470

    Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

    Not yet reported University Hospital, Tours 286 participants Est. completion 2015-03 16 sites
    Other conditions: De Novo Transplant Disease
    View official trial listing →
  • Withdrawn NCT NCT01752790

    Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease

    Not yet reported University of Roma La Sapienza Est. completion 2015-12 1 site Stand-alone
    Other conditions: Pediatric Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01764581

    Randomized Controlled Trial of ImmuKnow in Liver Transplantation

    Not yet reported University of Bologna 206 participants Est. completion 2012-03
    Other conditions: Liver Disease
    View official trial listing →
  • Terminated NCT NCT01764607

    Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma

    Not yet reported University of Florida 1 participants Est. completion 2014-06 1 site
    Other conditions: Squamous Cell Skin Carcinoma
    View official trial listing →
  • Terminated NCT NCT01765842

    Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy

    Not yet reported Fundación Pública Andaluza Progreso y Salud 9 participants Est. completion 2015-12 3 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01767350

    Determinants of Immunosuppressive Dose Requirements in Children After Solid Organ Transplantation

    Universitaire Ziekenhuizen KU Leuven 60 participants Est. completion 2015-01 1 site
    Other conditions: Transplantation Infection
    View official trial listing →
  • Completed NCT NCT01771809

    Long-Term Safety Of PF-00547659 In Ulcerative Colitis

    Not yet reported Shire 330 participants Est. completion 2017-12-13 99 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Terminated NCT NCT01775397

    A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System

    Not yet reported Astellas Pharma Europe Ltd. 12 participants Est. completion 2013-04-15 16 sites
    Other conditions: Clostridium Difficile
    View official trial listing →
  • Terminated NCT NCT01797315

    Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

    Not yet reported University Hospital of Berlin 40 participants Est. completion 2013-06
    Other conditions: Renal Transplant Patients at High-risk for Skin Cancer
    View official trial listing →
  • Status unknown NCT NCT01799460

    Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy

    Shanghai University of Traditional Chinese Medicine 80 participants Est. completion 2013-08 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT01801280

    Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS

    Not yet reported Klemens Budde 20 participants Est. completion 2014-03 1 site
    Other conditions: Transplantation, Immunosuppression, Drug Interaction
    View official trial listing →
  • Completed NCT NCT01802268

    Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

    Not yet reported Helio Tedesco Silva Junior 320 participants Est. completion 2012-10 6 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01804829

    Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

    Not yet reported Biotest Pharmaceuticals Corporation 80 participants Est. completion 2016-06 23 sites
    Other conditions: Hepatitis C Infection, Viruses, Hepatocellular Carcinoma, Hepatitis, Viral, Human, Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT01813617

    Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis

    Karolinska University Hospital 72 participants 1 site
    Other conditions: Polymyositis, Dermatomyositis
    View official trial listing →
  • Completed NCT NCT01817504

    Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure

    Not yet reported Hospices Civils de Lyon 56 participants Est. completion 2021-11 9 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01817959

    Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation

    Not yet reported Dompé Farmaceutici S.p.A 51 participants Est. completion 2017-12 9 sites
    Other conditions: Islet Transplantation in Diabetes Mellitus Type 1
    View official trial listing →
  • Terminated NCT NCT01818726

    Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients

    Not yet reported Novartis Pharmaceuticals 15 participants Est. completion 2016-10-17 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01834690

    Uses of Immunosuppression Therapy in Patients With Liver Transplantation

    Chang Gung Memorial Hospital 314 participants Est. completion 2014-12 1 site
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01839929

    A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF

    Not yet reported Astellas Pharma Korea, Inc. 138 participants Est. completion 2013-02 4 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01849939

    Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia

    Not yet reported University Hospital, Clermont-Ferrand 43 participants Est. completion 2017-02-15 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma
    View official trial listing →
  • Terminated NCT NCT01856257

    Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 71 participants Est. completion 2016-04 3 sites
    Other conditions: Primary Renal Allograft Candidate, Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT01858259

    Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

    Gabriela Riemekasten 1372 participants Est. completion 2016-06 11 sites
    Other conditions: Systemic Sclerosis, Interstitial Lung Diseases
    View official trial listing →
  • Completed NCT NCT01859832

    Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 19 participants Est. completion 2013-12 1 site
    Other conditions: Renal Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01860170

    Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

    Not yet reported, Not yet reported Corewell Health West 28 participants Est. completion 2018-03 1 site
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Completed NCT NCT01860963

    Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

    Not yet reported Stanford University 310 participants Est. completion 2013-06 1 site
    Other conditions: Anal Squamous Intraepithelial Lesion (ASIL), HPV DNA
    View official trial listing →
  • Completed NCT NCT01868269

    Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

    Not yet reported Institut Curie 102 participants Est. completion 2025-01-17 36 sites
    Other conditions: Opsoclonus Myoclonus Syndrome, Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT01877746

    CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)

    Not yet reported St. Anne's University Hospital Brno, Czech Republic 234 participants Est. completion 2015-09 2 sites
    Other conditions: Inflammatory Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT01878786

    A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys

    Not yet reported, Not yet reported Matthew Cooper 25 participants Est. completion 2017-12 1 site
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Status unknown NCT NCT01881802

    Study of Opioid Immunosuppressive Effects

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50 participants
    Other conditions: Opioid Abuse or Dependence
    View official trial listing →
  • Completed NCT NCT01882322

    A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects

    Not yet reported Astellas Pharma Korea, Inc. 36 participants Est. completion 2017-01-03 1 site
    Other conditions: de Novo Liver Transplant Subjects
    View official trial listing →
  • Status unknown NCT NCT01889017

    Generic Immunosuppressive Drugs After Lung Transplantation

    Hannover Medical School 600 participants Est. completion 2014-09 1 site
    Other conditions: Immunosuppressive After Lung Transplantation
    View official trial listing →
  • Terminated NCT NCT01889992

    Cardiac Allograft Remodeling and Effects of Sirolimus

    Not yet reported University of Nebraska 42 participants Est. completion 2018-09-27 1 site
    Other conditions: Cardiac Hypertrophy, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01895049

    Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

    Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 site
    Other conditions: Kidney Transplantation, Cytomegalovirus
    View official trial listing →
  • Completed NCT NCT01895894

    Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome

    Not yet reported Seoul National University Hospital 34 participants Est. completion 2016-12 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Terminated NCT NCT01896986

    HPV Vaccination in Special Risk Groups: 5 Year Follow-up

    Murdoch Childrens Research Institute 37 participants Est. completion 2012-03 1 site
    Other conditions: PRD (Paediatric Rheumatological Disease), IBD (Inflammatory Bowel Disease)
    View official trial listing →
  • Withdrawn NCT NCT01901471

    Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock

    Not yet reported Hospices Civils de Lyon Est. completion 2015-10 18 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01903473

    Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

    Not yet reported University of Liege 19 participants Est. completion 2022-09-12 2 sites
    Other conditions: Chronic Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Steroid Refractory Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT01903798

    A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis

    Not yet reported Southern California Institute for Research and Education 4 participants Est. completion 2016-04 3 sites
    Other conditions: Alcoholic Hepatitis
    View official trial listing →
  • Status unknown NCT NCT01905514

    ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients

    Not yet reported Seoul National University Hospital 140 participants Est. completion 2019-12-31 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01908283

    Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease

    Not yet reported Klara M. Pósfay Barbe 300 participants Est. completion 2016-12 1 site
    Other conditions: Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
    View official trial listing →
  • Active, not recruiting NCT NCT01909245

    Islet Cell Transplant for Type 1 Diabetes

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2027-08-31 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01909492

    Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

    Providence Health & Services 30 participants Est. completion 2023-10-05 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT01913392

    Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate

    Maisonneuve-Rosemont Hospital 15 participants Est. completion 2018-05 1 site
    Other conditions: Obesity, Morbid, Transplant; Failure, Kidney
    View official trial listing →
  • Completed NCT NCT01914770

    Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

    GlaxoSmithKline 1016 participants Est. completion 2010-11
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT01927588

    Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients

    Not yet reported Fundação Pró Rim 50 participants Est. completion 2015-11
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01936519

    Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.

    Not yet reported Milton S. Hershey Medical Center 24 participants Est. completion 2019-07-31 1 site
    Other conditions: Immunosuppression, Renal Failure
    View official trial listing →
  • Completed NCT NCT01938625

    A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

    Not yet reported Janssen R&D Ireland 35 participants Est. completion 2015-07-28 6 sites
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Enrolling by invitation NCT NCT01957696

    The Norwegian Pancreas Transplantation (PTx) Study

    Oslo University Hospital 80 participants Est. completion 2028-10 1 site
    Other conditions: Diabetes Mellitus, Pancreas Transplantation, Allograft Rejection, Surgical Complication Nec, Allograft Biopsies
    View official trial listing →
  • Status unknown NCT NCT01959308

    Adherence to Immunosuppressive Therapy Liver Transplant Recipients

    National University Hospital, Singapore 100 participants Est. completion 2014-06 1 site
    Other conditions: Focus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.
    View official trial listing →
  • Terminated NCT NCT01962636

    Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 200 participants Est. completion 2026-05-14 1 site
    Other conditions: Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelofibrosis, Myelodysplasia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Lymphoblastic Lymphoma, Burkitt's Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01974674

    Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes

    Not yet reported Assistance Publique - Hôpitaux de Paris 19 participants Est. completion 2022-01 1 site
    Other conditions: Patients With Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01976182

    Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia

    Not yet reported Rennes University Hospital 166 participants Est. completion 2024-10-07 59 sites
    Other conditions: Large Granular Lymphocytes Leukemia
    View official trial listing →
  • Status unknown NCT NCT01995331

    Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia

    Not yet reported Xiaofan Zhu 30 participants Est. completion 2015-03 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT01997372

    Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia

    Not yet reported Chinese Academy of Medical Sciences 100 participants Est. completion 2015-11 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02004860

    Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis

    Not yet reported University Hospital, Rouen 120 participants Est. completion 2017-10 1 site
    Other conditions: Severe Seborrheic Dermatitis
    View official trial listing →
  • Completed NCT NCT02015351

    Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

    Not yet reported University of Sao Paulo 9 participants Est. completion 2018-10 1 site
    Other conditions: Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT02016625

    Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus

    Not yet reported Boehringer Ingelheim 32 participants Est. completion 2014-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02027805

    Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

    Not yet reported, Not yet reported Xenikos 20 participants Est. completion 2016-11-03 2 sites
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02034747

    A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients

    Not yet reported Astellas Pharma Korea, Inc. 150 participants Est. completion 2015-11-07 9 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT02038088

    The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication

    Lu KZ 30 participants Est. completion 2015-01 1 site
    Other conditions: HBV Infection
    View official trial listing →
  • Status unknown NCT NCT02044185

    Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation

    Seoul St. Mary's Hospital 100 participants Est. completion 2015-12 1 site
    Other conditions: Acute Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT02049476

    Study of the Effectiveness of Ozurdex for the Control of Uveitis

    Not yet reported Johns Hopkins University 20 participants Est. completion 2018-06-30 1 site
    Other conditions: Uveitis, Intermediate, Uveitis, Posterior
    View official trial listing →
  • Completed NCT NCT02058719

    Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung Disease

    University of Colorado, Denver 210 participants Est. completion 2019-12 1 site
    Other conditions: HIV, Smoking, COPD
    View official trial listing →
  • Withdrawn NCT NCT02058875

    Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring

    Not yet reported University of Saskatchewan Est. completion 2015-10 2 sites
    Cardiovascular disease Other conditions: Cardiovascular Outcomes, Kidney Transplant Recipients, Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT02062892

    Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients

    Not yet reported University of Colorado, Denver Est. completion 2014-06
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02062944

    SRL (Sirolimus) Withdrawal

    Not yet reported Northwestern University 21 participants Est. completion 2020-07 1 site
    Other conditions: Acute Rejection of Liver Transplant, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Completed NCT NCT02066935

    Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study

    Fundação Instituto Mineiro de Estudo Pesquisa Em Nefrologi 1105 participants Est. completion 2017-09-30 1 site
    Other conditions: Medication Adherence
    View official trial listing →
  • Status unknown NCT NCT02075242

    TO Compare the Triple Drug Therapy and Dual Therapy .

    Not yet reported Asan Medical Center 170 participants Est. completion 2016-01 1 site
    Other conditions: HEPATITIS
    View official trial listing →
  • Enrolling by invitation NCT NCT02081755

    Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

    Not yet reported Baylor Research Institute 336 participants Est. completion 2027-03 9 sites
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT02083991

    Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

    Not yet reported Vastra Gotaland Region 224 participants Est. completion 2017-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02091973

    MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation

    Not yet reported Chulalongkorn University 50 participants Est. completion 2015-12 1 site
    Other conditions: microRNA Profiles
    View official trial listing →
  • Terminated NCT NCT02092389

    Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

    AbbVie 10 participants Est. completion 2016-03
    Other conditions: Moderate to Severe Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02094417

    A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia

    Not yet reported Kyowa Kirin Korea Co., Ltd. 35 participants Est. completion 2017-11-07 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02103049

    The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

    Not yet reported University Medical Centre Ljubljana 80 participants Est. completion 2015-12 1 site
    Other conditions: Dyslipidemia, Transplants
    View official trial listing →
  • Active, not recruiting NCT NCT02105766

    Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 56 participants Est. completion 2027-12-31 1 site
    Other conditions: Sickle Cell Disease, Thalassemia, Stem Cell Transplantation, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02107807

    Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

    Not yet reported Seqirus 539 participants Est. completion 2015-05 17 sites
    Other conditions: Influenza, Human, Flu, Human, Flu, Avian, Influenza, Influenza A Virus, H5N1 Subtype
    View official trial listing →
  • Completed NCT NCT02108600

    Tocilizumab for Renal Graft Inflammation

    Not yet reported Flavio Vincenti 33 participants Est. completion 2018-12-16 1 site
    Other conditions: Late Complication From Kidney Transplant
    View official trial listing →
  • Completed NCT NCT02108860

    Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

    Not yet reported University of South Florida 65 participants Est. completion 2023-12-20 20 sites
    Other conditions: Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis, Wegener's Granulomatosis, ANCA-Associated Vasculitis
    View official trial listing →
  • Completed NCT NCT02115113

    REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy

    Not yet reported Novartis Pharmaceuticals 78 participants Est. completion 2016-09-30 14 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02118896

    Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant

    Not yet reported Astellas Pharma Europe Ltd. 850 participants Est. completion 2009-10-07 105 sites
    Other conditions: Heart Transplantation, Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02120157

    Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2020-10-01 9 sites
    Other conditions: Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival, Transplantation, Bone Marrow
    View official trial listing →
  • Status unknown NCT NCT02123836

    Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome

    Not yet reported National University Hospital, Singapore 20 participants Est. completion 2020-10 1 site
    Other conditions: Acute Leukaemia, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT02128503

    Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease

    Not yet reported Chinese University of Hong Kong 430 participants Est. completion 2015-10-16 1 site
    Other conditions: Inflammatory Bowel Disease, Crohn Disease, Ulcerative Colitis, Rheumatic Diseases, Hepatitis B, Chronic
    View official trial listing →
  • Active, not recruiting NCT NCT02130362

    A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

    AbbVie 1446 participants Est. completion 2030-11 148 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02130414

    PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects

    Not yet reported Sigmoid Pharma 48 participants Est. completion 2015-02
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02134288

    Belatacept for Renal Transplant Recipients With Delayed Graft Function

    Not yet reported Ohio State University 8 participants Est. completion 2019-01-18 1 site
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Completed NCT NCT02134314

    C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

    Not yet reported, Not yet reported Cedars-Sinai Medical Center 70 participants Est. completion 2017-03-13 1 site
    Other conditions: End Stage Renal Disease, Kidney Failure, Delayed Graft Function, Ischemic Reperfusion Injury
    View official trial listing →
  • Status unknown NCT NCT02135380

    Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis

    Not yet reported, Not yet reported Kasiak Research Pvt. Ltd. 60 participants 1 site
    Other conditions: Idiopathic Pulmonary Fibrosis
    View official trial listing →
  • Completed NCT NCT02152345

    Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

    Not yet reported Columbia University 57 participants Est. completion 2016-12-31 1 site
    Other conditions: Implant or Graft; Rejection
    View official trial listing →
  • Status unknown NCT NCT02154854

    Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)

    Not yet reported University Hospital, Tours 104 participants Est. completion 2015-03 11 sites
    Other conditions: De Novo Transplant Disease
    View official trial listing →
  • Completed NCT NCT02160054

    Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

    Astellas Pharma Inc 289 participants Est. completion 2016-03-31 30 sites
    Other conditions: the Maintenance Phase After Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02179229

    Effect of Pre- and Probiotics on P-cresol Plasma Levels in Patients Bearing a Kidney Allograft

    Not yet reported Federico II University 30 participants Est. completion 2015-08 1 site
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Active, not recruiting NCT NCT02181257

    Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

    Not yet reported Washington University School of Medicine 280 participants Est. completion 2028-12 22 sites
    Other conditions: Bronchiolitis Obliterans Syndrome (BOS)
    View official trial listing →
  • Completed NCT NCT02182986

    Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

    National Institute of Allergy and Infectious Diseases (NIAID) 944 participants Est. completion 2019-05-15 7 sites
    Other conditions: Heart Transplant, Small Intestine Transplant, Kidney Transplant, Liver Transplant, EBV-Related PTLD, PTLDs
    View official trial listing →
  • Completed NCT NCT02186275

    The Vitamin D in Pediatric Crohn's Disease

    Not yet reported St. Justine's Hospital 25 participants Est. completion 2019-12-20 10 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02199145

    Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy

    Not yet reported Centre Hospitalier Universitaire de Nice 52 participants Est. completion 2020-06-04 3 sites
    Other conditions: Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT02201576

    Bortezomib in Rejection of Kidney Transplants

    Not yet reported Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2020-07-16 1 site
    Other conditions: Chronic Antibody-mediated Transplant Rejection
    View official trial listing →
  • Completed NCT NCT02203396

    A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 40 participants Est. completion 2017-09 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02213068

    Belatacept 3 Month Post Transplant Conversion Study

    Not yet reported Lorenzo Gallon 28 participants Est. completion 2020-09 1 site
    Other conditions: Transplant; Failure, Kidney, EBV
    View official trial listing →
  • Completed NCT NCT02221583

    Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy

    Not yet reported University of Cincinnati 26 participants Est. completion 2015-02 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT02229604

    Electroacupuncture for Diminished Ovarian Reserve

    Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 57 participants Est. completion 2016-09
    Other conditions: Irregular Menses
    View official trial listing →
  • Completed NCT NCT02240888

    Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

    Not yet reported Region Skane 300 participants Est. completion 2018-05-31 1 site
    Other conditions: RA, SLE, Vasculitis, Scleroderma, Sjögrens, Syndrome
    View official trial listing →
  • Status unknown NCT NCT02251691

    Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant

    Not yet reported National Taiwan University Hospital 90 participants Est. completion 2020-03-31 1 site
    Other conditions: Adherence to Medication Regime
    View official trial listing →
  • Status unknown NCT NCT02252328

    Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients

    Not yet reported, Not yet reported University College, London 50 participants Est. completion 2019-08 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Status unknown NCT NCT02254668

    Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography

    Not yet reported University of Zurich 278 participants Est. completion 2023-02 1 site
    Other conditions: Intimal Proliferation, Immunosuppression
    View official trial listing →
  • Terminated NCT NCT02255227

    Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 104 participants Est. completion 2022-07-06 8 sites
    Other conditions: Infections, Pneumococcal, Bowel Diseases, Inflammatory
    View official trial listing →
  • Terminated NCT NCT02268201

    A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

    Not yet reported Astellas Pharma China, Inc. 17 participants Est. completion 2015-03-31 7 sites
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT02270957

    Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

    Not yet reported Oklahoma Medical Research Foundation 66 participants Est. completion 2021-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02280902

    Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases

    University Hospital, Bordeaux 72 participants Est. completion 2021-11-19 7 sites
    Other conditions: Immunologic and Inflammatory Diseases
    View official trial listing →
  • Terminated NCT NCT02282514

    Stem Cell Transplantation for Stiff Person Syndrome (SPS)

    Not yet reported, Not yet reported Northwestern University 23 participants Est. completion 2019-08-30 1 site
    Other conditions: Stiff-Person Syndrome
    View official trial listing →
  • Completed NCT NCT02286609

    A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort Pharmacokinetics

    Not yet reported PTC Therapeutics 16 participants Est. completion 2015-02 2 sites
    Other conditions: Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT02286622

    A Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort Pharmacokinetics

    Not yet reported PTC Therapeutics 16 participants Est. completion 2015-02 2 sites
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT02286635

    Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort

    Not yet reported PTC Therapeutics 58 participants Est. completion 2014-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT02287311

    Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

    Not yet reported Baylor College of Medicine 38 participants Est. completion 2029-03 2 sites
    Other conditions: Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus, T/NK-lymphoproliferative Disease, Nasopharyngeal Carcinoma, Smooth Muscle Tumor
    View official trial listing →
  • Completed NCT NCT02294032

    The Role of B Cells in Kidney Allograft Dysfunction

    Loma Linda University 180 participants Est. completion 2023-04-24 1 site
    Other conditions: Kidney; Complications, Allograft, Transplantation Infection
    View official trial listing →
  • Status unknown NCT NCT02294097

    Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation

    Not yet reported Chulalongkorn University 100 participants Est. completion 2016-12 1 site
    Other conditions: Surveillance Protocol Biopsy
    View official trial listing →
  • Completed NCT NCT02294552

    Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

    Not yet reported Ivan S Moiseev 200 participants Est. completion 2017-11 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Lymphoma, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT02295748

    An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

    Not yet reported PTC Therapeutics 24 participants Est. completion 2017-08-24 4 sites
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT02307643

    Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients

    Not yet reported Tanabe Pharma Corporation 17 participants Est. completion 2017-05 14 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT02311010

    Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

    Not yet reported Université Catholique de Louvain 150 participants Est. completion 2015-01 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Status unknown NCT NCT02314312

    Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors

    Not yet reported Mahidol University 48 participants Est. completion 2015-06
    Other conditions: Transplantation of Kidney, Expanded Criteria Donor, ECD
    View official trial listing →
  • Completed NCT NCT02319525

    Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus

    Not yet reported University of Alabama at Birmingham 301 participants Est. completion 2016-12 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02328963

    Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

    Not yet reported University Hospital, Bordeaux 186 participants Est. completion 2018-10-10 9 sites
    Other conditions: Transplantation Infection, Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT02329808

    Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics

    Radboud University Medical Center 93 participants Est. completion 2021-12-03 1 site
    Other conditions: Hematologic Diseases, Oncology Problem, Kidney Diseases, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT02334488

    Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

    Not yet reported Poitiers University Hospital 329 participants Est. completion 2020-07-03 14 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02339441

    Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

    University of Manchester 320 participants Est. completion 2016-03
    Other conditions: Early Diffuse Cutaneous Systemic Sclerosis
    View official trial listing →
  • Status unknown NCT NCT02342028

    The Number and Function of Regular T Cell in Patients With Obstructive Sleep Apnea

    Taipei Veterans General Hospital, Taiwan 80 participants Est. completion 2015-12 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02347371

    Heart Transplant Registry of Városmajor

    Semmelweis University Heart and Vascular Center 11 participants Est. completion 2020-05 1 site
    Other conditions: Disorder Related to Cardiac Transplantation
    View official trial listing →
  • Status unknown NCT NCT02356445

    Use of Immunosuppressive Therapy for Sarcoidosis

    University of Cincinnati 2000 participants Est. completion 2018-12 1 site
    Other conditions: Sarcoidosis
    View official trial listing →
  • Completed NCT NCT02371434

    The ONE Study nTreg Trial (ONEnTreg13)

    Not yet reported, Not yet reported Prof. Dr. Petra Reinke 17 participants Est. completion 2017-11-01 1 site Stand-alone
    Other conditions: Immunosuppressive Treatment of Living-donor Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02388802

    Human Clinical Trial of Uterine Transplantation in the United Kingdom

    Not yet reported Womb Transplant UK 10 participants Est. completion 2020-01 Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02397018

    Cord Blood Infusion for Ischemic Stroke

    Not yet reported Joanne Kurtzberg, MD 10 participants Est. completion 2017-02-23 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02401932

    Retrospective Analysis for Patients With Hemophagocytosis in Bone Marrow

    Samsung Medical Center 300 participants Est. completion 2015-09 1 site
    Other conditions: Hemophagocytosis
    View official trial listing →
  • Completed NCT NCT02402140

    Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations

    Not yet reported Hospital do Rim e Hipertensão 128 participants Est. completion 2014-12
    Other conditions: Renal Transplant Graft Failure
    View official trial listing →
  • Completed NCT NCT02404025

    Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

    Not yet reported Novartis Pharmaceuticals 10 participants Est. completion 2017-09-06 11 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT02409576

    Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas

    Not yet reported, Not yet reported National University Hospital, Singapore 20 participants Est. completion 2020-09 1 site
    Obstructive sleep apnea Other conditions: Ewing Sarcoma
    View official trial listing →
  • Status unknown NCT NCT02416674

    Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

    Not yet reported Brigham and Women's Hospital 10 participants Est. completion 2025-02 1 site Stand-alone
    Other conditions: Abdominal Wall Defect
    View official trial listing →
  • Status unknown NCT NCT02426502

    Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients

    Not yet reported University of British Columbia 76 participants Est. completion 2024-12 3 sites
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Status unknown NCT NCT02432339

    Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

    Not yet reported, Not yet reported Augusta University 50 participants Est. completion 2019-11-30 1 site
    Other conditions: Psychological Stress, Hypertension, Renal
    View official trial listing →
  • Completed NCT NCT02435901

    HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

    Not yet reported, Not yet reported Northwell Health 29 participants Est. completion 2019-12 1 site
    Other conditions: Sickle Cell Disease, Beta Thalassemia-Major
    View official trial listing →
  • Completed NCT NCT02444429

    3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation

    Not yet reported Hospices Civils de Lyon 346 participants Est. completion 2024-06-21 8 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02452697

    Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT

    Not yet reported Cristina Gasparetto 36 participants Est. completion 2024-10 1 site
    Other conditions: Myeloid Malignancies, Lymphoid Malignancies
    View official trial listing →
  • Status unknown NCT NCT02453867

    Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients

    Not yet reported Klemens Budde 400 participants Est. completion 2019-07
    Other conditions: Immunosuppression After Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02458196

    Study of Treatment Response on IgG4 Related Disease (IgG4RD)

    Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2018-06 1 site
    Other conditions: Autoimmune Disease
    View official trial listing →
  • Completed NCT NCT02461758

    Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients

    Not yet reported University of Wisconsin, Madison 81 participants Est. completion 2018-07 1 site
    Other conditions: Inflammatory Bowel Disease (IBD)
    View official trial listing →
  • Completed NCT NCT02474199

    Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2019-12-16 3 sites
    Other conditions: Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient)
    View official trial listing →
  • Completed NCT NCT02505542

    Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo

    Not yet reported UCB BIOSCIENCES GmbH 736 participants Est. completion 2019-04 108 sites
    Other conditions: Axial Spondyloarthrithis, Ankylosing Spondylitis
    View official trial listing →
  • Terminated NCT NCT02523768

    Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 117 participants Est. completion 2020-02-24 15 sites
    Other conditions: Glomerulonephritis, IgAN
    View official trial listing →
  • Terminated NCT NCT02531308

    Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)

    Not yet reported Rush University Medical Center 5 participants Est. completion 2016-07 1 site
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02540395

    Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation

    Not yet reported Prof. Dr. Petra Reinke 184 participants Est. completion 2020-10-31 8 sites
    Other conditions: Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Terminated NCT NCT02546492

    Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar

    Not yet reported University of Maryland, Baltimore 6 participants Est. completion 2021-05-27 2 sites Stand-alone
    Other conditions: Transplant Glomerulopathy
    View official trial listing →
  • Completed NCT NCT02552212

    Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

    Not yet reported UCB BIOSCIENCES GmbH 317 participants Est. completion 2020-05 105 sites
    Other conditions: Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis, Nr-axSpA
    View official trial listing →
  • Status unknown NCT NCT02554578

    Impact of mHealth in Heart Transplant Management

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 158 participants
    Other conditions: Heart Transplant
    View official trial listing →
  • Completed NCT NCT02560220

    MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

    Not yet reported Heidelberg University 14 participants Est. completion 2017-04-18 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT02560558

    Bela 8 Week Dosing

    Not yet reported Emory University 166 participants Est. completion 2019-08-29 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02561767

    Effect of BM-MSCs in DCD Kidney Transplantation

    Not yet reported, Not yet reported First Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2017-10 1 site
    Other conditions: Kidney Transplantation, Acute Kidney Tubular Necrosis
    View official trial listing →
  • Withdrawn NCT NCT02563782

    Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD

    Not yet reported Astellas Institute for Regenerative Medicine Est. completion 2017-05-05 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02581436

    Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 70 participants Est. completion 2018-02-01 1 site
    Other conditions: Disorder Related to Renal Transplantation, Renal Transplant Rejection, Acute Graft Rejection
    View official trial listing →
  • Terminated NCT NCT02584647

    PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

    Not yet reported, Not yet reported Gulam Manji 39 participants Est. completion 2024-10-01 5 sites
    Other conditions: Sarcoma, Malignant Peripheral Nerve Sheath Tumors
    View official trial listing →
  • Approved For Marketing NCT NCT02592941

    Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

    PTC Therapeutics 42 sites
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT02596828

    Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

    Not yet reported University of Regensburg 4 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Pineoblastoma
    View official trial listing →
  • Completed NCT NCT02623075

    Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients

    Northwestern University 19 participants Est. completion 2023-12 1 site
    Other conditions: Influenza
    View official trial listing →
  • Terminated NCT NCT02627573

    Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

    Not yet reported St. Petersburg State Pavlov Medical University 32 participants Est. completion 2019-04-03 1 site
    Other conditions: Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
    View official trial listing →
  • Active, not recruiting NCT NCT02629120

    High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2028-12-30 1 site
    Other conditions: Chronic Granulomatous Disease Transplant
    View official trial listing →
  • Completed NCT NCT02639949

    Measuring and Improving Medication Adherence in Kidney Transplant Patients

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45 participants Est. completion 2017-07
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT02646657

    An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis

    Not yet reported Geert D'Haens 120 participants Est. completion 2020-08 20 sites
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Terminated NCT NCT02647255

    Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

    Not yet reported, Not yet reported Peking University First Hospital 10 participants Est. completion 2020-10 2 sites
    Other conditions: Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency, Rapidly Progressive Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT02654964

    Cancer Stem Cell High-Throughput Drug Screening Study

    Not yet reported Swedish Medical Center 9 participants Est. completion 2023-06 1 site
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT02667132

    Granulomatous Mastitis Current Approach and Treatment

    Granulomatous Mastitis Working Group 400 participants Est. completion 2018-01-04 1 site
    Other conditions: Granulomatous, Mastitis
    View official trial listing →
  • Status unknown NCT NCT02682459

    ACE-inhibitors in Extracapillary Glomerulonephritis

    Not yet reported Monia Lorini 22 participants Est. completion 2019-12 2 sites
    Other conditions: Extracapillary Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT02684734

    Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis

    University of British Columbia 50 participants Est. completion 2019-12 1 site
    Other conditions: Ulcerative Colitis, Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT02707822

    The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration

    National Taiwan University Hospital 440 participants Est. completion 2018-12 1 site
    Other conditions: Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02711202

    Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

    Not yet reported Institute for Clinical and Experimental Medicine 20 participants Est. completion 2009-03
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02711826

    Treg Therapy in Subclinical Inflammation in Kidney Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2023-08-04 6 sites
    Other conditions: Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney Donor
    View official trial listing →
  • Terminated NCT NCT02723786

    Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

    Not yet reported GlaxoSmithKline 7 participants Est. completion 2018-03-06 4 sites
    Other conditions: Kidney Transplantation (Status Post)
    View official trial listing →
  • Completed NCT NCT02741960

    The Effect of Metformin on Reducing Lupus Flares

    Not yet reported RenJi Hospital 180 participants Est. completion 2018-12-07 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT02743793

    A Cohort Study of Operationally Tolerant Allograft Recipients

    National Institute of Allergy and Infectious Diseases (NIAID) 41 participants Est. completion 2020-03-24 5 sites
    Other conditions: Kidney Transplant, Liver Transplant
    View official trial listing →
  • Completed NCT NCT02745717

    The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2021-12 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02773290

    Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

    Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 46 participants Est. completion 2020-07-28 3 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02799147

    GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

    Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 27 participants Est. completion 2020-11 1 site
    Other conditions: Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias
    View official trial listing →
  • Status unknown NCT NCT02799316

    Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?

    Not yet reported Sherief Abd-Elsalam 100 participants Est. completion 2018-01 1 site
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT02806375

    PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

    Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 20 participants Est. completion 2019-04 1 site
    Other conditions: Primary Myelofibrosis, Myeloproliferative Disorders
    View official trial listing →
  • Completed NCT NCT02821026

    Omental Islet Transplant

    Not yet reported, Not yet reported University of Alberta 4 participants Est. completion 2019-11-13 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02827227

    Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)

    Hospices Civils de Lyon 99 participants Est. completion 2016-02 1 site
    Other conditions: HIV-infected Patients
    View official trial listing →
  • Status unknown NCT NCT02838992

    ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia

    Not yet reported Jinan Military General Hospital 130 participants Est. completion 2019-07 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT02839941

    Iguratimod in Kidney Transplant Recipients

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2019-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02843841

    Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation

    Not yet reported Centre Hospitalier Universitaire de Besancon 63 participants Est. completion 2017-03-01 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02845596

    Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

    Not yet reported Michael Pulsipher 40 participants Est. completion 2023-07-19 13 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT02855359

    Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

    Not yet reported Seagen Inc. 24 participants Est. completion 2018-05-15 35 sites
    Other conditions: Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCL
    View official trial listing →
  • Completed NCT NCT02857907

    Anti-thymocyte Globulin-induced Immune Senescence

    Centre Hospitalier Universitaire de Besancon 97 participants Est. completion 2013-01 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02874586

    Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis

    Not yet reported Xiaoli Fan 20 participants Est. completion 2021-09 1 site
    Other conditions: Hepatitis, Autoimmune
    View official trial listing →
  • Completed NCT NCT02875743

    King's Invasive Aspergillosis Study II

    Not yet reported King's College Hospital NHS Trust 120 participants Est. completion 2019-10-31 1 site
    Other conditions: Aplastic Anemia, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Bone Marrow Transplantation
    View official trial listing →
  • Status unknown NCT NCT02875990

    Characterization of Immunosuppressive Signing of Cervical Cancer

    Not yet reported Assistance Publique Hopitaux De Marseille 50 participants Est. completion 2024-09 1 site
    Other conditions: Cervical Cancer
    View official trial listing →
  • Status unknown NCT NCT02877212

    Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

    Not yet reported National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75 participants Est. completion 2017-09 1 site
    Other conditions: Immune Thrombocytopenic Purpura (ITP)
    View official trial listing →
  • Completed NCT NCT02877628

    Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation

    Rennes University Hospital 110 participants Est. completion 2018-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT02878018

    Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis

    Liaoning University of Traditional Chinese Medicine 600 participants Est. completion 2020-05 1 site
    Other conditions: Henoch-Schonlein Purpura Nephritis
    View official trial listing →
  • Completed NCT NCT02878603

    Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

    Not yet reported Sanofi 104 participants Est. completion 2020-10-23 45 sites Stand-alone
    Other conditions: Acquired Thrombotic Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT02885610

    Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

    Not yet reported RemeGen Co., Ltd. 249 participants Est. completion 2019-07-09 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02888080

    Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

    Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2019-03-04 8 sites
    Other conditions: Pulmonary Sarcoidosis
    View official trial listing →
  • Status unknown NCT NCT02896270

    Valproic Acid for Idiopathic Nephrotic Syndrome

    Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 15 participants Est. completion 2019-12 2 sites
    Other conditions: Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease
    View official trial listing →
  • Withdrawn NCT NCT02904772

    Alipogene Tiparvovec for the Treatment of LPLD Patients

    Not yet reported UniQure Biopharma B.V. Est. completion 2020-09 2 sites
    Other conditions: LPL Deficiency
    View official trial listing →
  • Completed NCT NCT02917577

    Hepatitis A Vaccine Dosing Regimens Among Pediatric Patients on Immunosuppressive Therapy

    Not yet reported University of Calgary 19 participants Est. completion 2023-06 1 site
    Other conditions: Autoimmune Rheumatologic Disease
    View official trial listing →
  • Status unknown NCT NCT02931942

    Changing Over Time of Ascorbic Acid After Chemotherapy

    Maastricht University Medical Center 150 participants Est. completion 2023-12 1 site
    Other conditions: Leukemia (Both ALL and AML), Cancer of Lung, Myeloma
    View official trial listing →
  • Status unknown NCT NCT02936505

    Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.

    Not yet reported Vastra Gotaland Region 249 participants Est. completion 2026-10-30 5 sites
    Other conditions: Lung Transplantation, Allografts
    View official trial listing →
  • Status unknown NCT NCT02936596

    Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

    Not yet reported Xiaoli Fan 53 participants Est. completion 2022-06-01 1 site Stand-alone
    Other conditions: Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary, Cholestasis
    View official trial listing →
  • Status unknown NCT NCT02938741

    ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 130 participants Est. completion 2022-12 2 sites Stand-alone
    Other conditions: Lymphoblastic Lymphoma
    View official trial listing →
  • Terminated NCT NCT02949492

    Low-dose IL-2 for Treg Expansion and Tolerance (LITE)

    Not yet reported King's College London 6 participants Est. completion 2019-01-31 1 site
    Other conditions: Transplantation, Liver Diseases
    View official trial listing →
  • Status unknown NCT NCT02957552

    Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation

    Not yet reported University Hospital Tuebingen 7 participants Est. completion 2021-12 1 site
    Other conditions: Pediatric Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT02963103

    A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

    Not yet reported Astellas Pharma Korea, Inc. 13 participants Est. completion 2012-10 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT02979873

    Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 84 participants Est. completion 2030-06-30 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02990286

    Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases

    Not yet reported University Hospital, Tours 122 participants Est. completion 2020-02-17 5 sites
    Other conditions: Lung Disease, Interstitial
    View official trial listing →
  • Status unknown NCT NCT03009565

    Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?

    Rabin Medical Center 800 participants Est. completion 2019-01
    Other conditions: Coronary (Artery) Disease
    View official trial listing →
  • Completed NCT NCT03025698

    A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

    Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2025-01-27 20 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT03031470

    Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation

    Not yet reported Dompé Farmaceutici S.p.A 40 participants Est. completion 2017-03-31 7 sites
    Other conditions: Ischemia-reperfusion Injury in Liver Transplant, Early Allograft Dysfunction
    View official trial listing →
  • Completed NCT NCT03035422

    Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 24 participants Est. completion 2021-12-18 1 site
    Other conditions: Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT03043300

    A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US

    Emory University 10 participants Est. completion 2018-12-01 2 sites
    Other conditions: Dysbiosis
    View official trial listing →
  • Completed NCT NCT03056924

    Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

    Boston Medical Center 173 participants Est. completion 2019-01-15 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03062579

    A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

    Not yet reported, Not yet reported Fu-Dong Shi 10 participants Est. completion 2018-05-15 1 site
    Other conditions: Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica, Devic's Disease
    View official trial listing →
  • Completed NCT NCT03079089

    Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40 participants Est. completion 2023-09-11 1 site
    Other conditions: Refractory or Relapsed Lymphoid Haemopathy
    View official trial listing →
  • Completed NCT NCT03082677

    Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

    Not yet reported Memorial Sloan Kettering Cancer Center 20 participants Est. completion 2021-09-02 1 site
    Other conditions: Myeloid Hematologic Malignancy, Lymphoid Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT03083769

    Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.

    Southern Medical University, China 1502 participants Est. completion 2019-08-01 2 sites
    Other conditions: Transplantation
    View official trial listing →
  • Status unknown NCT NCT03088280

    Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

    Not yet reported Hospital Geral de Fortaleza 200 participants Est. completion 2020-01 1 site
    Other conditions: Thymoglobulin Dose
    View official trial listing →
  • Status unknown NCT NCT03096717

    Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing

    Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 300 participants Est. completion 2021-01-21 1 site
    Other conditions: Dysplasia in IBD
    View official trial listing →
  • Completed NCT NCT03125772

    Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics

    Not yet reported Fortis Escorts Heart Institute 1830 participants Est. completion 2016-05 1 site
    Type 2 diabetes Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT03131934

    Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

    Not yet reported University College, London 4 participants Est. completion 2026-03-12 2 sites
    Other conditions: Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT03136588

    Information and Communication Technology (ICT) Based Centralized Clinical Trial Monitoring System for Drug Adherence

    Not yet reported Kyungpook National University Hospital 114 participants Est. completion 2018-12-31 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Suspended NCT NCT03139747

    UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

    Not yet reported Thomas Jefferson University 5 participants Est. completion 2022-05-30 1 site
    Other conditions: Thyroid Cancer
    View official trial listing →
  • Completed NCT NCT03147183

    Kinetic Study of CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients After Receiving Thymoglobulin

    Maimónides Biomedical Research Institute of Córdoba 150 participants Est. completion 2019-10-21 1 site
    Other conditions: Renal Transplant Infection
    View official trial listing →
  • Status unknown NCT NCT03150134

    Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100 participants Est. completion 2021-01-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Disorder Related to Bone Marrow Transplantation
    View official trial listing →
  • Completed NCT NCT03161886

    A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).

    Not yet reported Azienda Policlinico Umberto I 48 participants Est. completion 2017-01-10 Stand-alone
    Other conditions: Inflammatory Bowel Diseases, Children, Only
    View official trial listing →
  • Terminated NCT NCT03172195

    Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 80 participants Est. completion 2024-05-16 1 site
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Status unknown NCT NCT03192878

    Infliximab Biosimilar in Takayasu's Arteritis

    Ospedale San Raffaele 30 participants Est. completion 2019-07 1 site
    Other conditions: Takayasu Arteritis
    View official trial listing →
  • Suspended NCT NCT03193073

    Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient

    Not yet reported Omnia Mohammed Hashem 80 participants Est. completion 2020-12-01 1 site
    Chronic kidney disease Other conditions: Endothelial Dysfunction, Left Ventricular Hypertrophy, Fibroblast Growth Factor 23
    View official trial listing →
  • Status unknown NCT NCT03216447

    A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

    Not yet reported Chang Gung Memorial Hospital 150 participants Est. completion 2025-09-30 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03222687

    Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis

    Not yet reported Shandong University 25 participants Est. completion 2017-05-31
    Other conditions: Henoch-Schönlein Purpura Nephritis
    View official trial listing →
  • Completed NCT NCT03232268

    HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies

    Not yet reported Institut Paoli-Calmettes 25 participants Est. completion 2026-01-07 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT03235128

    Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome

    Assiut University 50 participants Est. completion 2019-10-01
    Other conditions: Nephrotic Syndrome Steroid-Resistant
    View official trial listing →
  • Completed NCT NCT03243656

    Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia

    Not yet reported Assiut University 20 participants Est. completion 2020-01-05 1 site
    Other conditions: Eltrombopag
    View official trial listing →
  • Active, not recruiting NCT NCT03249831

    A Blood Stem Cell Transplant for Sickle Cell Disease

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2027-01-25 1 site
    Other conditions: Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies, Thalassemia, Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT03277703

    Flu Vaccine Response in Patients on Biologic Therapies

    Not yet reported Stony Brook University 30 participants Est. completion 2019-12-30 1 site
    Other conditions: Rheumatologic Disorder, Inflammatory Bowel Diseases, Immune Complex Diseases
    View official trial listing →
  • Withdrawn NCT NCT03279094

    Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

    Not yet reported City of Hope Medical Center Est. completion 2027-01-25
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT03283085

    A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

    Not yet reported Shire 557 participants Est. completion 2023-12-13 419 sites
    Other conditions: Crohn's Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT03289650

    Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

    Not yet reported Lorenzo Gallon 29 participants Est. completion 2021-02-23 1 site
    Other conditions: End Stage Renal Disease, Rejection of Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT03292445

    Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation

    Not yet reported Samuel Strober 24 participants Est. completion 2024-02-14 2 sites
    Other conditions: Immune Tolerance
    View official trial listing →
  • Enrolling by invitation NCT NCT03292861

    The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients

    Not yet reported Cedars-Sinai Medical Center 60 participants Est. completion 2026-03-31 2 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT03301350

    Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

    Not yet reported University of Wisconsin, Madison 29 participants Est. completion 2022-02-07 6 sites
    Other conditions: Breast Cancer, Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03304626

    Budesonide for Liver Transplant Immune Suppression

    Not yet reported University of Cincinnati 40 participants Est. completion 2019-12-31 1 site
    Other conditions: Acute Cellular Graft Rejection, New Onset Diabetes After Transplant
    View official trial listing →
  • Completed NCT NCT03312907

    A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

    Not yet reported GlaxoSmithKline 292 participants Est. completion 2021-07-07 79 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT03314909

    Initial Hemopurification Strategy for Acute Paraquat Poisoning in Adults

    Not yet reported Peking Union Medical College Hospital 360 participants Est. completion 2022-02-28
    Other conditions: Poisoning
    View official trial listing →
  • Withdrawn NCT NCT03315052

    Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

    Not yet reported Montefiore Medical Center Est. completion 2022-01
    Other conditions: Acute Cellular Graft Rejection, Liver Transplant Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT03323476

    Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

    Not yet reported Centre Hospitalier Departemental Vendee 136 participants Est. completion 2031-03 57 sites
    Other conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT03342638

    Maximizing Outcome of Multiple Sclerosis Transplantation

    Not yet reported Northwestern University 66 participants Est. completion 2019-10-09 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT03349450

    DPX-Survivac and Checkpoint Inhibitor in DLBCL

    Not yet reported Sunnybrook Health Sciences Centre 25 participants Est. completion 2023-07-18 6 sites
    Other conditions: Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03360175

    Correlation of Eicosanoid and Proresolving Lipid Mediator Temporal Profiles and Resolution of Pain After Thoracic Surgery

    Brigham and Women's Hospital 40 participants Est. completion 2019-12-01
    Other conditions: Pain, Postoperative
    View official trial listing →
  • Status unknown NCT NCT03368105

    Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain

    Not yet reported Medical University of Silesia 300 participants Est. completion 2021-07-01
    Other conditions: Clostridium Difficile
    View official trial listing →
  • Terminated NCT NCT03370601

    Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases

    Not yet reported University Hospital, Lille 9 participants Est. completion 2019-01 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03371095

    Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease

    Not yet reported Assistance Publique - Hôpitaux de Paris 53 participants Est. completion 2022-04-11 27 sites
    Other conditions: Behcet's Disease, Vasculitis
    View official trial listing →
  • Completed NCT NCT03393013

    A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis

    Not yet reported, Not yet reported Kezar Life Sciences, Inc. 69 participants Est. completion 2022-08-04 36 sites
    Other conditions: Lupus Nephritis, Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT03408210

    Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 191 participants Est. completion 2022-08 1 site
    Other conditions: Myelodysplastic Syndromes, Acute Leukemia
    View official trial listing →
  • Status unknown NCT NCT03408223

    Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia

    Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 100 participants Est. completion 2022-12 1 site
    Other conditions: Acute Leukemia
    View official trial listing →
  • Completed NCT NCT03414086

    Predictor of Clinical Response to Acthar in Myositis

    University of Pittsburgh 20 participants Est. completion 2022-07-30 1 site
    Other conditions: Myositis, Dermatomyositis, Polymyositis
    View official trial listing →
  • Active, not recruiting NCT NCT03414658

    The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

    Not yet reported Adrienne G. Waks 100 participants Est. completion 2027-05-31 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03418779

    Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

    Not yet reported, Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60 participants Est. completion 2024-12-31 1 site
    Other conditions: IgA Nephropathy at High Risk of Developing ESRD
    View official trial listing →
  • Withdrawn NCT NCT03427008

    A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients

    Not yet reported Johns Hopkins University Est. completion 2020-11-12 1 site
    Other conditions: Medication Adherence, Transplant; Kidney
    View official trial listing →
  • Status unknown NCT NCT03438773

    Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients

    Not yet reported California Institute of Renal Research 50 participants Est. completion 2023-12 1 site
    Other conditions: Kidney Transplant; Complications, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT03452735

    Fertility Study of Women With Chronic Inflammatory Rheumatism

    University Hospital, Toulouse 2900 participants Est. completion 2019-07 1 site
    Other conditions: Arthritis, Psoriatic, Arthritis, Rheumatoid, Ankylosing Spondylitis, Chronic Juvenile Arthritis
    View official trial listing →
  • Terminated NCT NCT03454932

    Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases

    Bone Therapeutics S.A 30 participants Est. completion 2017-06-04
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis
    View official trial listing →
  • Status unknown NCT NCT03465397

    Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients

    Not yet reported ORIOL BESTARD 164 participants Est. completion 2021-11 6 sites
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Terminated NCT NCT03466801

    The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.

    Not yet reported Wenhu Liu 6 participants Est. completion 2019-06-30 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Status unknown NCT NCT03468972

    Effect of Immunosuppression in IgA Nephropathy

    Not yet reported Yonsei University 174 participants Est. completion 2023-05 1 site
    Other conditions: Biopsy-proven IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT03483675

    Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease

    Not yet reported Fred Hutchinson Cancer Center 21 participants Est. completion 2021-03-03 1 site
    Other conditions: Chronic Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT03487666

    OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

    Not yet reported Georgetown University 45 participants Est. completion 2024-05-02 4 sites
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03504137

    A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients

    Not yet reported Johns Hopkins University 1 participants Est. completion 2020-08-28 1 site
    Other conditions: Medication Adherence, Kidney Transplant
    View official trial listing →
  • Withdrawn NCT NCT03515330

    A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients

    Not yet reported Johns Hopkins University Est. completion 2020-11-12 1 site
    Other conditions: Medication Adherence, Liver Transplant
    View official trial listing →
  • Completed NCT NCT03517982

    Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan

    Hikma Pharmaceuticals LLC 12 participants Est. completion 2016-09 1 site
    Other conditions: Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant
    View official trial listing →
  • Completed NCT NCT03530215

    Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)

    Groupe Hospitalier Pitie-Salpetriere 500000 participants Est. completion 2023-04-08 1 site
    Other conditions: Cardiac Disease, Cancer
    View official trial listing →
  • Completed NCT NCT03558373

    The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

    Chiesi Farmaceutici S.p.A. 158 participants Est. completion 2020-02-26 12 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT03562845

    Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant

    Biohope Scientific Solutions for Human Health, S.L. 164 participants Est. completion 2019-05-31 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT03562975

    Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus

    University of South Florida 18 participants Est. completion 2023-01-11 1 site
    Other conditions: Multiple Sclerosis, Pathologic Processes, Demyelinating Diseases, Nervous System Diseases, Autoimmune Diseases, Immune System Diseases, Primary Progressive Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT03567161

    Ultrasonic Surgical Aspirator to Treat Deep Infrabony Defects

    Not yet reported University of Milan 11 participants Est. completion 2017-09-01 1 site
    Other conditions: Periodontitis
    View official trial listing →
  • Completed NCT NCT03577431

    Liver Transplantation With Tregs at MGH

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2026-02-05 1 site
    Other conditions: Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT03587493

    T-lymphocytes CD8+/HLA-DR+ and Acute Rejection After Lung Transplantation

    Not yet reported Assistance Publique Hopitaux De Marseille 110 participants Est. completion 2022-09 1 site
    Other conditions: Transplant Failure
    View official trial listing →
  • Terminated NCT NCT03591770

    Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

    Not yet reported Boston Medical Center 15 participants Est. completion 2024-07-04 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Withdrawn NCT NCT03596970

    Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.

    Not yet reported Novartis Pharmaceuticals Est. completion 2020-12
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT03603418

    Role Of Dexamethasone In Induction Of Labor

    Not yet reported Ain Shams University 80 participants Est. completion 2019-02 1 site
    Other conditions: Dexamethasone Effect on Induction of Labor
    View official trial listing →
  • Withdrawn NCT NCT03605654

    Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

    Not yet reported, Not yet reported Medeor Therapeutics, Inc. Est. completion 2026-10
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT03626714

    Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study

    Not yet reported Auritec Pharmaceuticals 8 participants Est. completion 2019-01-05 1 site
    Other conditions: Organ Transplant Rejection, Psoriasis
    View official trial listing →
  • Completed NCT NCT03627026

    Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients

    Not yet reported Institut Claudius Regaud 78 participants Est. completion 2024-06-03 2 sites
    Other conditions: Melanoma
    View official trial listing →
  • Status unknown NCT NCT03631563

    ATG-F VS ATG for the Prevention of GVHD

    Not yet reported, Not yet reported Fujian Medical University 120 participants Est. completion 2020-12-01 1 site
    Other conditions: GVHD in the Setting of Haplo-HSCT
    View official trial listing →
  • Completed NCT NCT03656926

    Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

    Not yet reported Zambon SpA 169 participants Est. completion 2024-03-12 40 sites
    Other conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
    View official trial listing →
  • Completed NCT NCT03657004

    Immunosuppressive Regimen on Changes in Renal Function and Transplant Rejection Rate in Patients With Lung Transplant

    University of Giessen 145 participants Est. completion 2019-08-29 1 site
    Chronic kidney disease Other conditions: Lung Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03657342

    Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

    Not yet reported Zambon SpA 62 participants Est. completion 2024-04-16 39 sites
    Other conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
    View official trial listing →
  • Status unknown NCT NCT03662087

    HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 100 participants Est. completion 2022-10 1 site
    Other conditions: Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
    View official trial listing →
  • Completed NCT NCT03663335

    Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 418 participants Est. completion 2021-10-29 74 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT03671174

    Immunosuppressant Regimens for Living Fetuses Study

    Not yet reported RenJi Hospital 420 participants Est. completion 2023-02 1 site
    Other conditions: Undifferentiated Connective Tissue Disease, Recurrent Pregnancy Loss
    View official trial listing →
  • Status unknown NCT NCT03672110

    Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

    Not yet reported Technische Universität Dresden 400 participants Est. completion 2025-12 1 site
    Other conditions: Renal Failure, Renal Insufficiency, Renal Disease, Renal Insufficiency, Chronic
    View official trial listing →
  • Active, not recruiting NCT NCT03726307

    Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

    Not yet reported Angus W. Thomson PhD DSc 28 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Kidney Transplant, Renal Transplant Recipients
    View official trial listing →
  • Completed NCT NCT03732248

    Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders

    Not yet reported Medical University of South Carolina 21 participants Est. completion 2020-01-20 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT03760003

    Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

    Not yet reported Abivax S.A. 355 participants Est. completion 2021-04-16 130 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT03760263

    Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus

    Not yet reported Sentara Norfolk General Hospital 46 participants Est. completion 2023-11-01 1 site
    Other conditions: Transplant;Failure,Kidney
    View official trial listing →
  • Completed NCT NCT03773666

    A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)

    Not yet reported Dana-Farber Cancer Institute 12 participants Est. completion 2021-08-02 2 sites
    Other conditions: Muscle Invasive Bladder Cancer
    View official trial listing →
  • Completed NCT NCT03775824

    Faecal Analyses in Rheumatoid Arthritis Therapy

    Region Skane 50 participants Est. completion 2019-06-01
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT03781830

    mDOT for Immunosuppressant Adherence in Adolescent Liver Transplant Recipients

    Not yet reported Johns Hopkins University Est. completion 2020-11-12 1 site
    Other conditions: Medication Adherence, Liver Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03797196

    RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients

    Not yet reported University Medical Center Groningen 374 participants Est. completion 2026-12 7 sites
    Other conditions: Renal Transplant Recipients, Elderly Patients, Immunosuppression
    View official trial listing →
  • Completed NCT NCT03800576

    Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression

    National Taiwan University Hospital 113 participants Est. completion 2020-09-22 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03812419

    Esomeprazole or Pantoprazole in Renal Transplantation

    Not yet reported Future University in Egypt 47 participants Est. completion 2016-12-30
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03828019

    Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

    Not yet reported JHSPH Center for Clinical Trials 227 participants Est. completion 2024-09-09 26 sites
    Other conditions: Uveitis
    View official trial listing →
  • Active, not recruiting NCT NCT03844061

    Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

    Not yet reported Hospital for Special Surgery, New York 30 participants Est. completion 2027-12-30 1 site Stand-alone
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Terminated NCT NCT03848585

    Medicine Adherence and Effects on Transplants With Pilloxa's Electronic Pillbox

    Not yet reported Pilloxa 25 participants Est. completion 2020-10-12 1 site
    Other conditions: Kidney Transplant; Complications, Liver Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03864796

    Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level

    Assiut University 80 participants Est. completion 2021-01-01 1 site
    Other conditions: Idiopathic Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT03864926

    Envarsus in Delayed Graft Function (E-DGF)

    Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2022-07-22 1 site
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Active, not recruiting NCT NCT03867617

    Cell Therapy for Immunomodulation in Kidney Transplantation

    Not yet reported, Not yet reported Thomas Wekerle 12 participants Est. completion 2028-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT03871361

    Abatacept in Patients With Birdshot HLA A29 Uveitis

    Not yet reported Universitaire Ziekenhuizen KU Leuven 15 participants Est. completion 2023-12-01 1 site
    Other conditions: Eye Diseases, Uveitis
    View official trial listing →
  • Completed NCT NCT03881566

    Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients

    Jongmin Lee 119 participants Est. completion 2020-12-31 1 site
    Other conditions: Sepsis, Immune Deficiency
    View official trial listing →
  • Status unknown NCT NCT03886233

    Treatment Outcome of Uveitis in Autoimmune Diseases

    Assiut University 1 participants Est. completion 2021-02
    Other conditions: Autoimmune Uveitis
    View official trial listing →
  • Status unknown NCT NCT03889808

    Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients.

    Hospital Universitari de Bellvitge 500 participants Est. completion 2021-12 1 site
    Other conditions: Clostridium Difficile, Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03892317

    Improving Adherence in Nonadherent Kidney Transplant Patients

    Not yet reported Imperial College London 42 participants Est. completion 2020-07-27 1 site
    Other conditions: Medication Adherence, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT03896971

    Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia

    Not yet reported Safaa AA Khaled 66 participants Est. completion 2021-06-01 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT03910452

    Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4 participants Est. completion 2034-06-15 1 site
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Status unknown NCT NCT03932539

    Improving Immunosuppressive Therapy in Heart Transplantation

    Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2021-12 4 sites
    Other conditions: Rejection Heart Transplant, Immunosuppression
    View official trial listing →
  • Active, not recruiting NCT NCT03935893

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

    Not yet reported Udai Kammula 20 participants Est. completion 2038-06-30 1 site
    Obstructive sleep apnea Other conditions: Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Sarcoma, Mesothelioma, Neuroendocrine Tumors, Squamous Cell Cancer, Merkel Cell Carcinoma, Mismatch Repair Deficiency
    View official trial listing →
  • Completed NCT NCT03951259

    Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

    Not yet reported RenJi Hospital 32 participants Est. completion 2023-10-19 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT03957694

    Study of AMG531(Romiplostim) in Patients With Aplastic Anemia

    Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 17 participants Est. completion 2021-05-26 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT03964844

    Clostridium Difficile Infection (CDI) in Hematologic Patients.

    Hospital General Universitario Gregorio Marañon 450 participants Est. completion 2020-12-31 1 site
    Other conditions: C.Difficile Diarrhea
    View official trial listing →
  • Completed NCT NCT03977051

    Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients

    Imperial College London 26 participants Est. completion 2017-06-20 1 site
    Other conditions: Adherence, Medication, Transplantation, Kidney
    View official trial listing →
  • Terminated NCT NCT03995901

    A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

    Not yet reported Talaris Therapeutics Inc. 15 participants Est. completion 2023-02-16 18 sites
    Other conditions: Transplanted Organ Rejection
    View official trial listing →
  • Terminated NCT NCT03999580

    The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )

    Not yet reported Jantchou Prevost 55 participants Est. completion 2023-09-29 7 sites Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT04013646

    Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

    Not yet reported, Not yet reported Bundang CHA Hospital 24 participants Est. completion 2021-11-02 1 site
    Cardiovascular disease Other conditions: Umbilical Cord Blood, Erythropoietin, Safety, Treatment Outcome
    View official trial listing →
  • Status unknown NCT NCT04020328

    Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

    Not yet reported Shenzhen Second People's Hospital 70 participants Est. completion 2022-05-31 1 site
    Other conditions: Glomerulonephritis, IGA, Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT04023760

    Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients

    Not yet reported University of Saskatchewan 14 participants Est. completion 2020-03-30 1 site
    Other conditions: Pharmacokinetics, Kidney Transplant, Lung Transplant
    View official trial listing →
  • Active, not recruiting NCT NCT04028063

    Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

    Not yet reported University of Colorado, Denver 65 participants Est. completion 2027-12-31 1 site
    Other conditions: Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma
    View official trial listing →
  • Terminated NCT NCT04032756

    Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

    Ced Service GmbH 50 participants Est. completion 2020-11-15 1 site
    Other conditions: Colitis, Ulcerative, Biologics, Tofacitiniib, Chronic Inflammatory Small Bowel Disease, Bowel Diseases, Inflammatory, Bowel Disease, CED
    View official trial listing →
  • Completed NCT NCT04034316

    Reduce Immunosuppression With Atmp in NS ChildrEn

    Not yet reported Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20 participants Est. completion 2023-08-31 1 site
    Other conditions: Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome, Idiopathic Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT04036097

    Prospective Stratification of Infectious Risks in Multiple Sclerosis

    University Hospital, Basel, Switzerland 298 participants Est. completion 2023-12-31 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT04039425

    Effects of Chemotherapy on the Concentration of Minerals in Hair

    Loma Linda University 5 participants Est. completion 2020-04-27 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT04042272

    Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation

    Akdeniz University 80 participants Est. completion 2021-01-15 1 site
    Other conditions: Kidney Transplant; Complications, Neurologic Manifestations, Uremic Encephalopathy
    View official trial listing →
  • Terminated NCT NCT04044560

    Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant

    Not yet reported University of British Columbia 8 participants Est. completion 2022-02-02 3 sites
    Other conditions: B-cell Adult Acute Lymphoblastic Leukemia, Stem Cell Leukemia, Minimal Residual Disease
    View official trial listing →
  • Completed NCT NCT04057092

    Perioperative Immunonutrition in Patients Undergoing Gynecologic or General Elective Surgery (PURPOSE)

    Not yet reported Hamilton Health Sciences Corporation 72 participants Est. completion 2020-12-31 1 site
    Other conditions: Surgical Site Infection, Post-Op Complication
    View official trial listing →
  • Completed NCT NCT04066114

    Treg Modulation With CD28 and IL-6 Receptor Antagonists

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2023-09-14 7 sites
    Other conditions: Living-Donor Kidney Transplant, Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT04074187

    A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

    Not yet reported, Not yet reported Sanofi 21 participants Est. completion 2021-05-19 12 sites
    Other conditions: Thrombotic Thrombocytopenic Purpura
    View official trial listing →
  • Status unknown NCT NCT04078750

    PLATO - Medication Adherence in Transplant Recipients

    Not yet reported University of British Columbia 99 participants Est. completion 2024-12-31 2 sites
    Other conditions: Kidney Disease, Chronic, Medication Adherence, Renal Disease, Kidney Rejection Transplant
    View official trial listing →
  • Completed NCT NCT04082416

    Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

    Not yet reported RemeGen Co., Ltd. 335 participants Est. completion 2022-06-30 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04095936

    Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia

    Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 24 participants Est. completion 2021-10-29 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT04101578

    Clinical Prognosis and Progression of Myasthenia Gravis Patients

    Da, Yuwei, M.D. 2000 participants Est. completion 2024-12-31 1 site
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Status unknown NCT NCT04124861

    Withdraw Drug in Stable IgG4-Related Disease

    Not yet reported Peking Union Medical College Hospital 138 participants Est. completion 2023-06-30 1 site
    Other conditions: Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT04136587

    The Bacterial Secretome in IBD

    Medical University of Graz 74 participants Est. completion 2024-07-31 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT04145440

    Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

    Not yet reported, Not yet reported HI-Bio, A Biogen Company 31 participants Est. completion 2022-08-02 45 sites
    Other conditions: Glomerulonephritis, Membranous, antiPLA2R Positive
    View official trial listing →
  • Status unknown NCT NCT04152356

    Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

    Guangxi Medical University 50 participants Est. completion 2020-09-01 1 site
    Other conditions: HepatoCellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT04156204

    Immunosuppressant Medication Dosed Daily After Kidney Transplant

    Not yet reported University of Colorado, Denver 1 participants Est. completion 2020-11-27 1 site
    Other conditions: Kidney Transplant Rejection, Medication Adherence
    View official trial listing →
  • Status unknown NCT NCT04163237

    Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

    Not yet reported Guangxi Medical University 50 participants Est. completion 2020-11-30 1 site
    Other conditions: Advanced Liver Cancer
    View official trial listing →
  • Status unknown NCT NCT04168944

    Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

    Not yet reported, Not yet reported RenJi Hospital 108 participants Est. completion 2022-09
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT04188639

    Emicizumab in Acquired Hemophilia A

    Not yet reported GWT-TUD GmbH 47 participants Est. completion 2023-01-04 16 sites
    Other conditions: Hemophilia A, Acquired
    View official trial listing →
  • Completed NCT NCT04191707

    Metabolomic Markers of Fatigue in Inflammatory Bowel Disease

    Corporacion Parc Tauli 18 participants Est. completion 2019-12-01
    Other conditions: Fatigue, Inflammatory Bowel Disease, Ulcerative Colitis, Crohn Disease
    View official trial listing →
  • Completed NCT NCT04199715

    Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients

    Not yet reported Baylor Research Institute 10 participants Est. completion 2022-01-20 1 site
    Other conditions: Hepatitis B
    View official trial listing →
  • Terminated NCT NCT04200365

    A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

    Not yet reported SCRI Development Innovations, LLC 15 participants Est. completion 2023-09-07 5 sites
    Other conditions: Chronic Graft-versus-host-disease
    View official trial listing →
  • Status unknown NCT NCT04203459

    The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation

    First Affiliated Hospital of Harbin Medical University 80 participants Est. completion 2022-12-31 1 site
    Other conditions: Pancreatic Cancer, Gut Microbiota, CAR-T
    View official trial listing →
  • Status unknown NCT NCT04207177

    Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects

    Not yet reported Oslo University Hospital 100 participants Est. completion 2025-12-31 1 site
    Other conditions: Kidney Transplant; Complications, Immune Suppression
    View official trial listing →
  • Completed NCT NCT04233164

    Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 47 participants Est. completion 2022-05-03 1 site
    Other conditions: Systemic Lupus Erythematous (SLE)
    View official trial listing →
  • Completed NCT NCT04247490

    Autoimmune Hepatitis in Pediatric Patients

    University Hospital of Ferrara 109 participants Est. completion 2019-12-31 1 site
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Completed NCT NCT04259138

    Determination of the Optimal Treatment Target in Ulcerative Colitis

    Not yet reported Alimentiv Inc. 672 participants Est. completion 2026-04-13 58 sites
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Withdrawn NCT NCT04262375

    A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION

    Not yet reported University Health Network, Toronto Est. completion 2024-01 1 site
    Other conditions: Non Small Cell Lung Cancer, Renal Cell Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT04262388

    A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation

    Not yet reported University Health Network, Toronto Est. completion 2023-01 1 site
    Other conditions: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck
    View official trial listing →
  • Active, not recruiting NCT NCT04262843

    Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported City of Hope Medical Center 33 participants Est. completion 2027-05-11 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT04263519

    A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

    Not yet reported Massachusetts General Hospital Est. completion 2023-01-01
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT04272788

    Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease

    Second Affiliated Hospital of Wenzhou Medical University 32 participants Est. completion 2019-09-29 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT04288271

    Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 96 participants Est. completion 2023-06-30 8 sites
    Other conditions: Medication Adherence, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT04294641

    Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

    Not yet reported National Cancer Institute (NCI) 10 participants Est. completion 2024-10-01 2 sites
    Other conditions: Chronic GVHD
    View official trial listing →
  • Status unknown NCT NCT04295928

    Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients

    Not yet reported University Hospital, Tours 1716 participants Est. completion 2025-09-11 12 sites
    Other conditions: Personalized Pharmaceutical Plan After Transpantation
    View official trial listing →
  • Terminated NCT NCT04305444

    Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

    Not yet reported Zhejiang DTRM Biopharma 55 participants Est. completion 2024-12-31 8 sites
    Other conditions: Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's Transformation
    View official trial listing →
  • Status unknown NCT NCT04317248

    "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

    Not yet reported Yuehua Huang 600 participants Est. completion 2022-04-30 4 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04324866

    Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy

    Universita di Verona 300 participants Est. completion 2020-12
    Other conditions: Coronavirus Infection
    View official trial listing →
  • Completed NCT NCT04328727

    Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

    Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2024-12-06 12 sites
    Other conditions: Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Status unknown NCT NCT04345315

    Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.

    Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 500 participants Est. completion 2022-03 2 sites
    Other conditions: COVID-19, SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT04350606

    A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia

    Not yet reported Pfizer 3 participants Est. completion 2021-04-19 3 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT04354818

    Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

    Kirby Institute 27 participants Est. completion 2022-04-27 11 sites
    Other conditions: HIV-1-infection, Cancer, Primary Immune Deficiency Disorder, Immunosuppression Disorders, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04355806

    Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

    Shanghai Pulmonary Hospital, Shanghai, China 160 participants Est. completion 2023-05-31 2 sites
    Other conditions: Non Small Cell Lung Cancer, Influenza Vaccine
    View official trial listing →
  • Terminated NCT NCT04356404

    Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

    Chinese University of Hong Kong 68 participants Est. completion 2022-01-12 1 site
    Other conditions: Occult Hepatitis B, Biological Substance; Adverse Effect, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT04360031

    The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation

    Université Catholique de Louvain 100 participants Est. completion 2021-03 1 site
    Other conditions: Kidney Transplant; Complications, Immunosuppression, Transplant Failure
    View official trial listing →
  • Withdrawn NCT NCT04370795

    Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2025-11-26 1 site
    Other conditions: Severe Combined Immune Deficiency (SCID)
    View official trial listing →
  • Status unknown NCT NCT04376528

    Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

    Not yet reported West China Hospital 89 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT04382781

    Immunosupressive Treatment in COVID-19 Patients

    Spanish Network for Research in Infectious Diseases 500 participants Est. completion 2020-05 1 site
    Other conditions: COVID-19 Infection
    View official trial listing →
  • Status unknown NCT NCT04385641

    Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer

    Not yet reported Shandong Golden Brick Biotechnology Co., Ltd. 18 participants Est. completion 2022-10-08 1 site
    Other conditions: Advanced Gastric Cancer, Gastroesophageal Cancer
    View official trial listing →
  • Status unknown NCT NCT04401228

    Predictive Models for Intensive Care Admission and Death of COVID-19

    Clinique Saint Pierre Ottignies 60 participants Est. completion 2021-01-01 1 site
    Other conditions: COVID19, Pneumonia, Viral, Inflammatory Response
    View official trial listing →
  • Terminated NCT NCT04409080

    REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy

    Not yet reported Regeneron Pharmaceuticals 17 participants Est. completion 2024-10-17 10 sites
    Other conditions: Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Completed NCT NCT04420195

    Envarsus XR in Lung Transplant

    Not yet reported NYU Langone Health 41 participants Est. completion 2022-11-30 1 site
    Other conditions: Lung Transplant
    View official trial listing →
  • Terminated NCT NCT04426279

    Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants

    University Hospital, Lille 539 participants Est. completion 2021-08-30 1 site
    Other conditions: Sars-CoV2, Rheumatoid Arthritis, Rheumatic Diseases
    View official trial listing →
  • Completed NCT NCT04431219

    First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

    Not yet reported, Not yet reported Xenothera SAS 10 participants Est. completion 2022-03-28 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Active, not recruiting NCT NCT04431245

    Stopping Antiviral Treatment in Chronic Hepatitis B

    The University of Hong Kong 54 participants Est. completion 2026-12-31 1 site
    Other conditions: Chronic Hepatitis b
    View official trial listing →
  • Completed NCT NCT04436367

    Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy

    National Heart, Lung, and Blood Institute (NHLBI) 38 participants Est. completion 2022-03-15 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT04436380

    Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy

    National Heart, Lung, and Blood Institute (NHLBI) 173 participants Est. completion 2023-03-15 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT04438603

    The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2022-09-30 1 site
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Status unknown NCT NCT04444843

    Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-12-31 1 site
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT04447144

    Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome

    Cairo University 200 participants Est. completion 2020-09-01 1 site
    Other conditions: Covid19, Chronic Inflammation, Non-Communicable Chronic Diseases
    View official trial listing →
  • Completed NCT NCT04464434

    Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

    Not yet reported UMC Utrecht 60 participants Est. completion 2026-03-19 8 sites
    Other conditions: Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma, Scleroderma, Diffuse, Autologous Stem Cell Transplantation, Cyclophosphamide, Mycophenolate Mofetil, Treatment Strategy
    View official trial listing →
  • Status unknown NCT NCT04473131

    Immune Profiling of COVID19-patients Admitted to ICU

    Hamad Medical Corporation 300 participants Est. completion 2022-06 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04474392

    Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins

    University of Colorado, Denver 340 participants Est. completion 2026-01-14 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04481633

    Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection

    Not yet reported University Hospital, Toulouse 547 participants Est. completion 2022-12-06 12 sites
    Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT04483466

    Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH)

    Not yet reported George Washington University 150 participants Est. completion 2027-08-30 1 site
    Other conditions: Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease Severity
    View official trial listing →
  • Completed NCT NCT04487457

    Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy

    University Hospital, Tours 31 participants Est. completion 2022-09-29 2 sites
    Other conditions: Non Small Cell Lung Cancer, Bladder Cancer, ENT Cancer
    View official trial listing →
  • Status unknown NCT NCT04492267

    Inflammatory Bowel Disease (IBD) and Covid-19 Infection

    University Hospital, Strasbourg, France 700 participants Est. completion 2021-01-07 1 site
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Status unknown NCT NCT04528056

    Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension

    Not yet reported, Not yet reported RenJi Hospital 80 participants Est. completion 2022-10-31 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT04558268

    Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss

    Not yet reported, Not yet reported Soroka University Medical Center 242 participants Est. completion 2021-10 1 site
    Other conditions: Recurrent Pregnancy Loss(RPL), Recurrent Miscarriage
    View official trial listing →
  • Status unknown NCT NCT04559048

    Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients

    The Second Hospital of Tangshan 300 participants Est. completion 2024-06-30 1 site
    Other conditions: Chronic Pain, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT04568421

    Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection

    Sociedad Argentina de Reumatologia 2982 participants Est. completion 2022-12-31 1 site
    Other conditions: Rheumatic Diseases
    View official trial listing →
  • Completed NCT NCT04576819

    Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis

    University of Florida 58 participants Est. completion 2023-04-01 1 site
    Other conditions: Sepsis, Shock, Septic
    View official trial listing →
  • Terminated NCT NCT04584541

    SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism

    Not yet reported Assistance Publique - Hôpitaux de Paris 150 participants Est. completion 2022-02-21 1 site
    Other conditions: Spondyloarthritis, Rheumatoid Arthritis, Covid19
    View official trial listing →
  • Completed NCT NCT04587024

    A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients

    Not yet reported Johns Hopkins University 75 participants Est. completion 2023-08-31 2 sites
    Other conditions: Medication Adherence, Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT04596579

    SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida

    H. Lee Moffitt Cancer Center and Research Institute 1135 participants Est. completion 2021-07-25 1 site
    Other conditions: Coronavirus Infection
    View official trial listing →
  • Status unknown NCT NCT04610476

    Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

    Not yet reported University of Erlangen-Nürnberg Medical School 270 participants Est. completion 2025-10-19 1 site
    Other conditions: Psoriatic Arthritis, Withdrawal, Reduction
    View official trial listing →
  • Status unknown NCT NCT04615962

    Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.

    Not yet reported Seanergy Dermatology Ltd. 66 participants Est. completion 2022-01
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT04630782

    Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease

    Singapore General Hospital 70 participants Est. completion 2023-01-31 5 sites
    Other conditions: Systemic Sclerosis, Scleroderma
    View official trial listing →
  • Status unknown NCT NCT04657562

    The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma

    National Science Centre, Poland 380 participants Est. completion 2023-05 1 site
    Other conditions: Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications, Liver Transplant Rejection, Liver Transplant; Complications, Metabolism Medication Toxicity, Genetic Predisposition
    View official trial listing →
  • Completed NCT NCT04660539

    A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Not yet reported Hoffmann-La Roche 119 participants Est. completion 2024-05-28 53 sites
    Other conditions: Neuromyelitis Optica Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT04670094

    Comorbidities and Risk Score in COVID-19 Patients

    University of Milano Bicocca 4555 participants Est. completion 2021-05-29 5 sites
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04672161

    Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients

    Not yet reported Weill Medical College of Cornell University 200 participants Est. completion 2023-06-30 1 site
    Other conditions: Crohn Disease (CD), Ulcerative Colitis (UC), Indeterminate Colitis
    View official trial listing →
  • Completed NCT NCT04688216

    Developing a Risk Assessment System of Multidrug-resistant Organisms Infection

    Second Affiliated Hospital, Zhejiang University, School of Medicine 917 participants Est. completion 2022-12-30 1 site
    Other conditions: Bacterial Infections
    View official trial listing →
  • Status unknown NCT NCT04696250

    Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR)

    University Hospital, Caen 5000000 participants Est. completion 2025-01-01 1 site
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT04698213

    Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma

    Not yet reported Consorzio Oncotech 75 participants Est. completion 2024-10 20 sites
    Other conditions: Renal Carcinoma Metastatic
    View official trial listing →
  • Completed NCT NCT04701528

    Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients

    Not yet reported Leiden University Medical Center 20 participants Est. completion 2022-10-25 1 site
    Other conditions: Covid19, Kidney Transplant Infection
    View official trial listing →
  • Completed NCT NCT04715412

    Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients

    Not yet reported Future University in Egypt 60 participants Est. completion 2020-12-31 1 site
    Other conditions: Transplant;Failure,Kidney
    View official trial listing →
  • Completed NCT NCT04720326

    Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

    Not yet reported Edward Geissler 268 participants Est. completion 2026-10-29 15 sites
    Other conditions: Prophylaxis Against Liver Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT04733131

    Long-term Outcomes After Conversion to Belatacept

    Paris Translational Research Center for Organ Transplantation 324 participants Est. completion 2021-12
    Other conditions: Kidney Transplant Failure and Rejection, Immunosuppression, Graft Loss, Drug Effect Prolonged
    View official trial listing →
  • Completed NCT NCT04734197

    A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

    Not yet reported Surface Ophthalmics, Inc. 349 participants Est. completion 2022-03-25 40 sites
    Other conditions: Dry Eye Disease
    View official trial listing →
  • Withdrawn NCT NCT04748939

    Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT

    Not yet reported Tuen Mun Hospital Est. completion 2026-09-29 1 site
    Other conditions: Herpes Zoster
    View official trial listing →
  • Completed NCT NCT04762615

    Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients

    Wroclaw Medical University 153 participants Est. completion 2020-12-01 1 site
    Other conditions: Anti-Mullerian Hormone Deficiency, Immunosuppression, Ovarian Reserve, X-rays; Effects
    View official trial listing →
  • Terminated NCT NCT04773392

    Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

    Not yet reported University of Southern California 20 participants Est. completion 2024-02-23 1 site
    Other conditions: Kidney Transplantation, Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT04775563

    COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients

    National Institute of Medical Sciences and Nutrition, Salvador Zubiran 891 participants Est. completion 2021-10-01 1 site
    Other conditions: Covid19
    View official trial listing →
  • Active, not recruiting NCT NCT04789070

    Phase III Trial of Sirolimus in IBM

    Not yet reported University of Kansas Medical Center 140 participants Est. completion 2027-12 10 sites
    Other conditions: Inclusion Body Myositis
    View official trial listing →
  • Active, not recruiting NCT NCT04798625

    Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication

    Diakonhjemmet Hospital 2300 participants Est. completion 2027-02-15 2 sites
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis, Crohn Disease, Ulcerative Colitis, Autoimmune Hepatitis, Liver Transplant; Complications
    View official trial listing →
  • Terminated NCT NCT04809623

    Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

    Not yet reported Gilead Sciences 3 participants Est. completion 2022-10-18 5 sites
    Other conditions: Cutaneous Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04818892

    Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease

    University of Wisconsin, Madison 222 participants Est. completion 2022-11-11 1 site
    Other conditions: IBD, Covid19 Vaccine
    View official trial listing →
  • Completed NCT NCT04835441

    ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

    Not yet reported Alpine Immune Sciences Inc, A Subsidiary of Vertex 76 participants Est. completion 2024-07-09 46 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04848493

    National Project on Vaccines, COVID-19 and Frail Patients

    Azienda USL Reggio Emilia - IRCCS 747 participants Est. completion 2022-12-31 12 sites
    Other conditions: COVID-19, Solid Tumor, Hematologic Diseases, Neurologic Disorder, Rheumatic Diseases
    View official trial listing →
  • Completed NCT NCT04870359

    Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation

    Not yet reported The University of Hong Kong 49 participants Est. completion 2022-03-31 2 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT04870411

    Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics

    Assistance Publique - Hôpitaux de Paris 78 participants Est. completion 2022-03-13 1 site
    Other conditions: Autoimmune Diseases, Inflammatory Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT04877691

    Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

    Not yet reported AstraZeneca 367 participants Est. completion 2026-11-06 140 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT04878770

    NMF-CsA-Dupi Trial

    Not yet reported Erasmus Medical Center 318 participants Est. completion 2025-01-01 1 site
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Status unknown NCT NCT04883164

    Immunity After COVID-19 Vaccination

    Plexision 300 participants Est. completion 2023-03-31 1 site
    Other conditions: Immunity to COVID-19
    View official trial listing →
  • Status unknown NCT NCT04886206

    Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported Nantes University Hospital 12 participants Est. completion 2024-11 1 site
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Status unknown NCT NCT04892212

    Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

    Not yet reported, Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2023-10-30
    Other conditions: Lupus Nephritis, Immunosuppression, Effect of Drug
    View official trial listing →
  • Status unknown NCT NCT04895423

    Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood

    Not yet reported National Medical Research Center for Children's Health, Russian Federation 160 participants Est. completion 2023-07-25 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Withdrawn NCT NCT04898309

    Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema

    Not yet reported, Not yet reported AO GENERIUM Est. completion 2023-05-31 5 sites
    Other conditions: Hereditary Angioedema
    View official trial listing →
  • Withdrawn NCT NCT04903054

    Selective CD28 Blockade in Renal Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2022-09-22 1 site
    Other conditions: Kidney Transplantation, Renal Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT04904588

    HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

    Not yet reported Center for International Blood and Marrow Transplant Research 300 participants Est. completion 2026-12 39 sites
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04915482

    TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

    Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 94 participants Est. completion 2025-02-28 1 site
    Other conditions: Immune Thrombocytopenia (ITP), Autoantibodies, Evan Syndrome, Connective Tissue Diseases
    View official trial listing →
  • Status unknown NCT NCT04928586

    Immunosuppressant Combined With Pirfenidone in CTD-ILD

    Not yet reported Qilu Hospital of Shandong University 200 participants Est. completion 2025-06-01 1 site
    Other conditions: Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease
    View official trial listing →
  • Terminated NCT NCT04930055

    Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)

    Indiana University 2206 participants Est. completion 2022-03-08 2 sites
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT04942314

    Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study

    Jia Deng 600 participants Est. completion 2023-06-01
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04945889

    Sepsis in Geriatric Patients With Suspected Infection.

    A.O.U. Città della Salute e della Scienza 580 participants Est. completion 2019-10-31 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Status unknown NCT NCT04946669

    An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 20 participants Est. completion 2022-07-31 1 site
    Other conditions: Dermatomyositis, Abatacept
    View official trial listing →
  • Completed NCT NCT04955366

    Abatacept Conversion in Kidney Transplantation

    Not yet reported Emory University 87 participants Est. completion 2026-06-10 1 site
    Other conditions: Renal Transplant Recipient
    View official trial listing →
  • Withdrawn NCT NCT04963673

    Evaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant Patients

    Centre Hospitalier Universitaire, Amiens Est. completion 2023-09-12 1 site
    Other conditions: Kidney Transplant, Immunosuppression, Uremic; Toxemia
    View official trial listing →
  • Completed NCT NCT04976933

    Post-HSCT Medication Adherence mHealth App

    Micah Skeens 15 participants Est. completion 2023-01-31 1 site
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT04978623

    Role of High Frequency Ultrasound in Demyelinating Polyneuropathies

    Centre Hospitalier Universitaire de Nice 48 participants Est. completion 2022-12-01 1 site
    Other conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    View official trial listing →
  • Completed NCT NCT04989686

    Microsampling Assays for Immunosuppressive Drugs in Children

    Children's Hospital of Philadelphia 66 participants Est. completion 2025-05-01 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Completed NCT NCT04995770

    Text Messages for Liver Transplant Recipients

    Not yet reported Children's Hospital Los Angeles 35 participants Est. completion 2020-12-26 1 site
    Other conditions: Medication Adherence, Liver Transplant Disorder
    View official trial listing →
  • Terminated NCT NCT05000216

    COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 258 participants Est. completion 2024-03-28 29 sites
    Other conditions: Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris, Multiple Sclerosis (MS), Systemic Sclerosis (SSc), Pediatric SLE, Juvenile Idiopathic Arthritis (JIA), Juvenile Dermatomyositis (JDM), Pediatric-Onset Multiple Sclerosis (POMS)
    View official trial listing →
  • Status unknown NCT NCT05001386

    In Vitro Drug Sensitivity Testing of Fresh Human Samples

    Not yet reported Hospices Civils de Lyon 800 participants Est. completion 2025-03 2 sites
    Other conditions: Myeloproliferative Disorders, Lymphoproliferative Disorders
    View official trial listing →
  • Completed NCT NCT05005637

    The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA

    Not yet reported Fakultas Kedokteran Universitas Indonesia 78 participants Est. completion 2024-11-20 1 site
    Other conditions: Tuberculous Uveitis
    View official trial listing →
  • Completed NCT NCT05020145

    COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

    Pfizer 1277747 participants Est. completion 2021-12-17 1 site
    Other conditions: Immunocompromised, Immunosuppressed, Covid-19, SARS-COV-2, SARS-COV-2 Infection, Breakthrough Infection
    View official trial listing →
  • Completed NCT NCT05030974

    RECOVAC Repeated Vaccination Study

    Not yet reported University Medical Center Groningen 336 participants Est. completion 2022-03-12 4 sites
    Other conditions: Covid19, Kidney Diseases, Vaccine Response Impaired, SARS-CoV2 Infection
    View official trial listing →
  • Completed NCT NCT05038982

    Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

    Not yet reported Johns Hopkins University 20 participants Est. completion 2022-07-11 1 site
    Other conditions: Prurigo Nodularis, Pruritus, Chronic Pruritus, Chronic Prurigo, Skin Diseases
    View official trial listing →
  • Status unknown NCT NCT05047406

    Bacillus Clausii in Liver Transplantation

    Not yet reported Ain Shams University 60 participants Est. completion 2023-08-30 1 site
    Other conditions: Transplantation Infection, Liver Grafting, Hepatic Transplantation
    View official trial listing →
  • Status unknown NCT NCT05051605

    Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation

    Ain Shams University 50 participants Est. completion 2023-11-30 1 site
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT05060354

    COVID-19 Vaccine Response in Treated MS Patients

    Brigham and Women's Hospital 159 participants Est. completion 2023-09-28 1 site
    Other conditions: Multiple Sclerosis, Healthy
    View official trial listing →
  • Completed NCT NCT05077254

    COVID Protection After Transplant-Immunosuppression Reduction

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2025-02-21 15 sites
    Other conditions: Kidney Transplant Recipients, Liver Transplant Recipients
    View official trial listing →
  • Terminated NCT NCT05078710

    Telitacicept in Primary APS Patients

    Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2025-06-01 1 site
    Other conditions: Anti Phospholipid Syndrome
    View official trial listing →
  • Completed NCT NCT05089370

    Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

    Not yet reported, Not yet reported University of Colorado, Denver 8 participants Est. completion 2026-08-10 1 site
    Other conditions: Malignant Melanoma
    View official trial listing →
  • Completed NCT NCT05089565

    Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

    Northwestern University 101 participants Est. completion 2022-12-31 1 site
    Other conditions: Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired
    View official trial listing →
  • Status unknown NCT NCT05110040

    Multi-model Image of Immunosuppressive Agents in TAO

    Not yet reported Sun Yat-sen University 12 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Thyroid Associated Ophthalmopathy
    View official trial listing →
  • Status unknown NCT NCT05112484

    Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis

    University Hospital Ostrava 600 participants Est. completion 2026-05 2 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Active, not recruiting NCT NCT05132166

    A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

    Not yet reported University Health Network, Toronto 50 participants Est. completion 2026-04-26 1 site
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Status unknown NCT NCT05138666

    Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.

    Not yet reported Centre Hospitalier Universitaire de Besancon 363 participants Est. completion 2024-03 1 site
    Other conditions: Invasive Pulmonary Aspergillosis
    View official trial listing →
  • Status unknown NCT NCT05140616

    Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 20 participants Est. completion 2024-05-31 1 site
    Other conditions: Safety and Efficacy
    View official trial listing →
  • Status unknown NCT NCT05154370

    China National Registry of Neuro-Inflammatory Diseases

    Beijing Tiantan Hospital 10000 participants Est. completion 2026-11-01 1 site
    Other conditions: Multiple Sclerosis, NMO Spectrum Disorder, Clinically Isolated Syndrome, CNS Demyelinating Autoimmune Diseases, Acute Disseminated Encephalomyelitis, Primay Angiitis of the Central Nervous System, Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
    View official trial listing →
  • Status unknown NCT NCT05157750

    Endoscopic Remission, Histologic Remission and Barrier Healing for Predicting Disease Behaviour in IBD

    University of Erlangen-Nürnberg Medical School 180 participants Est. completion 2022-05-01 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT05195086

    A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

    Nada Magdy Mansour 122 participants Est. completion 2021-06-05 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT05195645

    AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS

    Not yet reported Assistance Publique - Hôpitaux de Paris 21 participants Est. completion 2025-01-28 1 site
    Other conditions: Myocarditis
    View official trial listing →
  • No Longer Available NCT NCT05215288

    Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients

    Direct Biologics, LLC 2 sites
    Other conditions: Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection
    View official trial listing →
  • Withdrawn NCT NCT05218408

    CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

    Not yet reported, Not yet reported Celularity Incorporated Est. completion 2021-10-23
    Other conditions: Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma, Glioblastoma Multiforme
    View official trial listing →
  • Terminated NCT NCT05220397

    Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

    Not yet reported Mark Stegall 468 participants Est. completion 2025-02-28 3 sites
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Completed NCT NCT05237323

    Micophenolate Mofetil Versus Azathioprine in Myocarditis

    Not yet reported I.M. Sechenov First Moscow State Medical University 50 participants Est. completion 2025-07-10 1 site
    Heart failureSubstance use disorder Other conditions: Lymphocytic Myocarditis (Disorder), Dilated Cardiomyopathy, Cardiomyopathies
    View official trial listing →
  • Completed NCT NCT05238467

    Immunological Responses of COVID-19 Vaccination

    University Hospitals Cleveland Medical Center 42 participants Est. completion 2023-02-13 1 site
    Other conditions: Cancer; Chemotherapy
    View official trial listing →
  • Completed NCT NCT05245344

    Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

    Neuromed IRCCS 154 participants Est. completion 2023-10-31 3 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis (RRMS), Neuromyelitis Optica, Healthy
    View official trial listing →
  • Completed NCT NCT05247203

    Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus

    Not yet reported RemeGen Co., Ltd. 92 participants Est. completion 2023-11-13 19 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT05248022

    Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

    Not yet reported The Central Hospital of Lishui City 98 participants Est. completion 2024-12-31 Stand-alone
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Active, not recruiting NCT NCT05256537

    Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil

    Not yet reported Ronald Paquette 60 participants Est. completion 2027-01-07 1 site
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT05274308

    Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples

    Thermo Fisher Scientific Oy 46 participants Est. completion 2022-07-26 1 site
    Other conditions: Transplantation Drugs Stability
    View official trial listing →
  • Status unknown NCT NCT05277285

    STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care

    Not yet reported Hellenic Institute for the Study of Sepsis 30 participants Est. completion 2023-12-31 1 site
    Other conditions: COVID-19, Virus Diseases, Corona Virus Infection
    View official trial listing →
  • Status unknown NCT NCT05282875

    Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis

    Central Hospital, Nancy, France 430 participants Est. completion 2022-09-01 1 site
    Other conditions: Kidney Transplantation, Immunosuppressive Agents, HLA Sensitization, Dialysis
    View official trial listing →
  • Status unknown NCT NCT05294822

    Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

    Not yet reported Shanghai Changzheng Hospital 20 participants Est. completion 2023-12 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT05303402

    A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.

    Not yet reported, Not yet reported Hipra Scientific, S.L.U 240 participants Est. completion 2024-01-09 6 sites
    Other conditions: SARS CoV 2 Infection
    View official trial listing →
  • Status unknown NCT NCT05308628

    Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel

    Not yet reported RenJi Hospital 1200 participants Est. completion 2025-11-30 2 sites
    Other conditions: Liver Fibrosis, Pediatric Disorder, Liver Transplant; Complications
    View official trial listing →
  • Withdrawn NCT NCT05323617

    Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy

    Not yet reported Amgen Est. completion 2025-02-25
    Other conditions: Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Active, not recruiting NCT NCT05342519

    Daily Topical Rapamycin for Vitiligo

    Not yet reported Medical University of South Carolina 20 participants Est. completion 2027-12-01 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Active, not recruiting NCT NCT05345197

    Emicizumab in Patients With Acquired Hemophilia A

    Not yet reported University of Washington 51 participants Est. completion 2026-12 16 sites
    Other conditions: Acquired Hemophilia A
    View official trial listing →
  • Completed NCT NCT05354583

    Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome

    King Chulalongkorn Memorial Hospital 36 participants Est. completion 2023-09-30 1 site
    Other conditions: Mycobacterium Abscessus Infection, Adult-Onset Immunodeficiency With Acquired Anti-Interferon-Gamma Autoantibodies, Nontuberculous Mycobacterial Pulmonary Infection
    View official trial listing →
  • Status unknown NCT NCT05366062

    ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

    Not yet reported Epitopoietic Research Corporation 28 participants Est. completion 2026-07-31 1 site
    Other conditions: Glioma, Malignant
    View official trial listing →
  • Completed NCT NCT05367986

    Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis

    Not yet reported Guangdong Provincial Hospital of Traditional Chinese Medicine 78 participants Est. completion 2022-01-30 1 site
    Other conditions: Sepsis, Immune Dysfunction
    View official trial listing →
  • Completed NCT NCT05369975

    Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts

    Not yet reported Hansa Biopharma AB 113 participants Est. completion 2026-04-21 22 sites
    Other conditions: Kidney Transplantation in Highly Sensitized Patients
    View official trial listing →
  • Completed NCT NCT05399641

    Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

    Not yet reported Scynexis, Inc. 150 participants Est. completion 2023-08-02 25 sites
    Other conditions: Vulvovaginal Candidiasis
    View official trial listing →
  • Suspended NCT NCT05400122

    Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

    Not yet reported David Wald 12 participants Est. completion 2027-06-01 1 site
    Other conditions: Colorectal Cancer, Hematologic Malignancy, Rectum Cancer, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloproliferative Syndrome, Plasma Cell Myeloma, Gastric Cancer, Esophageal Cancer, Esophagus Cancer, Gastric Cancer, Metastatic, Unresectable Esophageal Cancer, Metastatic Esophageal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05415579

    Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)

    Dongzhimen Hospital, Beijing 2000 participants Est. completion 2030-05-31
    Other conditions: Demyelinating Diseases of the Central Nervous System (DDC)
    View official trial listing →
  • Status unknown NCT NCT05415995

    A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

    Not yet reported Zhejiang Zylox Medical Device Co., Ltd. 202 participants Est. completion 2024-12 20 sites Stand-alone
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Withdrawn NCT NCT05423496

    KidneyCare Immuno-optimization in Renal Allografts (KIRA)

    Not yet reported CareDx Est. completion 2023-02-23
    Other conditions: Kidney Transplant, Immunosuppression, Allograft
    View official trial listing →
  • Completed NCT NCT05452187

    Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study

    Hospital Mutua de Terrassa 79 participants Est. completion 2021-12-20 1 site
    Other conditions: Inflammatory Bowel Diseases, Hepatitis C Virus Infection
    View official trial listing →
  • Status unknown NCT NCT05459181

    HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)

    Not yet reported CareDx 930 participants Est. completion 2026-09
    Other conditions: Heart Transplant, Immunosuppression, Allograft
    View official trial listing →
  • Completed NCT NCT05464043

    Hyperglycemia and (Pre)Diabetes in Pediatric Renal and Liver Transplantation.

    Not yet reported Université Catholique de Louvain 250 participants Est. completion 2022-04-30 1 site
    Other conditions: Diabetes Mellitus Risk
    View official trial listing →
  • Completed NCT NCT05468320

    Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

    Not yet reported Sanofi 51 participants Est. completion 2024-12-26 27 sites
    Other conditions: Thrombotic Thrombocytopenic Purpura
    View official trial listing →
  • Status unknown NCT NCT05498740

    Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

    Not yet reported Zhejiang Zylox Medical Device Co., Ltd. 200 participants Est. completion 2024-12 24 sites Stand-alone
    Other conditions: Peripheral Arterial Disease (PAD)
    View official trial listing →
  • Status unknown NCT NCT05505409

    Efficacy and Safety of Pirfenidone in CTD-ILD

    Not yet reported Qilu Hospital of Shandong University 120 participants Est. completion 2025-12-01 1 site
    Other conditions: Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05537948

    Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 59 participants Est. completion 2025-01-31 1 site
    Other conditions: Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder, Immunosuppression, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Statins
    View official trial listing →
  • Completed NCT NCT05542381

    The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

    Not yet reported Virginia Polytechnic Institute and State University 64 participants Est. completion 2025-05-01 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Terminated NCT NCT05570409

    Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

    Not yet reported, Not yet reported LMU Klinikum 9 participants Est. completion 2025-04-14 14 sites
    Other conditions: Inflammatory Cardiomyopathy
    View official trial listing →
  • Status unknown NCT NCT05590416

    A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

    Tianjin Medical University 15 participants Est. completion 2024-12-30 1 site
    Other conditions: Vogt-Koyanagi-Harada Disease, Adalimumab
    View official trial listing →
  • Status unknown NCT NCT05592717

    A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

    Tianjin Medical University 15 participants Est. completion 2026-11-01 1 site
    Other conditions: Uveitis, YUTIQ
    View official trial listing →
  • Terminated NCT NCT05600426

    A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

    Not yet reported Boston Children's Hospital 53 participants Est. completion 2026-08-06 52 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT05605145

    PCP in Immunocompromised Population in Southern China

    First Affiliated Hospital of Guangxi Medical University 300 participants Est. completion 2023-06-30 1 site
    Other conditions: Immunocompromised Patients, Pneumocystis Pneumonia, Diagnosis, Polymerase Chain Reaction
    View official trial listing →
  • Withdrawn NCT NCT05607589

    The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects

    Not yet reported Daewoong Pharmaceutical Co. LTD. Est. completion 2024-03-08
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05607901

    A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

    Not yet reported Tanta University 100 participants Est. completion 2023-08-20 1 site
    Other conditions: Dermatologic Disease
    View official trial listing →
  • Status unknown NCT NCT05621356

    Monitoring Allergen Immunotherapy in Allergic Rhinitis

    Rijnstate Hospital 25 participants Est. completion 2023-03-31 1 site
    Other conditions: Immunotherapy, Rhinitis, Allergic, Treatment Outcome
    View official trial listing →
  • Active, not recruiting NCT NCT05626387

    An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 144 participants Est. completion 2026-10-23 9 sites
    Other conditions: Hypersensitivity Pneumonitis
    View official trial listing →
  • Withdrawn NCT NCT05627089

    Rheumatoid Arthritis and Myositis Cohort

    Attune Health Research, Inc. Est. completion 2035-01-01
    Other conditions: Rheumatoid Arthritis, Myositis
    View official trial listing →
  • Active, not recruiting NCT NCT05637112

    A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice.

    AstraZeneca 551 participants Est. completion 2030-12-30 74 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT05679336

    Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy

    Not yet reported St. Petersburg State Pavlov Medical University 40 participants Est. completion 2024-08-31 1 site
    Other conditions: Membranous Nephropathy - PLA2R Induced
    View official trial listing →
  • Status unknown NCT NCT05696106

    Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID

    Assistance Publique - Hôpitaux de Paris 750000 participants Est. completion 2024-01-15 1 site
    Other conditions: Inflammatory Disease
    View official trial listing →
  • Completed NCT NCT05697809

    Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

    Not yet reported Oxular Limited 3 participants Est. completion 2024-12-05 9 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT05700565

    Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype

    Lucie Heinzerling 46 participants Est. completion 2025-10-01 1 site
    Other conditions: Immune-related Adverse Event
    View official trial listing →
  • Status unknown NCT NCT05707520

    Long-term Benefit of MPA in Liver Transplantation

    Third Affiliated Hospital, Sun Yat-Sen University 500 participants Est. completion 2023-09-30 1 site
    Other conditions: Liver Transplant Rejection, Immunosuppressant Adverse Reaction
    View official trial listing →
  • Status unknown NCT NCT05727709

    Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients

    Tongji Hospital 220 participants Est. completion 2024-06-30 5 sites
    Other conditions: Kidney Transplant Rejection, Kidney Transplant Infection, Virus, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT05744635

    Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients

    Chiesi Hungary Ltd. 110 participants Est. completion 2026-06-01 2 sites
    Other conditions: Liver Failure
    View official trial listing →
  • Terminated NCT NCT05747053

    Personalization of Immunosuppressive Treatment for Organ Transplant Recipients

    George Washington University 105 participants Est. completion 2022-12-08 1 site
    Other conditions: Kidney Injury, Kidney Failure, Kidney Failure, Chronic, Kidney Failure, Acute, Kidney Diseases, Kidney Transplant Rejection, Kidney Transplant Infection, Kidney Transplant; Complications, Kidney Disease, Chronic, Kidney Ischemia
    View official trial listing →
  • Completed NCT NCT05765955

    Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses

    Not yet reported Poolbeg Pharma plc 36 participants Est. completion 2022-12-16 1 site
    Other conditions: Influenza, Human
    View official trial listing →
  • Status unknown NCT NCT05772871

    The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children

    Not yet reported Jianhua Zhou 402 participants Est. completion 2025-10-30 26 sites
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Active, not recruiting NCT NCT05782907

    Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

    Not yet reported AbbVie 122 participants Est. completion 2031-10 89 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT05799755

    Myositis Interstitial Lung Disease Nintedanib Trial

    Not yet reported Rohit Aggarwal, MD 62 participants Est. completion 2025-12-31 10 sites
    Other conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)
    View official trial listing →
  • Active, not recruiting NCT NCT05806749

    Immunological Tolerance in Patients With Mismatched Kidney Transplants

    Not yet reported University of California, Los Angeles 16 participants Est. completion 2028-08 1 site
    Chronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Completed NCT NCT05808192

    De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

    University of Rome Tor Vergata 92 participants Est. completion 2022-05-01 1 site
    Other conditions: Single Transplant, 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
    View official trial listing →
  • Completed NCT NCT05816486

    BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

    Biohope Scientific Solutions for Human Health, S.L. 443 participants Est. completion 2024-06-30 15 sites
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT05848427

    The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19

    Lebanese University 1000 participants Est. completion 2025-12-30 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05852977

    Study of Dengue in Patients With Autoimmune Diseases During the Epidemics of 2020 and 2021 in Reunion Island

    Centre Hospitalier Universitaire de la Réunion 90 participants Est. completion 2026-06
    Other conditions: Dengue
    View official trial listing →
  • Completed NCT NCT05854472

    Using Smartphone Application After Liver Transplantation

    Not yet reported Saglik Bilimleri Universitesi 55 participants Est. completion 2024-02-26 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT05863936

    Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

    Not yet reported Nanjing University School of Medicine 15 participants Est. completion 2024-12-31 1 site
    Other conditions: Lupus Nephritis, Remission, Safety Issues
    View official trial listing →
  • Status unknown NCT NCT05872815

    Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients

    The Second Affiliated Hospital of Chongqing Medical University 120 participants Est. completion 2024-07-01 1 site
    Other conditions: Kidney Transplantation, Immunosuppressive Agents
    View official trial listing →
  • Active, not recruiting NCT NCT05873205

    Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

    Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2027-06-29 7 sites
    Other conditions: Blood Cancer, Refractory Immune Cytopenias
    View official trial listing →
  • Completed NCT NCT05874349

    Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease

    Hospital Mutua de Terrassa 200 participants Est. completion 2023-01-01 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05879419

    Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

    Not yet reported University of Sao Paulo General Hospital 2005 participants Est. completion 2032-06-30 1 site
    Other conditions: Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome, Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Vasculitis, Systemic, Juvenile Idiopathic Arthritis, Dermatomyositis, Juvenile, Behçet Disease
    View official trial listing →
  • Withdrawn NCT NCT05881668

    MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University Est. completion 2025-04-30 1 site
    Other conditions: Liver Failure, Acute on Chronic
    View official trial listing →
  • Status unknown NCT NCT05891379

    Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

    Xuanwu Hospital, Beijing 50 participants Est. completion 2025-07-31 1 site
    Other conditions: Neuromyelitis Optica Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT05894512

    Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy

    Istanbul University 44 participants Est. completion 2026-02-15 1 site
    Other conditions: Membranous Nephropathy, Membranous Nephropathy - PLA2R Induced, Membranous Nephropathy - THSD7A Induced
    View official trial listing →
  • Completed NCT NCT05924685

    PREPARE-iVAC Trial

    Not yet reported University Medical Center Groningen 110 participants Est. completion 2024-02-27 7 sites
    Other conditions: COVID-19 Vaccines, Varicella Zoster Vaccine, Vaccine Response, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT05925140

    LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

    Not yet reported Lebanese University 1000 participants Est. completion 2025-12-30 2 sites
    Other conditions: COVID-19, Hospitalized COVID-19 Patients
    View official trial listing →
  • Active, not recruiting NCT NCT05925803

    Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

    Not yet reported AstraZeneca 314 participants Est. completion 2028-04-05 150 sites
    Other conditions: Systemic Sclerosis, Scleroderma
    View official trial listing →
  • Not yet recruiting NCT NCT05928754

    Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS

    Not yet reported Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 2000 participants Est. completion 2028-08
    Other conditions: Non-infectious Uveitis
    View official trial listing →
  • Status unknown NCT NCT05928780

    An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

    Not yet reported, Not yet reported Fudan University 125 participants Est. completion 2025-09-01
    Other conditions: TNBC - Triple-Negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05947864

    Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients

    Not yet reported Hospices Civils de Lyon 60 participants Est. completion 2026-07 1 site
    Other conditions: Transplantation, Hematopoietic Stem Cell
    View official trial listing →
  • Completed NCT NCT05975450

    Subcutaneous Abatacept in Renal Transplant Recipients

    Not yet reported Idelberto Badell 16 participants Est. completion 2025-02-14 2 sites
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Status unknown NCT NCT05975996

    Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 43 participants Est. completion 2025-12-31 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT05995938

    Mindfullnes-Based Cognitive Therapy Effect

    Not yet reported SEMRA BÜLBÜLOĞLU 140 participants Est. completion 2023-01-30 1 site
    Other conditions: Mindfullnes-Based Cognitive Therapy and Adherence to Immunosuppressive Therapy
    View official trial listing →
  • Completed NCT NCT05999955

    Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis

    Not yet reported Huro Biotech Joint Stock Company 60 participants Est. completion 2023-05-25 1 site
    Other conditions: Rhinosinusitis, Rhinitis
    View official trial listing →
  • Active, not recruiting NCT NCT06001385

    HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

    Not yet reported Center for International Blood and Marrow Transplant Research 313 participants Est. completion 2026-12-30 32 sites
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Neoplasm, Lymphoma, Chronic Myelomonocytic Leukemia, Pro-Lymphocytic Leukemia, Myelofibrosis
    View official trial listing →
  • Completed NCT NCT06004102

    Medication Adherence in Kidney Transplant

    Not yet reported Akdeniz University Hospital 100 participants Est. completion 2023-02-08 1 site
    Other conditions: Medication Adherence
    View official trial listing →
  • Status unknown NCT NCT06009965

    Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

    Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2025-01-31 1 site
    Other conditions: Aplastic Anemia, CSA, Drug Therapy
    View official trial listing →
  • Withdrawn NCT NCT06015750

    Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia

    Not yet reported Alexion Pharmaceuticals, Inc. Est. completion 2030-03-13
    Other conditions: Hypophosphatasia
    View official trial listing →
  • Status unknown NCT NCT06019234

    Juvenile Systemic Sclerosis, a Retrospective Epidemiological Study on a French Cohort

    University Hospital, Strasbourg, France 30 participants Est. completion 2024-10-03 1 site
    Other conditions: Juvenile Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT06026787

    Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

    Not yet reported Ain Shams University 60 participants Est. completion 2023-08-01 1 site
    Other conditions: Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors
    View official trial listing →
  • Completed NCT NCT06046534

    Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

    AstraZeneca 46 participants Est. completion 2024-06-10 15 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Not yet recruiting NCT NCT06084780

    Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

    Not yet reported Case Comprehensive Cancer Center 20 participants Est. completion 2027-12-31 1 site
    Other conditions: Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum, Pseudomyxoma Peritonei
    View official trial listing →
  • Status unknown NCT NCT06105658

    Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

    Not yet reported Anhui Provincial Hospital 20 participants Est. completion 2026-02-01 1 site
    Other conditions: Acute Myelocytic Leukemia
    View official trial listing →
  • Completed NCT NCT06106854

    Medication Adherence in Kidney Transplant Patients: SystemCHANGE™ Results of the Turkish MAGIC Randomized Clinical Trial

    Not yet reported Dokuz Eylul University 42 participants Est. completion 2022-09-15 1 site
    Other conditions: Medication Adherence
    View official trial listing →
  • Status unknown NCT NCT06109064

    Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS

    Not yet reported Anhui Provincial Hospital 14 participants Est. completion 2026-02-01 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Not yet recruiting NCT NCT06109961

    Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study

    Not yet reported, Not yet reported University of British Columbia 54 participants Est. completion 2028-03
    Other conditions: Inflammatory Bowel Disease (IBD), Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT06121804

    Immunosuppressants to Postoperative Infection and Death

    Chung Shan Medical University 20000 participants Est. completion 2024-12-20 1 site
    Other conditions: Organ Transplantation, Immunosuppressive Agents, Cohort Study
    View official trial listing →
  • Status unknown NCT NCT06125457

    Epidemiology of IgA Selective Deficiency - Clinical Manifestations and Risk of Transmission

    University Hospital, Strasbourg, France 120 participants Est. completion 2023-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT06138379

    Video-supported Training in Line With the Health Belief Model

    Not yet reported Inonu University 90 participants Est. completion 2024-08-16 1 site
    Other conditions: Education
    View official trial listing →
  • Not yet recruiting NCT NCT06147375

    Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation

    Not yet reported Wei Gao 47 participants Est. completion 2028-12 1 site
    Other conditions: Immune Tolerance, Immunosuppression, Liver Transplant; Complications
    View official trial listing →
  • Not yet recruiting NCT NCT06150287

    Effect of Probiotics on Immunosuppressive-drug-associated Diarrhea Among Renal Transplant Recipients

    Not yet reported State University of New York - Upstate Medical University 70 participants Est. completion 2027-05
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT06178146

    Thymosin Alpha-1 for irAE Secondary to ICIs

    Not yet reported Jun Wang 40 participants Est. completion 2025-04 1 site
    Other conditions: IrAE
    View official trial listing →
  • Status unknown NCT NCT06196996

    Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

    Not yet reported Shanghai Changzheng Hospital 18 participants Est. completion 2026-09 1 site
    Other conditions: Brittle Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT06219616

    Prediction of BK Virus Reactivation in Kidney Transplant Recipient

    Not yet reported King Chulalongkorn Memorial Hospital 80 participants Est. completion 2025-05-31 1 site
    Other conditions: Kidney Transplant Infection, BK Virus Infection, BK Virus Nephropathy
    View official trial listing →
  • Withdrawn NCT NCT06224270

    Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications

    Not yet reported University of Wisconsin, Madison Est. completion 2027-09 6 sites
    Other conditions: Inflammatory Bowel Diseases, IBD
    View official trial listing →
  • Completed NCT NCT06231745

    Paroxetine Safety and Efficacy in Rheumatoid Arthritis

    Not yet reported Mostafa Bahaa 100 participants Est. completion 2025-07-20 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT06238336

    Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

    Not yet reported, Not yet reported Shanxi Bethune Hospital 30 participants Est. completion 2025-12-20 1 site
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Active, not recruiting NCT NCT06268769

    Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs

    Not yet reported Edward Geissler 322 participants Est. completion 2028-11 13 sites
    Other conditions: Immunosuppression
    View official trial listing →
  • Not yet recruiting NCT NCT06271681

    Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

    Not yet reported VA Sierra Nevada Health Care System 45 participants Est. completion 2027-06-01
    Other conditions: Pneumococcal Vaccines, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT06297408

    Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus

    Not yet reported Shanghai Ming Ju Biotechnology Co., Ltd. 24 participants Est. completion 2026-05
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT06307808

    Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination

    University Hospital, Grenoble 66 participants Est. completion 2025-10-01 1 site
    Other conditions: HBV, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT06310837

    Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis

    Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 128 participants Est. completion 2026-07-03 1 site Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Active, not recruiting NCT NCT06332534

    Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

    Not yet reported AbbVie 111 participants Est. completion 2031-01 85 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Status unknown NCT NCT06341686

    Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection

    Not yet reported Hospital do Rim e Hipertensão 100 participants Est. completion 2025-05
    Other conditions: CMV Infection
    View official trial listing →
  • Not yet recruiting NCT NCT06352515

    T Lymphocyte Subsets in Ulcerative Colitis

    Assiut University 80 participants Est. completion 2027-06-01
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Not yet recruiting NCT NCT06356506

    A Study on Factors of Biochemical Response in Autoimmune Hepatitis

    Beijing Friendship Hospital 630 participants Est. completion 2034-05-01 1 site
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Status unknown NCT NCT06364046

    Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC

    Not yet reported The Central Hospital of Lishui City 56 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Carcinoma, Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT06368349

    Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma

    Chang Gung Memorial Hospital 190 participants Est. completion 2023-06-30 1 site
    Other conditions: Lymphopenia
    View official trial listing →
  • Completed NCT NCT06457035

    Development and Validation of a Nomogram for Predicting Surgery in Newly-diagnosed Crohn's Disease: a Retrospective Cohort Study

    First Affiliated Hospital, Sun Yat-Sen University 490 participants Est. completion 2023-12-01
    Other conditions: Newly-diagnosed Crohn's Disease
    View official trial listing →
  • Completed NCT NCT06460987

    Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

    The Fourth Affiliated Hospital of Zhejiang University School of Medicine 245 participants Est. completion 2024-03-31 1 site
    Other conditions: Finerenone, IgA Nephropathy, Proteinuria, Safety Issues
    View official trial listing →
  • Withdrawn NCT NCT06461546

    Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients

    Not yet reported Fundacion Clinic per a la Recerca Biomédica Est. completion 2027-05
    Other conditions: Kidney Transplant Candidates
    View official trial listing →
  • Status unknown NCT NCT06469424

    An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)

    Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 104 participants Est. completion 2026-03-31 5 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT06479603

    RCT of Nintedanib in Fibrotic Sarcoidosis

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 120 participants Est. completion 2026-01-31 1 site
    Other conditions: Sarcoidosis, Pulmonary
    View official trial listing →
  • Status unknown NCT NCT06504784

    The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative Colitis

    Not yet reported Sahlgrenska University Hospital 150 participants Est. completion 2025-10 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT06512766

    a Retrospective Study on the Systemic Treatment of LPP and FFA

    Erasmus Medical Center 315 participants Est. completion 2023-02-01 1 site
    Other conditions: Cicatricial Alopecia, Lichen Planopilaris, Lichen Plano-Pilaris, Frontal Fibrosing Alopecia, Hair Diseases, Scarring Alopecia, Hair Loss/Baldness
    View official trial listing →
  • Status unknown NCT NCT06523049

    Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

    Not yet reported Hao Zeng 67 participants Est. completion 2026-09 1 site
    Other conditions: Renal Cell Carcinoma, Immunotherapy, Molecular Targeted Therapy
    View official trial listing →
  • Status unknown NCT NCT06544343

    Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy

    Not yet reported University Of Perugia 190 participants Est. completion 2026-03-18 1 site
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Spondyloarthritis, Axial, Ankylosing Spondylitis
    View official trial listing →
  • Status unknown NCT NCT06584773

    Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients

    Not yet reported University of Sao Paulo General Hospital 80 participants Est. completion 2025-07 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Enrolling by invitation NCT NCT06596148

    Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression

    Not yet reported University of California, San Francisco 130 participants Est. completion 2026-06-30 1 site
    Other conditions: Immunosuppresion
    View official trial listing →
  • Status unknown NCT NCT06601361

    Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients at Assiut University Hospital

    Assiut University 112 participants Est. completion 2025-12
    MASLD
    View official trial listing →
  • Active, not recruiting NCT NCT06613880

    Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 48 participants Est. completion 2027-09-30 1 site
    Other conditions: Aplastic Anemia, TPO Receptor Agonists
    View official trial listing →
  • Enrolling by invitation NCT NCT06635863

    Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat

    Not yet reported Roderick Tung 40 participants Est. completion 2027-10 1 site
    Other conditions: Ventricular Arrythmia, Non-ischemic Cardiomyopathy, Arrhythmogenic Inflammatory Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT06637683

    Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)

    Not yet reported Anabio R&D 60 participants Est. completion 2020-06-20 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT06637865

    A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

    Not yet reported Immutep S.A.S. 79 participants Est. completion 2026-08-27 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06650124

    Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMF

    Not yet reported, Not yet reported Institute of Liver and Biliary Sciences, India 108 participants Est. completion 2025-12-31
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Active, not recruiting NCT NCT06673134

    Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease

    Tongji Hospital 100 participants Est. completion 2028-07-24 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT06689098

    Magnetocardiography as a Diagnostic Screening Tool for Myocarditis and Other Types of Cardiomyopathy

    German Heart Institute 330 participants Est. completion 2024-12-01 1 site
    Other conditions: Cardiomyopathies
    View official trial listing →
  • Suspended NCT NCT06694454

    Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

    Not yet reported, Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2034-12-31 1 site
    Other conditions: Non-small Cell Lung Cancer (NSCLC), Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Carcinoma, Non Small Cell Lung Cancer, Non Small Cell Lung Carcinoma
    View official trial listing →
  • Terminated NCT NCT06695741

    Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 14 participants Est. completion 2025-06-30 1 site
    Other conditions: Severe Aplastic Anemia, Cyclophosphamide Reduced-dose, Immunosuppressive Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT06700343

    Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

    Not yet reported Amgen 152 participants Est. completion 2027-10-04 109 sites
    Other conditions: Relapsing-remitting Multiple Sclerosis (RRMS)
    View official trial listing →
  • Not yet recruiting NCT NCT06723548

    Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

    Not yet reported First Affiliated Hospital of Wenzhou Medical University 30 participants Est. completion 2026-12
    Other conditions: Myasthenia Gravis, Autoimmune Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06802822

    Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART)

    Not yet reported University of British Columbia 96 participants Est. completion 2027-12 1 site
    Other conditions: Kidney Transplant, Kidney Transplant Failure, Immunosuppresion
    View official trial listing →
  • Not yet recruiting NCT NCT06821659

    Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases

    Not yet reported, Not yet reported Peking University Third Hospital 9 participants Est. completion 2028-12-31
    Other conditions: Systemic Lupus Erthematosus, Systemic Sclerosis (SSc), Inflammatory Myopathies, ANCA Associated Vasculitis (AAV), Sjogren Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT06821971

    Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy

    Centre Hospitalier Universitaire, Amiens 200 participants Est. completion 2025-08 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Not yet recruiting NCT NCT06825572

    MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 30 participants Est. completion 2026-09-30 1 site
    Other conditions: Liver Failure, Mesenchymal Stem Cell, Extracellular Vesicles
    View official trial listing →
  • Not yet recruiting NCT NCT06846424

    SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

    Not yet reported Shanghai Gynecologic Oncology Group 24 participants Est. completion 2030-06-01 1 site
    Other conditions: Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT06851845

    Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study

    Novartis Pharmaceuticals 100 participants Est. completion 2028-02-01
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT06879106

    Effect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation

    Not yet reported Bitlis Eren University 140 participants Est. completion 2025-08-30 1 site
    Other conditions: Liver Transplant; Complications, Immunosuppression, Compliance, Treatment
    View official trial listing →
  • Not yet recruiting NCT NCT06886646

    Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

    Not yet reported Assistance Publique - Hôpitaux de Paris 22 participants Est. completion 2029-10-15 1 site
    Other conditions: Chronic Antibody-mediated Rejection (cABMR)
    View official trial listing →
  • Completed NCT NCT06914089

    Thin Versus Thicker Strut Thickness Stents in Primary Percutaneous Intervention

    Not yet reported Assiut University 146 participants Est. completion 2023-09-30 1 site
    Other conditions: Primary Percutaneous Coronary Intervention
    View official trial listing →
  • Active, not recruiting NCT NCT06924476

    Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study

    Yipeng Liu 282 participants Est. completion 2025-09-30 1 site
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Not yet recruiting NCT NCT06925698

    Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease

    Not yet reported Marmara University 110 participants Est. completion 2028-04-01 2 sites
    Other conditions: Behcet Disease, Behcet Disease and Vascular Involvement, Deep Venous Thromboses, Post Thrombotic Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT06942156

    Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

    Not yet reported Chong Kun Dang Pharmaceutical 140 participants Est. completion 2030-12 1 site
    Other conditions: Heart Transplant
    View official trial listing →
  • Not yet recruiting NCT NCT06971172

    Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.

    Not yet reported Cairo University 22 participants Est. completion 2025-09-01
    Other conditions: Pemphigus Vulgaris
    View official trial listing →
  • Not yet recruiting NCT NCT06981845

    Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

    Not yet reported China National Center for Cardiovascular Diseases 52 participants Est. completion 2028-06-01
    Cardiovascular disease Other conditions: In-stent Restenosis Lesion
    View official trial listing →
  • Not yet recruiting NCT NCT06993337

    Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Recurrent Aphthous Stomatitis

    Not yet reported Cairo University 63 participants Est. completion 2026-06-15
    Other conditions: Recurrent Aphthous Stomatitis
    View official trial listing →
  • Withdrawn NCT NCT07001254

    UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia

    Not yet reported Anjali Sharathkumar Est. completion 2031-12-31 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Not yet recruiting NCT NCT07001397

    Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA

    Not yet reported Peking Union Medical College Hospital 70 participants Est. completion 2027-03-23
    Other conditions: Aplastic Anemias
    View official trial listing →
  • Completed NCT NCT07005466

    Bronchoalveolar Lavage Combined With High-throughput Sequencing Technology

    Nanfang Hospital, Southern Medical University 500 participants Est. completion 2024-12-30 1 site
    Other conditions: Pneumonia
    View official trial listing →
  • Active, not recruiting NCT NCT07015983

    A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

    Not yet reported Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89 participants Est. completion 2032-06-15 97 sites
    Other conditions: Lupus Erythematosus, Systemic, Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT07032337

    Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

    Samsung Medical Center 2985 participants Est. completion 2022-12-31
    Other conditions: Neuromyelitis Optica Spectrum Disorder (NMOSD)
    View official trial listing →
  • Completed NCT NCT07035561

    Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis

    Not yet reported Shereen Medhat Mohammed Elsayed Nassar 30 participants Est. completion 2025-01-31 1 site
    Other conditions: Hypersenstivity Pneumonitis, ILD
    View official trial listing →
  • Not yet recruiting NCT NCT07052981

    Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis

    Not yet reported Guixia Ding 124 participants Est. completion 2027-06-30
    Other conditions: IgA Nephropathy (IgAN), IgAVN
    View official trial listing →
  • Active, not recruiting NCT NCT07071597

    The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome.

    Nanjing Children's Hospital 400 participants Est. completion 2026-12 1 site
    Other conditions: Nephrotic Syndrome, Adolescent, Biopsy
    View official trial listing →
  • Active, not recruiting NCT NCT07080125

    A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis

    Boehringer Ingelheim 2000 participants Est. completion 2033-12-31 1 site
    Other conditions: Interstitial Lung Diseases, Systemic Sclerosis Associated Interstitial Lung Disease
    View official trial listing →
  • Completed NCT NCT07080346

    Upadacitinib for Refractory Behcet's Syndrome

    Not yet reported Liu Tian 27 participants Est. completion 2025-07-08 1 site
    Other conditions: Behcet Syndrome
    View official trial listing →
  • Completed NCT NCT07089420

    ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

    American Laboratory Products Company 121 participants Est. completion 2026-04-15 1 site
    Other conditions: IBD (Inflammatory Bowel Disease), IBS - Irritable Bowel Syndrome, Crohn Disease (CD), UC - Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT07092865

    A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

    Not yet reported GlaxoSmithKline 168 participants Est. completion 2027-07-16 38 sites
    Other conditions: Respiratory Syncytial Virus Infections
    View official trial listing →
  • Active, not recruiting NCT NCT07098897

    To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

    Not yet reported The Affiliated Hospital of Xuzhou Medical University 150 participants Est. completion 2025-09-30 1 site
    Other conditions: IgA Nephropathy (IgAN)
    View official trial listing →
  • Enrolling by invitation NCT NCT07102849

    Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study

    National Heart, Lung, and Blood Institute (NHLBI) 1400 participants Est. completion 2030-07-11 1 site
    Other conditions: Bone Marrow Failure Disorders, VEXAS Syndrome, Hemoglobinurea, Paroxysmal, Myelodysplastic Syndromes, Bone Marrow Diseases
    View official trial listing →
  • Enrolling by invitation NCT NCT07113743

    Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2029-09-01 1 site
    Other conditions: Chronic Granulomatous Disease (CGD)
    View official trial listing →
  • Completed NCT NCT07114016

    Efficacy of Topical Glucosamine Versus Corticosteroid in Oral Lichen Planus

    Not yet reported Future University in Egypt 36 participants Est. completion 2025-07-31 1 site
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Not yet recruiting NCT NCT07172945

    Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

    Not yet reported Assistance Publique - Hôpitaux de Paris 4500 participants Est. completion 2040-11
    Other conditions: Crohn, Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease)
    View official trial listing →
  • Not yet recruiting NCT NCT07194057

    "A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Reference Network"

    Instituto de Investigación Hospital Universitario La Paz 200 participants Est. completion 2028-01 4 sites
    Other conditions: Transplant Complication, Kidney Transplant, Liver Transplant
    View official trial listing →
  • Not yet recruiting NCT NCT07203664

    Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

    Not yet reported Hospital Universitario La Paz 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT07219121

    Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

    Not yet reported Travere Therapeutics, Inc. 20 participants Est. completion 2027-05 8 sites
    Other conditions: Proteinuria, Immunoglobulin A (IgA) Nephropathy, Focal Segmental Glomerulosclerosis, Kidney Transplant
    View official trial listing →
  • Completed NCT NCT07235813

    IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy

    Not yet reported Kasr El Aini Hospital 16 participants Est. completion 2025-10-01 1 site
    Other conditions: Mycosis Fungoides
    View official trial listing →
  • Completed NCT NCT07239128

    Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus

    Not yet reported University of Seville 160 participants Est. completion 2025-06-01 2 sites
    Other conditions: Dry Eye Disease (DED)
    View official trial listing →
  • Not yet recruiting NCT NCT07248644

    Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission

    Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 304 participants Est. completion 2027-09
    Other conditions: Ulcerative Colitis (UC)
    View official trial listing →
  • Active, not recruiting NCT NCT07262437

    Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles

    Not yet reported University of Milan 220 participants Est. completion 2026-07-01 3 sites
    Other conditions: Uveitis Posterior Non-Infectious, Inflammation Eye, Uveitis, Uveitis, Anterior
    View official trial listing →
  • Not yet recruiting NCT NCT07297550

    Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia

    Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 42 participants Est. completion 2027-07-01
    Other conditions: Severe Aplastic Anemia, Refractory Aplastic Anemia, Newly Diagnosed Aplastic Anemia
    View official trial listing →
  • Enrolling by invitation NCT NCT07309588

    Hyaluronic Acid in the Treatment of Hyposalivation

    Not yet reported, Not yet reported Poznan University of Medical Sciences 100 participants Est. completion 2026-01-19 1 site
    Other conditions: Xerostomia Due to Hyposecretion of Salivary Gland
    View official trial listing →
  • Not yet recruiting NCT NCT07319793

    Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

    Not yet reported Peking University People's Hospital 200 participants Est. completion 2028-06-30
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS)
    View official trial listing →
  • Not yet recruiting NCT NCT07325357

    Effect of Pirfenidone on TA Fibrosis

    Not yet reported Shanghai Zhongshan Hospital 92 participants Est. completion 2030-12-31
    Other conditions: Takayasu Arteritis
    View official trial listing →
  • Not yet recruiting NCT NCT07329959

    CAR-DC for End-Stage IPF

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 8 participants Est. completion 2029-02-28
    Other conditions: Idiopathic Pulmonary Fibrosis(IPF)
    View official trial listing →
  • Not yet recruiting NCT NCT07338422

    HID-HSCT Versus IST as First-line Treatment for SAA

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 116 participants Est. completion 2030-09-14
    Other conditions: Aplastic Anaemia
    View official trial listing →
  • Completed NCT NCT07343401

    Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development

    Alexandria University 40 participants Est. completion 2026-01-01 1 site
    Other conditions: Sarcoidosis Lung
    View official trial listing →
  • Enrolling by invitation NCT NCT07343661

    Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

    Not yet reported Azienda Ospedaliero Universitaria di Cagliari 90 participants Est. completion 2028-09-30 1 site
    Other conditions: EGPA - Eosinophilic Granulomatosis With Polyangiitis, Severe Asthma, Eosinophilic Asthma
    View official trial listing →
  • Not yet recruiting NCT NCT07345000

    A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

    Not yet reported Qilu Pharmaceutical Co., Ltd. 210 participants Est. completion 2030-08
    Other conditions: Treatment-naïve Severe Aplastic Anemia
    View official trial listing →
  • Not yet recruiting NCT NCT07354503

    Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

    The Children's Hospital of Zhejiang University School of Medicine 300 participants Est. completion 2028-06-30
    Other conditions: IgAVN, IgA Vasculitis
    View official trial listing →
  • Not yet recruiting NCT NCT07364123

    Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE)

    Not yet reported University of Gaziantep 60 participants Est. completion 2026-08-15 1 site
    Other conditions: Kidney Transplantation, Medication Non-Adherence, Immunosuppressive Therapy, Renal Transplant Recipients
    View official trial listing →
  • Not yet recruiting NCT NCT07380659

    Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 18 participants Est. completion 2027-02-28 1 site
    Cardiovascular disease Other conditions: Cardiogenic Shock
    View official trial listing →
  • Not yet recruiting NCT NCT07382375

    AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection

    Not yet reported Nanjing Medical University 300 participants Est. completion 2027-12-31 8 sites
    Other conditions: Aortic Aneurysm and Dissection
    View official trial listing →
  • Completed NCT NCT07415083

    A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia

    Novartis Pharmaceuticals 13 participants Est. completion 2025-02-25 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT07430449

    The Effect of Education Given According to Roy's Adaptation Model

    Not yet reported Trakya University 78 participants Est. completion 2025-06-15 1 site
    Chronic kidney disease Other conditions: Immunosuppressive Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07431775

    Saphnelo Use in Females of Child-bearing Potential

    AstraZeneca 26000000 participants Est. completion 2032-03-31
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Not yet recruiting NCT NCT07447388

    Development, Pilot Testing and Evaluation of the Effectiveness of Immunosuppressive Medication Adherence Care Bundle in Patients Undergoing Solid Organ Transplantation

    Not yet reported Hacettepe University 100 participants Est. completion 2027-04-01
    Other conditions: Transplant Patients
    View official trial listing →
  • Not yet recruiting NCT NCT07448363

    Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

    Caja Costarricense de Seguro Social 50 participants Est. completion 2031-05 1 site
    Other conditions: Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema), Atopic Dermatitis Patients, Atopic Dermatitis / Eczema, Atopic Dermatitis, Unspecified
    View official trial listing →
  • Not yet recruiting NCT NCT07471165

    A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT)

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 25 participants Est. completion 2029-07-01 2 sites
    Other conditions: Locally Advanced Perihilar Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT07473752

    A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects

    Not yet reported Tonix Pharmaceuticals, Inc. 26 participants Est. completion 2024-02-22 1 site
    Other conditions: Phase 1 First-in-human Study Involving Healthy Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT07486206

    Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

    Not yet reported Hospital de Granollers 152 participants Est. completion 2027-09-30 1 site
    Other conditions: Interstitial Lung Disease (ILD), Fibrotic Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis, Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)
    View official trial listing →
  • Not yet recruiting NCT NCT07505576

    Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

    Assiut University 96 participants Est. completion 2027-10-01
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Active, not recruiting NCT NCT07519005

    Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

    Not yet reported Xijing Hospital 1 participants Est. completion 2026-12-31 1 site
    Other conditions: Hepatic Failure
    View official trial listing →
  • Not yet recruiting NCT NCT07543640

    EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.

    Not yet reported Eman Raafat Said 56 participants Est. completion 2026-08
    Other conditions: Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis
    View official trial listing →
  • Active, not recruiting NCT NCT07555106

    Dapagliflozin in Living-Donor Kidney Transplant Recipients

    Not yet reported University of Guadalajara 54 participants Est. completion 2026-09-30 1 site
    Other conditions: Kidney Transplant, Kidney Transplant Failure
    View official trial listing →
  • Enrolling by invitation NCT NCT07564609

    the REMONO-CD and the REMONO-UC Studies

    University Hospital, Clermont-Ferrand 420 participants Est. completion 2026-10 18 sites
    Other conditions: Crohn Disease (CD), Ulcerative Colitis (UC)
    View official trial listing →
  • Not yet recruiting NCT NCT07570433

    HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial

    Not yet reported Oriol Manuel 100 participants Est. completion 2028-03 4 sites
    Other conditions: CMV Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07572695

    Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12
    Other conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/Refractory
    View official trial listing →
  • Active, not recruiting NCT NCT07597733

    Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy

    Not yet reported Sichuan Academy of Medical Sciences 76 participants Est. completion 2027-08-31 1 site Stand-alone
    Other conditions: Refractory Chronic Inflammatory Demyelinating Polyneuropathy
    View official trial listing →
  • Not yet recruiting NCT NCT07638709

    Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases

    Xiangya Hospital of Central South University 150 participants Est. completion 2030-06-01 1 site
    Other conditions: Non Small Cell Lung, Brain Metastasases
    View official trial listing →
  • Not yet recruiting NCT NCT07642297

    TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)

    Fondazione Policlinico Universitario Campus Bio-Medico 20 participants Est. completion 2028-09-01 1 site
    Other conditions: Systemic Sclerosis (SSc), Diffuse Cutaneous Systemic Sclerosis, Skin Fibrosis
    View official trial listing →
  • Not yet recruiting NCT NCT07643038

    Treatment Strategy for Patients With RA-ILD

    Not yet reported Chinese SLE Treatment And Research Group 204 participants Est. completion 2029-07-31 22 sites
    Other conditions: Rheumatoid Arthritis Associated Interstitial Lung Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07643103

    Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 32 participants Est. completion 2030-05-31
    Other conditions: Ph- Acute Lymphoblastic Leukemia (Ph-ALL)
    View official trial listing →
  • Completed NCT NCT07662265

    Tocilizumab in Refractory ASS-ILD

    Hu Yinan 111 participants Est. completion 2025-10-31 1 site
    Other conditions: Antisynthetase Syndrome, Tocilizumab
    View official trial listing →
  • Not yet recruiting NCT NCT07682350

    SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial

    Not yet reported Odense University Hospital 184 participants Est. completion 2029-10-01 3 sites
    Other conditions: Kidney Transplant Recipient, Sodium Glucose Co-Transporter 2 Inhibitors, Non-Diabetic Patients, Randomized Controlled Trial (RCT), Placebo Control Design, Post Transplant Diabetes Mellitus
    View official trial listing →
  • Not yet recruiting NCT NCT07715565

    Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

    Not yet reported West China Hospital 66 participants Est. completion 2029-12 1 site
    Other conditions: Renal Cell Carcinoma (Kidney Cancer), Immunotherapy, Molecular Targeted Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07717060

    Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60 participants Est. completion 2028-09-01
    Other conditions: Systemic Sclerosis, Pulmonary Arterial Hypertension, Digital Ulcers, Vascular Complications
    View official trial listing →
  • Not yet recruiting NCT NCT07718633

    Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)

    Not yet reported Natera, Inc. 750 participants Est. completion 2031-07
    Other conditions: Kidney Transplant, Immunosuppresion
    View official trial listing →
  • Completed NCT NCT07728604

    Effect of Digital Follow-up Supported Patient Education on Immunosuppressive Medication Adherence and Quality of Life After Liver Transplantation

    Not yet reported Cansu Yıldız 48 participants Est. completion 2026-06-20 1 site
    Other conditions: Liver Transplantation, Medication Adherence
    View official trial listing →
  • Not yet recruiting NCT NCT07731672

    Incidence of Tuberculosis in Patients With Autoimmune Rheumatic Diseases

    Not yet reported University of Sao Paulo General Hospital 1660 participants Est. completion 2031-07-30 1 site
    Other conditions: Autoimmune Rheumatic Diseases, Prevention
    View official trial listing →
  • Enrolling by invitation NCT NCT07735650

    Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation

    Not yet reported Chang Gung Memorial Hospital 60 participants Est. completion 2027-07-31 1 site
    Other conditions: Liver Transplantation, Liver Transplantation in Long-term
    View official trial listing →
  • Not yet recruiting NCT NCT07736612

    A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Zhejiang University 80 participants Est. completion 2029-12-30 1 site
    Other conditions: Pancreatic Cancer, RAS Mutations or Amplifications
    View official trial listing →
  • Not yet recruiting NCT NCT07737249

    Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease

    Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2027-08-31 1 site
    Other conditions: Interstitial Lung Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT07743047

    Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality

    IRCCS San Raffaele 65 participants Est. completion 2030-12-31
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Not yet recruiting NCT NCT07762703

    Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

    Not yet reported, Not yet reported BreakBio Corp 10 participants Est. completion 2030-09 1 site
    Other conditions: Triple-Negative Breast Cancer (TNBC)
    View official trial listing →
  • Not yet recruiting NCT NCT07762716

    Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

    Not yet reported, Not yet reported BreakBio Corp 10 participants Est. completion 2030-09 1 site
    Other conditions: Glioblastoma (GBM)
    View official trial listing →
  • Not yet recruiting NCT NCT07765914

    Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome

    Not yet reported Children's Hospital of Fudan University 120 participants Est. completion 2028-12-31 9 sites
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT07773623

    An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory Uveitis

    Not yet reported Tianjin Medical University 30 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Not yet recruiting NCT NCT07785128

    Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA Nephropathy

    Not yet reported Shaheed Suhrawardy Medical College and Hospital 104 participants Est. completion 2027-08-31 3 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Not yet recruiting NCT NCT07786922

    A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment

    Not yet reported, Not yet reported Swedish Orphan Biovitrum 26 participants Est. completion 2029-12-31
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Enrolling by invitation NCT NCT07813416

    The mHTX APP Program

    Not yet reported University of Aarhus 200 participants Est. completion 2027-12-01 1 site
    Other conditions: Rehabilitation, Follow up
    View official trial listing →
  • Active, not recruiting NCT NCT07825207

    Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms

    Fondazione Italiana Sindromi Mielodisplastiche-ETS 100 participants Est. completion 2027-07-31 26 sites
    Other conditions: Myelodysplastic Neoplasm, Myelodysplastic Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07833163

    Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.

    Not yet reported Peking University People's Hospital 60 participants Est. completion 2029-09 1 site
    Other conditions: Behçet's Syndrome, Behçet's Syndrome (BS)
    View official trial listing →
  • Not yet recruiting NCT NCT07836790

    A Randomized, Double-Blind, Placebo-Controlled Trial of Fufei Huazhuo Tongluo Formula Combined With Standardized Medicine in Patients With Anti-Synthetase Syndrome-Associated Interstitial Lung Disease

    Not yet reported First People's Hospital of Hangzhou 54 participants Est. completion 2028-12-31 1 site
    Other conditions: Anti-Synthetase Syndrome, Interstitial Lung Disease (ILD)
    View official trial listing →
  • Not yet recruiting NCT NCT07844200

    The Primary Objective of the Trial is to Evaluate the Effect of the Addition of Belantamab Mafodotin to Standard of Care Therapy on the Titres of Serum Anti-dsDNA Antibodies in Patients With Previously Treated SLE.

    Not yet reported Medical Association for the Study of Cancer Biology and Treatment 12 participants Est. completion 2031-12
    Other conditions: SLE - Systemic Lupus Erythematosus
    View official trial listing →
  • Not yet recruiting NCT NCT07846943

    Epstein-Barr Virus Antibodies in Egyptian Patients With Multiple Sclerosis

    Assiut University 140 participants Est. completion 2027-11
    Other conditions: Multiple Sclerosis, Epstein-Barr Virus Infections, Epstein-Barr Virus (EBV) Infection
    View official trial listing →
  • Completed NCT NCT07850362

    Clinical Study of UC-MSC Combined With Immunosuppressive Agents in the Treatment of Pediatric HAAA

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 20 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Hepatitis-associated Aplastic Anemia, Severe Aplastic Anemia(SAA), Umbilical Cord Blood, Mesenchymal Stem Cells, Pediatric
    View official trial listing →
  • Completed NCT NCT07851142

    The Effect of the 5th Sign Intervention on Medication Adherence in Kidney Transplant Recipients

    Not yet reported Dokuz Eylul University 100 participants Est. completion 2025-12-31 1 site
    Other conditions: Kidney Transplant, Drug-Related Side Effects and Adverse Reactions (MeSH Term), Medication Adherence, Mobile Applications
    View official trial listing →
  • Not yet recruiting NCT NCT07858201

    Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression

    Not yet reported University Hospital, Montpellier 190 participants Est. completion 2028-10-01
    Other conditions: Human Papillomavirus Infection, Anal HPV Infection, Human Papillomavirus 16 Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07859839

    Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 177 participants Est. completion 2027-07-31 1 site
    Other conditions: Interstitial Lung Disease
    View official trial listing →
  • Completed NCT NCT07884084

    Effect of Probiotics on Immunosuppressant Therapy in Kidney Transplant Recipients

    Not yet reported Federico II University 40 participants Est. completion 2025-10-03 1 site
    Other conditions: Kidney Transplantation, Kidney Transplantation Recipients
    View official trial listing →
  • Not yet recruiting NCT NCT07893691

    Microbiota Changes Related to Outcomes in Kidney Transplantation

    Hospices Civils de Lyon 30 participants Est. completion 2029-01-15 1 site
    Other conditions: End-stage Renal Disease (ESRD), Kidney Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT07897968

    GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors

    Not yet reported Universität Münster 30 participants Est. completion 2032-12-31 1 site
    Obstructive sleep apnea Other conditions: Neuroblastoma (NBL), Ewing Sarcoma
    View official trial listing →
  • Not yet recruiting NCT NCT07901764

    MYTP01 for Immune-Mediated Diseases

    Not yet reported Zhejiang Provincial People's Hospital 160 participants Est. completion 2028-12 1 site
    Other conditions: IgA Nephropathy, Kidney Transplant Recipients, Lupus Nephritis, Primary Membranous Nephropathy, ANCA-associated Vasculitis, Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA), Sjogren's Syndrome, Hashimoto Thyroiditis
    View official trial listing →
  • Completed NCT NCT07903649

    A Randomized, Controlled Clinical Study on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Combined With Standard Immunosuppressants in the Treatment of Children With Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 64 participants Est. completion 2026-04-20 1 site
    Other conditions: Sever Aplastic Aneia, Children, Umbilical Cord Mesenchymal Stem Cells
    View official trial listing →
  • Completed NCT NCT07910526

    Umbilical Cord Mesenchymal Stem Cell Secretome in Patients With Sjogren's Syndrome

    Not yet reported, Not yet reported Universitas Sebelas Maret Hospital 29 participants Est. completion 2026-10-20 2 sites
    Other conditions: Sjogren's Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07927400

    An Exploratory Study of the Efficacy and Safety of SBRT Following Induction Therapy With Neoadjuvant Immunotherapy Combined With Chemotherapy in Muscle-Invasive Bladder Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 36 participants Est. completion 2030-12-01
    Other conditions: Muscle-invasive Bladder Cancer
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.